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Abstract 
 
ENU mutagenesis screening is a phenotype-driven approach to identify genes 
in a nonbiased manner. Through this approach we identified a previously 
uncharacterised gene, Hnrpll, which is involved in nascent mRNA alternative splicing. 
Thunder strain carries a point mutation in the Hnrpll gene (407T->A) in its first RNA 
recognition motif (RRM) which changes it function in regulating nascent mRNA 
alternative splicing.  
 
One of Hnrpll target genes is CD45 that undergoes alternative splicing in T 
cells depending on their development stages and activation status. We demonstrated 
that Hnrpllthu/thu T cells fail to silence 3 variable exons of CD45 and result in 
constitutive expression of CD45RA, B, and C epitopes on the cell surface. Retroviral 
based expression of wild-type Hnrpll cDNA in the Hnrpllthu/thu T cells compensates 
the effects of loss of function in the mutation. The mutated RRM1 domain remains the 
ability to bind the regulatory element of activation responsive sequence (ARS) within 
CD45 pre-mRNA but cripples the protein function by destabilising the proteins to 
unfold in a thermolible sensitive manner. 
 
We also found that Hnrpllthu/thu mutation disrupts peripheral T cell subsets. 
Thunder mice have normal T cell development in the thymus but specifically lost 
naïve T cells in the peripheral lymphoid tissues, whereas memory T cells are not 
affected. Hnrpllthu/thu naïve T cells can homeostatically proliferate but fail to persist for 
a long term in vivo, suggesting that thunder mutation influences naïve T cell longevity. 
 
                                                                                                                     
We observed that Hnrpllthu/thu naïve T cells express lower level of IL-7Ra and lower 
Bcl-2, together with the stronger pro-apoptotic BimS isoform due to alternative 
splicing. This highlights the nonredundant role of the Hnrpll gene in regulating 
peripheral T cell homeostasis.  
 
CD45 isoforms are widely used markers to distinguish naïve and memory T 
cell subsets. CD45 splicing does not account for the loss of naïve T cells in the 
thunder mice, however, CD45RABC shows stronger phosphatase activity than 
CD45RO when the amount of CD45 is dramatically reduced to 5% remaining on T 
cell surface, suggesting jointly regulation of CD45 catalytic activity by its expression 
and alternative splicing. 
 
Immunological memory is the hallmark of the adaptive immune system. 
Through Affymetrix mouse all exon arrays, we found that hnRNP LL protein plays a 
critical role in controlling an extensive program of alternative splicing as naïve T cells 
differentiate to the memory cell fate. It acts as an either trans- or cis- acting factor in 
regulating multiple nascent mRNA alternative splicing. This study provides an 
unprecedented insight into the extent of alternative splicing in the generation of 
immune memory. 
 
Contents 
Chapter 1: Introduction-----------------------------------------------------------------------1 
1.1    ENU mutagenesis to screen immune regulators----------------------------------2 
1.1.1   Genomic approaches to identify immune regulatory genes-------------3 
1.1.2   ENU mutagenesis-------------------------------------------------------------4 
1.1.3   Phenotype screening in immune system-----------------------------------6 
1.1.4   Spectrum of ENU-induced mutations--------------------------------------8 
1.1.5   Mapping and sequencing of ENU induced mutations-------------------9 
1.1.6   Recent progresses and future prospects----------------------------------10 
1.2   T cell development-------------------------------------------------------------------12 
1.3   T cell activation and differentiation -----------------------------------------------22 
1.3.1   TCR signal pathways in T cell activation--------------------------------23 
1.3.2   Differentiation of activated T cells---------------------------------------24 
1.3.3   Memory T cells--------------------------------------------------------------27 
1.4   T cell longevity and homeostasis --------------------------------------------------32 
1.4.1   Homeostasis: balance of production and loss, survival and death----32 
1.4.2   Factors influencing T cell homeostasis-----------------------------------32 
1.4.3   Life and death of peripheral T cells---------------------------------------39 
1.4.4   Survival signalling in naïve T cells---------------------------------------41 
1.5   Pre-mRNA alternative splicing ----------------------------------------------------43 
1.5.1   Regulation of alternative splicing-----------------------------------------44 
1.5.2   CD45 alternative splicing--------------------------------------------------52 
1.5.3   Apoptosis controlled by alternative splicing----------------------------61 
1.6   Focus of this thesis-------------------------------------------------------------------68 
Chapter 2: Material and methods---------------------------------------------------------70 
2.1   Mice------------------------------------------------------------------------------------71 
2.2   Flow cytometry-----------------------------------------------------------------------73 
2.3   Genome mapping and sequencing-------------------------------------------------75 
2.4   RT-PCR and real time PCR---------------------------------------------------------87 
2.5   Retrovirus based gene transfer-----------------------------------------------------91 
2.6   In vitro culture------------------------------------------------------------------------98 
2.7   Adoptive cell transfer----------------------------------------------------------------98 
2.8   All exon array-------------------------------------------------------------------------99 
Chapter 3: Immunological characterization of thunder trait: Loss of naive T cells 
and aberrant pre-mRNA alternative splicing----------------------------101 
Introduction---------------------------------------------------------------------------102 
3.1    Screening and identification of the thunder strain------------------------104 
3.2    Thunder mutation encodes a recessive trait that involves the loss of naive 
T cells in the peripheral lymphoid tissues----------------------------------105 
3.3    Aberrant CD45 pre-mRNA alternative splicing---------------------------108 
3.4    Discussion ---------------------------------------------------------------------111 
3.5    Chapter Summary ------------------------------------------------------------116 
Chapter 4: Identification of thunder mutation in a novel gene Hnrpll-----------117 
Introduction---------------------------------------------------------------------------118 
4.1 Genome mapping and sequencing thunder mutation----------------------118 
4.2   Hnrpll is a novel pre-mRNA alternative splicing regulator--------------122  
4.3   Thunder mutation destabilizes RRM1 domain of hnRNP LL protein--124 
4.4   Hnrpll expression in lymphocyte subsets-----------------------------------125 
4.5   Discussion ----------------------------------------------------------------------126 
4.6   Chapter Summary -------------------------------------------------------------131 
Chapter 5: Defective T cell homeostasis resulting from Hnrpllthu/thu mutation--133 
Introduction--------------------------------------------------------------------------134 
5.1   Defective T cell homeostasis in thunder mice: failure in persistence 
5.1.1   Normal T cell proliferation with  
anti-CD3/anti-CD28 stimulation in vitro----------------------------135 
5.1.2    Normal homeostatic proliferation of Hnrpllthu/thu naïve CD4 and 
CD8 cells with or without MHC restricted peptide presentation in 
irradiated B6 and Tap2 mutant mice---------------------------------135 
5.1.3    Hnrpllthu/thu T cells fail to persist after adoptive 
 transferring in RAG-1null hosts  --------------------------------------138 
5.1.4   Hnrpllthu/thu T cells fail to persist in lymphoreplete hosts ----------139 
5.2     Naive T cells in thunder mice show multiple phenotypic changes  
5.2.1 Lower expression of IL-7R in Hnrpllthu/thu naïve T cells----------141 
5.2.2 Bone marrow chimeras show T cell autonomous defects in  
CD45 splicing and IL-7R expression in naive T cells-------------142 
5.2.3 Normal common γ-chain cytokine receptor-------------------------144 
5.2.4 Change of IL-7R expression is not due to alternative splicing---144 
5.2.5 Lower expression of TCR/CD3 complex and coreceptors -------145 
5.2.6    Increased apoptosis in Hnrpllthu/thu naive T cells ------------------146 
5.3 Investigating the role of CD45 in regulation of  
T cell homeostasis in thunder mice---------------------------------------147 
5.3.1 CD45 reduction in a previous identified  
ENU mutant lochy strain ----------------------------------------------148 
5.3.2 Introducing Hnrpllthu/thu mutation to lochy mouse  
shows similar CD45 splicing defects on T cells -------------------149 
5.3.3 CD45 reduction can not repress the action of thu/thu  
on peripheral T cell numbers -----------------------------------------149 
5.3.4 CD45 splicing isoforms show different phosphatase 
 activities when CD45 is reduced ------------------------------------151 
5.3.5 Effects of thunder mutation on TCR coreceptor and  
IL-7 receptors in Ptprcloc/loc mice ------------------------------------153 
5.4      Discussion--------------------------------------------------------------------154 
5.4.1   Hnrpllthu/thu T cells homeostasis: proliferation vs persistence ----154 
5.4.2   Hnrpllthu/thu naive T cells display multiple cellular phenotypic 
changes ------------------------------------------------------------------156 
5.4.3   CD45 alternative splicing and overall CD45 expression jointly 
modify its phosphatase activity --------------------------------------158 
5.4.4 Interaction of TCR signalling and IL-7 signalling?----------------160 
Chapter 6: Effects of the Hnrpllthu/thu mutation on thymic T cell selection and the 
fate of transgenic T cells in the periphery---------------------------------162 
Introduction --------------------------------------------------------------------------163 
6.1      Normal positive and negative selection ----------------------------------163 
6.2    Different fate of thu/thu clonotype positive and clonotype negative T 
cells in the periphery-------------------------------------------------------166 
6.2.1 Hnrpllthu/thu 1G12+ T cells are maintained normal in the 
peripheral lymphoid tissues---------------------------------------166 
6.2.2 Transgenic TCR restores Hnrpllthu/thu naïve T cells in the 
periphery-----------------------------------------------------------168 
6.3      Discussions------------------------------------------------------------------170 
6.4      Chapter summary-----------------------------------------------------------173 
 
Chapter 7: General discussion------------------------------------------------------------174 
7.1  ENU mutagenesis: a non-biased approach to identify genes important in 
immune cell development, function and homeostasis----------------------175 
7.2  Thunder mutation affects naïve T cell longevity---------------------------177 
7.3  CD45 expression, alternative splicing, and TCR signalling--------------181 
7.4 Interplay of TCR signal and IL-7 signal pathways?------------------------185 
7.5  Preliminary evidence that Hnrpll is a global regulator of  
pre-mRNA alternative splicing in T cells----------------------------------188 
Concluding Remarks----------------------------------------------------------------192 
Reference--------------------------------------------------------------------------------------193 
 
Chapter 1. INTRODUCTION                                           1.1 ENU mutagenesis 
 
 
 
 
~Chapter 1~  
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
1 
Chapter 1. INTRODUCTION                                           1.1 ENU mutagenesis 
 
1.1 ENU mutagenesis to screen immune regulators 
 
The mouse has been an ideal genetic model for a long time, with many elegant 
approaches developed and tremendous resources set up especially since human and 
mouse genomic sequence were revealed. The similarity between mouse and human in 
genetics and biology provides golden opportunities in biomedical research. Among 
these, chemical mutagenesis is a powerful protocol to elucidate genome functions. 
 
Immunity is composed of the innate and the adaptive responses, which are 
different in the speed and specificity of the reaction. The innate immune system 
include physical, chemical, and microbiological barriers and more usually encompass 
the elements of neutrophils, monocytes, macrophages, complement, cytokines, and 
acute phase proteins which provide immediate host defence. Innate response is highly 
conserved across species. It provides important protection against pathogens in simple 
animals and interacts with adaptive immune system in higher animals to facilitate 
more efficient protection. Adaptive immunity is the hallmark of the immune system 
of higher animals, characterised with the immune homeostasis and immune memory. 
The major players are a spectrum of antigen-specific T lymphocytes and B 
lymphocytes composing the immune repertoires whose overall numbers are kept 
constant. Whereas the innate response is rapid but sometimes damages normal tissues 
due to lack of specificity, the adaptive response is precise, but takes several days or 
weeks to develop the primary reaction. However, upon second encountering the same 
antigen, the adaptive response has immune memory to develop more vigorous and 
rapid response, although not immediate (Janeway, C.A. et al. 2006). 
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Despite almost half a century’s of research in cellular and molecular immunology, 
many important questions have not been completely answered. For example, how is 
the number of immune cells so tightly and precisely regulated during the course of 
immune responses?  How does the immune system control the fate of autoreactive 
lymphocytes and resting lymphocytes in unstimulated animals? What controls the 
lifespan of different lymphocyte subsets and contribute to the longevity of memory T 
cells versus naïve T cells? Given the functional complexity of the immune system and 
the fact that there are much larger numbers of proteins than that of the genes encoding 
them because of a process of post-transcriptional modification termed pre-mRNA 
alternative splicing, how does alternative splicing control immune functions? To 
answer these questions, ENU mutagenesis is a powerful approach to provide ideal 
mouse models enabling us to study genes regulating immune functions. 
 
1.1.1     Genomic approaches to identify immune regulatory genes 
 
Two genomic approaches have been widely applied in biomedical researches for 
many years. Gene knock out (KO) technique establishes the base of reverse genetics 
studies by completely or partially deleting target gene(s). It is readily applied to study 
the pattern of the gene expression and the functions of the protein encoded by a 
known gene (Nelms, K.A. & Goodnow, C.C. 2001). One limitation of gene knockout 
approach is the possibility of embryonic lethality in some situations. The gene 
knockout may affect the breeding potential of mice and they may not produce viable 
progeny. On the other hand, some knockout animals show no phenotypes due to 
compensation by other related proteins. Forward genetics based on ENU mutagenesis 
3 
Chapter 1. INTRODUCTION                                           1.1 ENU mutagenesis 
has obvious advantages in identification of immune regulatory genes. Firstly, it is 
very efficient in inducing a mutation in a given locus at the rate of approximately one 
in every 1000 sperm and a spread of point mutations every 1-2 Mb throughout the 
genome (Hitotsumachi S. et al. 1985; Lyon, M. F. & Morris, T. 1966; Beier, D. 2000; 
Chen, Y. et al. 2000; Concepcion, D. et al. 2004; Coghill, E. L. et al. 2002; Kile, B.T. 
and Hilton, D, J. 2005). Secondly, as there is no prior assumption of the roles of a 
gene in a particular trait, it generates non-biased observations. Thirdly, ENU is a 
germline point mutagen and affects single loci with the mutation that can be inherited 
by the offsprings. Most importantly, it generates new alleles of known proteins and 
this may provide further insights into the functional role of a protein in a given 
biological function. 
 
Bruce Beutler’s group and our laboratory have identified a series of ENU 
mutations in novel genes or with novel alleles of known proteins governing different 
aspects of immunity e.g. Myd88, Lps2, CD14, CD36, TLR2, 4, 6, 7, 9, TNF-a etc 
(Hoebe, K. and Beutler, B. 2006; Hoebe K, and Beutler B. 2008.) and ZAP70, Slp76, 
Ikaros, Carma1, p53, NF-kB2 (Jun, J.E. et al. 2003; Miosge, L.A. et al. 2002; 
Papathanasiou, P. et al. 2003; Vinuesa, C.G. et al. 2005; Siggs O.M, et al. 2007; 
reviewed by Cook, M.C. 2006). Details are summarised in table 1.1 and table 1.2.   
 
1.1.2     ENU mutagenesis 
 
N-ethyl-N-nitrosourea (ENU) is a chemical mutagen that causes random point 
mutations in a variety of organisms firstly reported 3 decades ago (Russell, W.L. et al 
1979). The ethyl group can be transferred to some reactive oxygen or nitrogen 
4 
Table 1.1 Identification of TLR-deficient germline mutant mice (Hoebe K, and Beutler B. 2008.) 
Locus Allele Dominant/recessive Mutation characteristic 
Unc93b1 3d Autosomal recessive 1273 T → C transition of the Unc93b1 gene, in exon 9 of 11 total exons 
Cd36 Oblivious Autosomal recessive 1283 T → A transversion of the Cd36 gene. Results in a premature stop codon 
Cd14 Heedless Autosomal recessive 1013 C → T transition of the Cd14 gene, creating a premature stop codon 
Tlr2 Languid Autosomal recessive 487 Asn → Ile of the LRR module in the TLR2 protein 
Tlr4 Lps3 Autosomal codominant 709 Asp → Val of the TLR4 protein, affecting the BB loop of the TIR domain 
Tlr6 Insouciant Autosomal recessive 327 Val → Ala of TLR6 
Tlr7 Rsq1 X-linked recessive 68 Thr → Ile of TLR7, located within the first LRR 
CpG1 Autosomal codominant 499 Leu → Pro of the TLR9 protein (within the sixteenth LRR module of the ectodomain) 
CpG2 Autosomal codominant 985 Gln → Leu of the TLR9 protein, which lies in α-helix D of the TIR domain 
 
 
Tlr9 
CpG3 Autosomal recessive 214 Val → Glu of the TLR9 protein, which lies in the predicted sixth LRR module of the TLR9 ectodomain 
Trif/Ticam-1 Lps2 Autosomal codominant deletion of a G at position 2258, causing a frameshift deleting 24 a.a. and replacing with 11 unrelated amino acids 
pococurante Autosomal recessive 179 Ile → Asn, which exists near the center of the αα-helix of the MyD88 TIR domain   
MyD88 
lackadaisical Autosomal recessive 116 Tyr → Cys of MyD88 in the intermediate domain between the death domain and the TIR domain 
Tirap torpid Autosomal recessive a splice site mutation, the last 6 C-terminal amino acids of Tirap replaced by 3 unrelated residues 
Irak-4 otiose Autosomal recessive 327 Ile → Thr, located in subdomain 7 of the kinase domain, outside of the ATP-binding site 
Tnf Panr1 Autosomal dominant 138 Pro → Thr substitution in one of the α-helical elements and exposed at the surface of the molecule 
Table 1.2 Summary of novel alleles identified through ENU mutagenesis by C.C. Goodnow’s laboratory 
Strain Mutation Gene Phenotype 
Plastic Missense Ikaros T-cell lymphoma (dominant); aplastic anaemia (homozygotes) 
Xander Stop Nfkb2 Reduced follicular B cells; disrupted splenic architecture 
Unmodulated Missense Carma1 Increased IgM on peripheral B cells; defective polysaccharide antibody response; dermatitis and hyper IgE
Sanroque Missense Roquin Lupus; increased TFH
Aire Missense Aire Type 1 diabetes; central tolerence 
Murdock Missense Zap70 Decreased TCR signalling and thymic selection 
Mrtless Missense Zap70 Immune deficiency;  
thunder Missense Hnrpll T cell homeostasis; pre-mRNA alternative splicing 
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radicals of purine or pyrimidine, causing mistaken identity through alkylation of 
nucleic acids and resulting in mispairing during DNA replication in both somatic and 
germ cells (Figure 1.1.1) (Singer, B. and Dosahjh, M.K. 1990). It was recommended 
that an effective 3 ~ 4×100mg/kg dose is tolerated well by several inbred mouse 
strains (Russell, L.B. et al 1982a, 1982b; Justice, M.J. et al 2000). Pre-meiotic 
spermatogonial stem cells have the highest mutation rates with single locus mutation 
frequencies of ~ 1×10-3, about 100 fold higher than spontaneous mutation rate 
(Hitotsumachi, S. et al 1985, Justice, M.J. et al. 1999). After a sterile period of about 
10 weeks, the males regain fertility, allowing males to sire mutant offspring for 
extended period. A dominant trait can be recovered in a single generation with visible 
phenotypes or detectable changes, while recessive trait requires 3 generations 
breeding to pick up the homozygous (Favour, J. & Neuhauser-Klaus, A. 2000, Nelms, 
K.A. & Goodnow, C.C. 2001). 
 
An ENU treated male mouse was bred with wild-type female to generate multiple 
mutation carrying G1 offsprings. Each G1 mouse was used as a founder of a pedigree, 
backcrossed to wild-type, and paired with its G2 daughters potentially carrying the 
same mutation. For a recessive trait we would expect 25% of G3 offspring to be 
homozygous mutants expressing specific phenotypes.  
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Fig. 1.1.1 Top: Chemical structure of ENU. Transferable ethyl group is 
highlighted in red. Bottom: A typical 3 generation screening pedigree for a recessive 
trait. (From Nelms, K.A. and Goodnow, C.C. 2001).  
 
1.1.3     Phenotype screening in immune system 
 
To identify genes involved in lymphocyte development and homeostasis, 
phenotypic screens can be performed routinely on peripheral blood samples. It is a 
convenient cost-efficient method to carry out large scale and high throughput analyses 
on multiple samples.  The success of an ENU screen is underpinned by having a 
reliable and robust screening assay that can be used to measure quantitative and 
qualitative changes in cellular and humoral immunity under steady state conditions or 
following an immunogenic challenge. 
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Flow cytometry analysis (FACS) provides accurate and rapid detection of 
immunological cell populations and expression of both cell surface and intra-cellular 
proteins with a range of fluorescent antibodies (Ab). It is now possible to 
simultaneously measure 12 different cell surface markers with the development of 
new fluorochromes. This multi-parameter approach can identify either qualitative or 
quantitative changes in immune cell development and regulation that affect the 
adaptive and innate immune system. 
 
Enzyme-linked immunosorbance assays (ELISA) can be used to measure changes 
in the basal levels of immunoglobulin isotypes in the serum.  Any changes in basal 
antibody levels could indicate a defect in B cell differentiation. Alternatively ELISA 
assays can be used to measure the production of antigen specific antibodies following 
immunization. Defects in T cell help and/or B cell signalling could influence the 
production of immunoglobulin isotypes and the ability of B cells to undergo isotype 
switching. Finally ELISA assays can be used to measure the presence of auto-
antibodies in the serum that can help identify defects in immune tolerance. Mutations 
that affect tolerance mechanisms could lead to the activation of autoreactive T cells 
and B cells and predispose to the development of systemic autoimmune diseases such 
as systemic lupus erythematosus (SLE) where high affinity antibodies are generated 
to nuclear and cytoplasmic self proteins as well as DNA and RNA.  
 
Once a phenotype is observed, mice carrying the variant phenotypes are used for 
breeding to establish the heritability of the phenotype. When heritability is confirmed, 
further breeding is required to establish the mode of inheritance (dominant or 
7 
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recessive), and then a mapping cross needs to be setup to identify the gene mutation 
which will be discussed later. 
 
1.1.4     Spectrum of ENU-induced mutations 
 
A/T base pairs are the most frequently affected by ENU, with 87% of 62 pre-
meiotic germline mutations (44%A/T->T/A transversions, 38%A/T->G/C transitions, 
5%A/T->C/G transitions) in contrast with only 13% G/C base pairs modified (Justice, 
M.J. et al 1999). This effect is possibly due to alkylated O4- or O2-thymidine. Those 
ENU mutations that have phenotypic effects are 64% missense, 10% nonsense, and 
26% splicing errors. By contrast, spontaneous mutations in mouse germline reporter 
assays show approximately equal chance of A/T and G/C mutation rate, with 38% 
A/T->T/A transversions and 37% G/C->A/T transitions regardless of pre- or post-
meioses (Noveroske, et al. 2000). A/T base pair preference in ENU mutagenesis is 
confirmed by Sakuraba and colleagues. They identified 143 mutations by sequencing 
approximate 200 Mb genomic DNA and found that 67.6% of the mutations hit A/T 
sites, despite 52.7% A/T content in the sequenced region (Sakuraba, Y. et al 2005).  
ENU treatment yields a new loss of function allele in any given gene, on average , 
once per 1000 gametes and therefore screening 10,000 first generation (G1) offspring 
should yield at least one heterozygous loss-of-function mutation in the majority of 
immune regulatory genes (Hitotsumachi, S. et al. 1985, Lyon, M.F. & Morris, T. 
1966).  
 
Recently Barbaric and co-workers assembled published phenotypic screens and 
found that functional ENU mutations tend to be more frequently found in genes that 
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encode large proteins and that contain large numbers of exons.  The majority of ENU 
induced point mutations are located in coding sequence and splice sites, and 
surprisingly, tend to have higher %G+C content (54%) in the coding sequence 
compared to 45% for the average of all genes in the entire genome (Barbaric, I. et al. 
2007). Longer coding length provides a larger target for missense or nonsense 
mutations while more exons means more splice site targets to be mutated, but it is still 
not clear if G+C content in the coding sequence correlates to mutation preference. 
 
1.1.5     Mapping and sequencing of ENU induced mutations 
 
As opposed to the functional mutation spectrum, several groups have reported that 
unselected (underlying) mutation rate induced by ENU ranges from 1 base per 1.9 Mb 
(Coghill, E.L. et al. 2002) to 1 base per 1.0 Mb (Quwailid, M.M. et al. 2004) by DNA 
based screening of 2000-6000 generation 1 (G1) mice. To find the functional point 
mutation, the mouse carrying the variant genes is intercrossed or backcrossed to a 
different inbred mouse strain.  This provides DNA polymorphisms between the 
mutation-bearing chromosomes and those from the mapping partner strain that can be 
distinguished at the molecular level by single nucleotide polymorphisms (SNPs) or 
simple sequence length polymorphism (SSLP) (Silver, L. 1995). Meiotic mapping is 
then used to identify which chromosomal location segregates with the mutant 
phenotype of interest in F2 intercross or N2 backcross offspring. 
 
Mapping normally starts with a genome scan testing 2-3 markers on each 
chromosome in a group of 10-20 phenotypically mutant mice. Theoretically, the more 
frequently a marker is associated with the mutant mice, the closer the mutation is to 
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the loci of the marker. Fine mapping with higher resolution then enables to narrow 
down the chromosome interval by testing more affected mice with a panel of 
molecular markers in the region to find out informative meiotic recombination events. 
The chromosomal linkage is easy to distinguish if the mutant mice have clearly 
different phenotypes from wild type.  
 
Sequencing of genes within an interval to identify the causative mutation must 
take into consideration of the length of the chromosomal interval, the number of 
candidate genes in the region, the availability of extra polymorphic markers, and the 
likelihood of more recombinations. Candidate genes can be picked up by checking if 
the function of the gene in the interval or its family members in the same biochemical 
pathway is associated with a similar phenotype, or by lymphocyte-specific expression 
pattern of the gene. Given the fact that most ENU mutations identified so far locate in 
protein coding region or exon-intron boundaries, it is efficient to sequence only these 
regions. 
 
1.1.6     Recent progresses and future prospects 
 
Whole-animal vs. ES mutagenesis, Phenotype-driven vs. gene-driven screen: 
 
As an alternative to whole-animal ENU mutagenesis, chemical treatment with 
ENU or ethylmethane sulfonate (EMS) of embryonic stem (ES) cells provides an 
alternative way to generate mutations in genes of interest. This enables a gene-driven 
dissection of gene functions, as opposed to a phenotype driving strategy. Cultured ES 
cells can be inexpensively screened for phenotypes,  although this is limited to those 
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processes that can be interrogate in tissue culture and to heterozygous defects (Chen, 
Y. et al 2000, Munroe, R.J. et al 2000, Vivian, J.L. et al 2002).  
 
Insertional mutagenesis and gene trapping: 
 
The majority of ENU mutations are single base pair substitution, with a few small 
deletions reported (Shibuya, T. and Morimoto, K. 1993), while insertional 
mutagenesis provides an alternative by interrupting gene function through integration 
with plasmid or retroviral constructs. Transposon-mediated mutagenesis has been 
achieved in mouse ES cells and in the mouse germline (Luo,G. et al 1998; Ivics, Z. & 
Izsvák, Z. 2005; Ding, S. et al. 2005). However, this approach has specific 
requirements such as transgenic mice able to harbour mobile elements like 
transposons and limited expression of transposonase in the sperm stem cells and their 
progeny. The mutation is then tagged with a transposon, so that it is easier to identify 
the insertionally mutated gene by inverse PCR (polymerase chain reaction). Like 
knockout mice, transposon mutagenesis creates primarily null alleles, as opposed to 
the missense mutations in discrete domains typically resulting from ENU mutagenesis. 
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1.2 T cell development 
 
B and T lymphocytes play the major role in the adaptive immune system of 
mammals. Despite similarities between the two populations, they are distinct in many 
biological aspects. Contrasted with B cell’s continual production in the bone marrow 
(BM) throughout the life, mature T cells are generated in the thymus in large numbers 
in the juvenile and kept in a relatively constant level after the thymus involutes by 
homeostatic division of mature T cells in adults. Although the T cell and B cell 
progenitors  both originate from common lymphoid progenitor cells in the bone 
marrow, T and B cells undergo rearrangements of the antigen receptor genes that 
allows them to express a clone specific receptor and during their development the 
receptors are tested for binding to self antigens and depending on the affinity of the 
receptor for self antigens these cells will be allowed to finish their maturation known 
as positive selection, or alternatively cells with a receptor with high affinity for self 
antigens will be induce to die through a process termed negative selection. The work 
presented in this thesis will focus on T cell development, particularly αβ T cells. 
 
Immature T cells follow a well-defined programme of development in the thymus 
characterised by the expression of a variety of specific cell surface molecules driven 
by T-cell antigen receptor (TCR) gene rearrangement. The change in surface marker 
expression includes the TCR:CD3 antigen receptor complex and CD4 and CD8 co-
receptors (Figure 1. 2.1). 
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Haematopoietic progenitor cells that migrate from the bone marrow and enter the 
thymus express c-kit (CD117, receptor for stem cell factor SCF), CD127 (interleukin-
7 receptor α chain, IL-7Rα), and lack rearranged TCRs and T cell co-receptors CD4 
and CD8.  On colonizing the thymus they are termed CD4-CD8- double negative cells 
(DN) (Ciofani, M, and Zúñiga-Pflücker J.C. 2007). They represent approximately 5% 
total thymocytes and give rise to the major subset of αβ T cells and the minor subset 
of γδ T cells. DN cells begin to express T cell specific molecule Thy1 in mouse about 
one week after their relocation in the thymus and interaction with thymic stroma. 
Thy1+ DN cells can be subdivided into four phases on the basis of the expression of 
adhesion molecule CD44 and Interleukin-2 receptor α chain, CD25: DN1, CD44hi 
CD25-; DN2, CD44hi CD25+; DN3, CD44lo CD25+; DN4, CD44lo CD25-. DN3 
cells lose expression of kit and start to rearrange TCRβ chain (Jackson AM, and 
Krangel MS. 2006; Zediak VP, et al. 2005). Only those making productive TCRβ 
chain rearrangement can survive and proceed to DN4. DN4 cells subsequently 
become immature single-positive (ISP) cells that transiently express small amounts of 
CD8. The importance of immature single-positive cells is unclear, but it seems that 
most cells rapidly upregulate CD4 and enter the next stage of double-positive (DP) 
CD4+CD8+ population that constitutes the majority of thymocytes (Hayday, A.C. and 
Pennington, D.J. 2007). 
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Figure 1.2.1 Schematic view of T cell development within the thymus. 
 
The rearranged TCRβ chain initially pairs with the pre-T-cell receptor α chain 
(pTα), forming a complete pre-TCR that associates with CD3 as a complex expressed 
at the cell surface. Signals from the pre-TCR/CD3 complex lead to cell proliferation 
and expression of both CD4+ and CD8+ coreceptors to become CD4+CD8+, double 
positive ( DP) cells. At this point the TCRα chain locus undergoes rearrangement and 
only if the rearrangement is productive can a mature TCRαβ receptor be formed.  DP 
cells stop proliferating and become small resting DPs, initially with low TCR 
expression at the cell surface. 
 
Pre-TCRαβ serves as a surrogate for TCRα at an early stage of thymocyte 
development (DN3) before rearrangement at the TCRα locus. pTα has only a single 
extracellular Ig-domain without the variable region and a larger cytoplasmic domain 
in contrast with mature TCRα, which are associated with pre-TCR signalling 
(Groettrup M, et al. 1993; Saint-Ruf C, et al. 1994; Borowski C, et al. 2004; Aifantis I, 
et al. 2002). Structural models of pre- TCRαβ and TCRαβ are shown in Figure 1.2.2.  
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Figure 1.2.2 Structure models of pre-TCR and TCRαβ.  
Heterodimeric pre-TCR and TCRαβ both have conserved transmembrane 
regions with charged basic residues highlighted (R in blue and K in green). Pre-Tα 
has a single extracellular Ig fold domain whereas TCRαβ has two Ig domains. The 
larger cytoplasmic domain of pTα is not shown here (Call, M.E. & Wucherpfenning, 
K.W. 2005). 
 
In accordance with its extracellular structure, pre-TCR signalling is mediated by 
ligand-independent oligomerisation of pre-Tα chains, leading to constitutive 
internalisation of the pre-TCR complexes (Irving, B.A. et al. 1998; Yamasaki, S. et al. 
2006). It then induces transient expression of the transcription factor Egr3 (Early 
growth response gene 3) which is a member of Egr family and leads to the 
upregulation of Id3, a RORγt (orphan nuclear hormone receptor RORγt) inhibitor. 
This results in a rapid proliferation and expression of CD4, CD8 coreceptors on the 
thymocytes. Transient expression of Egr3 establishes a period of proliferation in 
response to pre-TCR signals by inhibition of RORγt expression and RORγt function 
(Xi, H. et al. 2006). RORγt is an isoform of RORγ that is predominantly expressed in 
lymphocyte compartment and lymphoid tissue inducer cells. It promotes survival and 
inhibits proliferation of DP thymocytes (Shao, H. et al. 1997; He, Y.W. et al. 1998; 
2002; Sun, Z. et al. 2000). E2A, a member of E proteins that are basic helix-loop-
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helix (bHLH) containing transcriptional regulators, encodes both E12 and E47 
isoforms and is inhibited by Egr1 (Bain, G. et al. 1997, 1999, 2001). E proteins can 
positively regulate RORγt expression, resulting in cell cycle arrest, TCRα gene 
rearrangement and survival of resting DP cells by inducing expression of Cpeb4, 
RAG-2 and Bcl-XL, respectively (Xi, H. et al. 2006; Moisge, L. & Zamoyska, R. 
2007). Signal transduction by the pre-TCR is shown in figure 1.2.3. 
 
 
Figure 1.2.3: pre-TCR signal transduction  
 
Over the last decade, several key transcription factors have been identified playing 
essential roles in pre-TCR responses (Michie, A.M. and Zúñiga-Pflücker J.C. 2002). 
Among them NF-κB and NFAT are essential for mediating pre-TCR signalling and 
thymocyte proliferation and differentiation (Aifantis, I. 2001, 2002, Voll, R.E. 2000) 
as well as their roles in mature T cell activation with TCR stimulation. NFAT and NF-
κB are central coordinators of adaptive immune system with broad roles in regulating 
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gene expression of numerous cell types during proliferation and apoptosis, 
inflammation and tumour genesis (Michie, A.M. and Zúñiga-Pflücker J.C. 2002; 
Karin, M. and Greten, F. R. 2005). Other transcriptional factors include transcription 
factors T cell factor-1 (TCF-1)/lymphocyte enhancer factor-1 (Lef-1) in the Wnt 
pathway via β-Catenin (Staal, F.J. et al. 2001), and Id proteins (Engel, I. and Murre, C. 
2001). 
 
Several studies have highlighted the important role for MAPK signalling in pre-
TCR function on immature thymocytes (Crompton, T. et al. 1996, Swat, 1996, Michie, 
A.M. et al. 1999). It was also shown that E2A and Id3 are regulated by the Ras-ERK 
MAPK cascade (Bain, G. et al. 2001). In addition the pre-TCR can stimulate the 
mobilization of intracellular [Ca2+]i and activation of a similar range of downstream 
effector proteins including NF-κB and NFAT (Aifantis, I. et al. 2001, 2002, Voll, R.E. 
et al. 2000, Sommers, C.L. et al. 2002, Aguado, E. et al. 2002).  
 
Pre-TCR signals inhibit further TCRβ rearrangement through allelic exclusion, 
induce cell proliferation, and drive the thymocytes into DP stage in which the 
majority express mature TCRαβ because of TCRα rearrangement. Most of those do 
not recognize self-peptide:MHC complexes and die from “neglect” in the thymic 
cortex. Those with high affinity TCRs for self-peptide presented by medullary 
epithelial and dendritic cells are deleted by apoptosis. Only those expressing a 
functional TCRαβ receptor with intermediate affinity can survive, undergoing positive 
selection and mature to either CD4+CD8- (MHC II restricted) or CD4-CD8+ (MHC I 
restricted) single positive cells (SP) (Hogquist, K.A. et al. 2005; Holländer G, et al. 
2006; Hayday, A.C. & Pennington, D.J. 2007). 
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TCR signal transduction is critical for clonal selection in the thymus and for 
clonal expansion of antigen-specific cells in the periphery (Davis, M.M. et al., 1998). 
However, TCR molecules have only a very short intracellular domain that is 
insufficient to transmit signals into cytoplasm. TCRαβ expression on T cells depends 
upon the association with CD3γε, CD3δε, and CD3ζζ signalling subunits (Wegener, X. 
et al., 1995; Call, M.E. and Wucherpfenning, K.W. 2005). The intracellular domains 
of the CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) 
that function as the nucleating point for the intracellular signal transduction 
machinery upon TCR ligation to the peptide/MHC complex on antigen presenting 
cells (APCs) (Kane, L.P. et al. 2000). The CD3 δ, γ, and ε chains each contain one 
ITAM, and CD3ζ contains three ITAMs (Figure 1.2.4). 
 
TCR on thymocytes and mature T cells activates three major signalling pathways: 
1. Mitogen activated protein (MAP) kinase pathways (ERK, Jnk, p38); 2. Intracellular 
calcium mobilization [Ca++]I; and 3. Protein kinase C (PKC). TCRαβ stimulation 
activates a cascade of tyrosine phosphorylation which involves: 1. Lck-mediated 
recruitment and activation of ZAP-70/Syk; 2. ZAP-70/Syk-mediated phosphorylation 
of LAT, SLP-76, and PLCγ1; 3. recruitment of adaptor molecules with guanine 
nucleotide exchange proteins to LAT and SLP-76; and 4. subsequent Ca2+ 
mobilization, PKC activation and Ras activation followed by MAPK activation 
(Michie, A.M. and Zúñiga-Pflücker JC. 2002). Figure 1.2.5 shows the current 
understanding of proximal TCR signal transduction. 
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Figure 1.2.4 Structural model of TCR:CD3 complex  
The “anatomy” of αβTCR/CD3 shows extracellular, transmembrane, and 
intracellular regions. The extracellular domains contain TCR variable region which is 
the antigen binding site and constant regions that may have some interaction with 
CD3 extracellular domains. Acidic residues in the CD3 dimer transmembrane regions 
highlighted in red have ionisable interaction with the basic residues in the TCR 
transmembrane residues in blue, which contributes to the formation of the complex. 
The two acidic-one basic electrostatic interactions are the driving forces to form 
TCRαβ:CD3 complex (Kuhns, M.S. et al, 2006). 
 
The fate of a DP cell is dependent on the affinity of the TCRαβ it expresses.  If the 
TCR has no affinity for self-peptide/MHC complexes presented on the surface of 
cortical epithelial cells they will die by neglect. Low –medium avidity of the TCR 
will promote positive selection whereas a high affinity interaction of the TCR with 
self-peptide/MHC results in clonal deletion (Jameson, S.C. et al 1995). Thus in the 
same population of cells the TCR can transmit signals that can lead to distinct 
outcomes, i.e. survival and differentiation or cell death depending on the nature of the 
interaction between the TCR with peptide/MHC ligand. Studies have shown that 
positively and negatively selecting peptides can induce both JNK and p38 signalling 
with similar kinetics. In contrast positive selection leads to a slow but sustained 
activation of ERK signalling, whereas negative selection coincides with a intense and 
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transient burst of ERK signalling which precedes activation of p38 & JNK 
(Bommhardt, U. et al. 2000, Mariathasan, S. 2001). The kinetics of activation of the 
various MAPKs may induce a specific set of transcription factors and this could have 
an important outcome of survival versus apoptosis (Swan, K.A. et al 1995, Alberolla-
Ila, J. et al. 1996, O’Shea, C.C. et al. 1996, Pages, G. et al. 1999, Dower, N.A. et al. 
2000, Rincon, M. et al. 1998 , Sugawara, T. et al. 1998; Dong, C. et al. 2000, Gong, Q. 
et al. 2001, Takagaki, Y. et al. 2001, Mora, A.L. et al. 2001),  
 
Figure 1.2.5 TCR signal transduction pathways  
Following TCR engagement, key transcription factors NF-kB and NFAT are 
activated through intracellular calcium mobilization, MAPK and PKC. This initiates the 
expression of a set of genes including IL-2, resulting in the entry of cell cycle and T 
cell activation (Abraham, R.T. and Weiss, A. 2004). 
 
The linker for activation of T cells (LAT) protein helps to recruit the Grb2 protein 
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 and this in turn help in activation of RAS and ERK signalling.  Mutations in Lat and 
Grb2 or deficiencies in Jnk and p38 can lead to autoimmunity as a result of failure in 
negative selection of autoreactive thymocytes indicating  that each of these signalling 
components downstream of  the TCR play critical roles in negative selection (Genton, 
C. et al. 2006; Salojin, K. et al. 1997; Johnson, G.L. & Lapadat, R. 2002).  The 
transcription factors Nur77 and NOR-1 are both induced in thymocytes in response to 
TCR triggering and calcium mobilization and both appear to be important in clonal 
deletion of autoreactive thymocytes. The expression of a dominant negative version of 
Nur77 blocks thymocyte apoptosis (Calnan, B.J. et al. 1995, Lee, S.T. et al. 1995), 
while transgenic expression of NOR1 in thymocytes leads to unbridled apoptosis 
(Cheng, L.E. et al. 1997).  Bim is a member of the Bcl2 protein family that plays a 
critical role in inducing apoptosis in thymocytes (Marsden, V.S. & Strasser, A. 2003).  
Bim deficient mice have defective negative selection but also mature T cells fail to 
undergo activation induced cell death (Bouillet, P. et al. 2002). 
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1.3 T cell activation and differentiation  
 
Macfarlane Burnet’s clonal selection theory is the central principle of adaptive 
immunity, not only to explain the generation of Ab specificity, but also the fate of T 
cells bearing specific TCRs for antigen. When a naive T cell encounters its specific 
foreign Ag presented by antigen presentation cells (APCs), it is activated and starts to 
proliferate, generating a clone of identical progeny all with the same binding 
specificity. The progeny proliferate and differentiate into effector cells to eliminate 
the Ag. The cell numbers decrease in contract phase and a proportion of the cells 
remain as memory T cells to retain immunological memory. 
 
In contrast with B cells recognizing extra-cellular antigen, T cells detect 
intracellular Ag generated inside infected cells or digested by professional APCs. 
Foreign Ag must be presented to T cells as peptide fragments bound to MHC on the 
surface of APCs, providing the first signal of TCR binding together with the 
costimulatory signals mediated by interactions of CD28 on T cells and CD86/CD80 
on APCs or other co-stimulatory signals. Too strong or too weak signals cause death 
of the T cell. MHC-I molecules collect peptides derived from synthesized protein in 
the cytosol and display fragments of viral proteins on the surface so that they can be 
taken up by cytotoxic CD8 T cells (Pamer, E. & Cresswell, P. 1998; Cresswell, P. et 
al. 2005). MHC-II molecules bind peptides derived from exogenous proteins 
internalized and degraded in intracellular vesicles of macrophages and B cells, and 
present them to CD4 cells (Menéndez-Benito V, Neefjes J. 2007). MHC-I restricted 
Ag cross-presentation of DCs to CD8 T cells provides important pathways in 
maintaining tolerance and protective immunity (Rock, K.L. and Shen, L. 2005). 
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1.3.1. TCR signal pathways in T cell activation 
 
When a mature T cell binds to specific peptide-MHC, co-receptor CD4 or CD8 
clusters to the TCR:CD3 complex. Src family protein tyrosine kinases (PTKs) p56Lck 
and p59Fyn are associated with the cytoplasmic domains of CD4/CD8 and CD3ζ 
chain respectively, and their clustering activates them to phosphorylate the ITAMs of 
CD3 ε and ζ chain. Doubly phosphorylated ITAMs create the docking site for ZAP70 
(ζ chain associated protein kinase of 70 kDa). Lck also activates ZAP70 by 
phosphorylation. Activated ZAP70 then activates signal pathways through PLC-γ, 
GEF, and Tec kinases, and ultimately leads to the induction of new gene synthesis 
including IL-2 by activating transcriptional factors NFκB, NFAT and AP-1 (Gallo, 
E.M. et al. 2007; Sundrud MS, Rao A. 2007). 
 
A wide range of factors can modulate TCR signals. First of all, the affinity of 
peptide-MHC complex binding to TCR determines the signal strength; the antigen 
concentration and the duration of T cell and APC interaction also determine the 
amount of TCR engagement and the duration of signalling respectively (Iezzi G, et al. 
1998; 1999). TCR signal is enhanced by co-receptor CD4/CD8 that binds the same 
ligand of MHC II/MHC I class molecule respectively and initiates Lck tyrosine kinase 
and ITAM (Denny MF, et al. 2000). Costimulatory molecules like B7.1 (CD80) and 
B7.2 (CD86) engage CD28, determining the rate of TCR triggering and signal 
amplification and playing a role in activating NFkB to provoke survival and 
proliferation (Viola A, et al. 1999).  In addition to MHC-TCR signalling, survival of 
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naïve T cells also requires a signal from cytokines, particularly IL-7 (interleukin-7) 
(Schluns, K.S. et al. 2000).  
 
Following T-cell activation, several attenuating mechanisms operate to avoid 
over-activation. The TCR is internalized following ubiquitylation by c-Cbl (Casitas 
B-lineage lymphoma) and Cbl-b and degraded mainly in the lysosome (Wiedemann, 
A. et al. 2005; von Essen, M. et al. 2004). An alternative receptor for B7.1 and B7.2, 
CTLA4 (cytotoxic T-lymphocyte-associated antigen 4), is induced and 
phosphorylated on inhibitory tyrosine immunoreceptor motifs (ITIM) that recruit 
protein tyrosine phosphatases SHP1 (SH2-domain-containing PTP1) and SHP2 to 
dephosphorylate the CD3 ζ -chain, protein kinases and other substrates. CD45 has a 
dual effect to dephosphorylate either activating or inhibitory residues of Lck to 
activate or attenuate TCR signalling respectively (McNeill, R.J. et al. 2007). We will 
discuss this issue further in chapter 1.4 of T cell homeostasis. 
 
1.3.2. Differentiation of activated T cells 
 
When a T cell encounters its specific Ag, it undergoes clonal expansion and 
differentiation into effector or memory T cells with same TCR specificity.  
 
Activated CD8 cells differentiate to cytotoxic T cells either alone or with the help 
of CD4 cells. Cytotoxic CD8 cells produce two broad classes of effector molecules, 
cytotoxins and cytokines, in addition to some membrane associated proteins like Fas 
ligand. Cytotoxins are stored in specialised lytic granules and include granzymes and 
perforin. Release of these granules is tightly focused at the site of cell contact and 
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triggers an intrinsic cell death program of the target cells. IFN-γ is the major cytokine 
produced by CD8 effector cells that can block viral replication. TNF-α and TNF-β 
from CD8 cells can deliver activating signals to innate immune system and have 
cytotoxic effects. 
 
 
Figure 1.3.3 Program of T helper cell differentiation  
Differentiation of memory/effector T cell subset from naïve CD4+ T cells is 
induced by specific cytokines secreted by innate immune system cells. Through the 
activation of specific transcription factors, T cells are programmed to differentiate into 
5 subsets of effector cells with a spectrum of cytokine production.  
 
CD4 cells can differentiate upon activation into TH1 or TH2 cells, which differ in 
cytokine production and regulate cellular and humoral immunity respectively, and 
more recently identified subpopulations including T follicular helpers (TFH), induced 
regulatory T cells (Tregs), and TH17 (Mosmann TR, Coffman RL. 1989; Tong, Q. & 
Bluestone, J.A. 2008; Dong, C. 2008; King C, Tangye SG, Mackay CR. 2008). 
Despite different cytokines produced by the innate immune system, it is not yet fully 
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understood what factors determine a proliferating CD4 T cell to differentiate into one 
or other subset of effectors. 
 
TH1 cell differentiation depends on the presence of IL-12. It expresses membrane-
associated proteins (CD40 ligand and Fas ligand) and a range of soluble cytokines 
(IFN-γ, IL-2, TNF etc) conferring immunity to intracellular bacteria. IFN-γ secreted 
by TH1 cells activate macrophages to kill engulfed bacteria; IL-2 induces T cell 
proliferation, increasing effector cell numbers and potentiating the release of other 
cytokines; IL-3 and GM-CSF stimulate the production of macrophages and 
granulocytes; TNFα and TNFβ act on endothelium to recruit macrophages to the site 
of infection; a chemokine from TH1 with macrophage chemotactic activity (CCL2) 
also causes accumulation of macrophages at the infection site (Mosmann, T.R. & Sad, 
S. 1996, Szabo, S.J. et al. 2003). The key transcription factor for TH1 differentiation is 
Tbet, a member of Tbox transcription factor family (Szabo, S.Z. et al. 2001). 
 
Under the control of IL-4, TH2 cell differentiation is important for T cell 
dependent B cell activation. Ag-binding B cells can present peptide:MHC complexes 
to the TCR of TH2 cells, leading to expression of the B cell stimulatory CD40 ligand 
on TH2 cells and the secretion of B cell stimulatory cytokines IL-4, IL-5, IL-6, IL-10, 
and IL-13, which in turn drive B cell proliferation and differentiation into Ab-
secreting plasma cells (Glimcher, L.H. & Murphy, K.M. 2000). Gata3 is the master 
regulator for TH2 cell differentiation (Zheng, W. & Flavell, R.A. 1997). 
 
Recently a distinct IL-17 producing lineage of CD4 effector cells have been 
identified in mouse and human which is different from TH1 and TH2 cells in terms of 
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the cytokines they produce and the programmes governing their differentiation 
(Harrington, L.E. et al. 2006, Park, H. et al. 2005, Chen, Z. et al. 2006, Reiner, S.L. 
2007). TH17 differentiation depends on TGFβ and IL-6 (Bettelli, E. et al. 2006, 
Mangan, P.R. et al. 2006), not IL-23 as previously reported (Aggarwal, S. et al. 2003), 
although IL-23 is important for maintaining the TH17 response. It was originally 
thought that TH17 effector cells exclusively secrete IL-17 but new evidence appears 
that TH17 cells can also secret IL-22 (Zheng, Y. et al. 2007). TH17 cells produce TNF 
but not IFNγ, which is different from TH1 cells (Infante-Duarte, C. et al. 2000). TH17 
have critical roles in immunity to fungi and tissue inflammation. RORγι has been 
proposed to be the essential transcription factor for TH17 differentiation (Ivanov II, et 
al. 2006). 
 
Natural regulatory T cells differentiate in the thymus, while induced Treg cells 
differentiate in the periphery in response to antigen signals and in the presence of 
TGF-β. The master transcription factor of Treg cells is Foxp3 and the effector 
cytokines secreted are IL-10 and TGFβ. Tregs have important immunomodulatory 
activity and play key roles in immune tolerance (Tang, Q. & Bluestone, J.A. 2008). 
 
TFH was named from their location or migration to the B cell follicles in the 
lymphoid tissues. TFH cells are distinguishable from other T cell subsets by the 
expression of chemokine receptor CXCR5. They function to provide help to B cells 
which is essential to humeral immunity. The major effector cytokine generated from 
TFH cells is IL-21 that potentially helps B cells to differentiate into Ab-forming cells 
(King, C., Tangye, S.G. & Mackay, C.R. 2008). 
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1.3.3  Memory T cells 
 
Immunological memory is the ability of immune system to respond more rapidly 
and effectively to previously encountered pathogens, reflecting the persistence of 
clonally expanded Ag specific lymphocytes as “memory T cells”. Most effector cells 
die at the end of immune response, and the differentiation of memory cells is still 
poorly understood. 
 
A linear pathway of memory commitment was proposed in 1999, suggesting 
sequential differentiation of naive T cells to effectors and then to memory T cells 
(Opferman, J.T. et, al. 1999). In this theory, naive T cells become activated following 
Ag stimulation, differentiate into effectors and quickly expand to clear pathogens. 
After Ag clearance most effectors die, the cell numbers contract, and only a 
proportion of Ag experienced cells revert to a slowly cycling long-lived memory T 
cells. This is supported by lymphocytic choriomeningitis virus (LCMV) infection 
experiments showing that virus specific memory CD8 cells are derived from 
expanded effector cells (Murali-Krishna, K. et al 1998; Kaech, S.M. et al. 2001, 2002), 
and by adoptive transfer experiments showing that memory CD4 cells originate from 
Ag-activated effector T cells in vivo (Swain, S.L.1994; Garcia, S. et al. 1999). 
 
However, accumulating evidence indicates the independence of memory T cell 
generation from effector differentiation. Lauvau G et al reported memory CD8+ T cell 
generation in vivo in the absence of an overt effector response (Lauvau, G. et al. 
2001). Manjunath and colleagues showed that effector differentiation is not a 
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prerequisite for memory CD8+ cells (Manjunath, N. et al. 2001). Wu CY et al 
reported distinct effector cells have differential capacities for memory generation (Wu, 
C.Y. et al 2002). Farber’s group proved that memory T cells have functional plasticity 
in cytokine production (Ahmadzadeh, M. and Farber, D.L. 2002). They also showed 
that memory CD4 cells can be produced at different states of differentiation upon Ag 
stimulation from activated precursors, which have gradations of effector functions 
(Moulton, V.R. et al. 2006). 
 
 
Figure 1.3.4 The intersecting pathway model of memory T cell formation  
This model takes into consideration proliferative turnover, acquisition of effector 
function and cell survival in memory T cell generation driven from two pathways: 
antigen dependent activation and independent homeostasis. Naive T cells upregulate 
IL-2R and downregulate IL-7R receptor expression after Ag stimulation, resulting in 
rapid proliferation and differentiation to effectors, then contract to memory subset 
after Ag clearance. Alternatively, naive T cells (CD25loIL-7Rhi) undergo slow 
proliferative turnover in the expose of homeostatic factors like IL-7 and differentiate to 
memory-phenotype cells with effector capacity in the absence of specific antigen 
(Moulton, VR. & Farber, DL. 2006). 
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Memory-like T cells also arise without effector differentiation during homeostatic 
expansion in T cell depleted hosts to restore the circulating T cell pool. When naive T 
cells are adoptively transferred into lymphopaenic hosts, they acquire memory T cell 
phenotypes and functional properties during homeostatic proliferation, which is 
referred to as homeostasis driven memory T cell differentiation (Cho, B. et al. 2000; 
Goldrath, A.W. et al 2000; Murali-Krishna, K. and Ahmed, R. 2000). 
 
Farber proposed a revised “intersecting pathway model” for memory T cell 
generation (Moulton, V.R. and Farber, D.L. 2006) (Figure 1.3.4). In this model, 
memory T cells can be generated through either Ag activation or Ag independent 
homeostatic factors. Naive T cells (CD25low IL-7Rhi) undergo rapid IL-2 driven 
proliferation by up-regulated CD25 (IL-2Rα chain) and down-regulation of CD127 
(IL-7Rα chain), and differentiate into effectors when further exposed to Ag. In the 
absence of further Ag stimulation, activated T cells undergo slow proliferative 
turnover driving to memory phenotype cell differentiation by homeostatic factors 
especially by IL-7. The intersection of these two pathways occurs at Ag clearance due 
to down-regulation of IL-2Rα and up-regulation of IL-7Rα on intermediate “pre-
memory” cells that can homeostatically differentiate into stable memory T cells. 
 
Memory T cells have high heterogeneity. Sallusto firstly reported two subsets of T 
cells with distinct homing potentials and effector functions in human (Sallusto, F. et al. 
1999). Central memory T cells (TCM) express CCR7 and CD62L that are required for 
T cells to recirculate into the T cell area of secondary lymphoid organs. TCM do not 
have immediate effector functions but they are sensitive to TCR stimulation and 
independent on costimulation. After priming, TCM produce IL-2 and then efficiently 
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differentiate into effector cells producing IFNγ or IL-4 (Sallusto, F. et al. 2004). 
Effector memory T cells (TEM) do not express CCR7 and only a proportion of TEM 
express CD62L. Instead TEM express a set of chemokine receptors and adhesion 
molecules required for homing to inflamed tissues. TEM have rapid effector functions 
and produce large amount of perforin from CD8 TEM and IL-4, IFNγ, and IL-5 from 
both CD4 and CD8 TEM (Williams, M.A. & Bevan, M.J. 2007). Even TCM and TEM 
are heterogeneous in expression of costimulatory molecules, adhesion molecules, and 
chemokine receptors, which discriminate TCM and TEM into functional subsets in 
resting status (Table 1.3). 
 
Transcription factor T-bet has been linked with long-term renewal of memory 
CD8+ T cells and their responsiveness to IL-15 (Intlekofer, A.M. et al. 2005). It was 
recently revealed that the amount of inflammatory cytokines (i.e., IL-12) during T cell 
priming determines the fate of short-lived effector cells (SLECs) and memory 
precursor effector cells (MPECs) through a gradient expression of T-bet transcription 
factor, which potentially regulates memory commitment from activated CD8+ T cells 
(Joshi, N.S. et al. 2007). 
 
In summary, memory T cells function as a dynamic repository of Ag experienced 
T lymphocytes that are generated from different precursors in multiple pathways. 
They are highly heterogeneous and mediate both protective and reactive immunity 
over the life time of the individual. 
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Table 1.3 Comparison of T cell subsets 
 
properties naïve effector memory 
homogeneity/heterogeneity homogeneous heterogeneous heterogeneous 
  TH1, TH2, TH17, Treg TCM TEM 
phenotype:  
cell size small large small  
adhesion molecules CD44lo CD44hi CD44hi CD44hi 
 CD11a (LFA-1)+ LFA-1 hi LFA-1 hi LFA-1 hi 
 CD62Lhi CD62Llo CD62Lhi CD62Llo 
activation markers CD69lo CD69hi/lo CD69lo CD69lo 
 CD25- CD25+ CD25- CD25- 
chemokine receptors CCR7hi CCR7lo CCR7hi CCR7lo 
others CD45RA/RB/AC CD45RO CD45RO CD45RO 
 IL7Rhi IL7Rlo IL7Rhi IL-7Rhi 
 CD43lo CD43hi CD43hi CD43hi 
 Ly6c-  Ly6C+ Ly6C+ 
effector functions mainly IL-2 IL-2, IFNr, TNF (TH1) effectors effectors 
  IL-4, IL-5, IL-10, IL-13 (TH2)   
  IL-17, IL-22 (TH17)   
  IL-10, TGFbeta (Treg)   
  Cytotoxicity of CD8 cells   
maximum cytokine secretion days hours (Rapid) days hours (rapid) 
homing lymphoid tissues 
lymphoid and non-lymphoid 
tissues Lymphoid tissues non-lymphoid tissues 
telomerase long long shorter shortest 
half life weeks hours ~ days years Weeks-months 
requirement of immune 
response Ag at high concentration Ag at high concentration 
Ag at low 
concentration 
Ag at low 
concentration 
  IL-10, TGFbeta (Treg)   
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1.4  T cell longevity and homeostasis  
 
1.4.1. Homeostasis: balance of production and loss, survival and death 
 
Maintaining a constant number of T cells is an important aspect of adaptive 
immunity. In spite of variable T cell production by thymus as a function of age and 
clonal expansion/contraction during the course of infection, circulating T cell 
numbers remain remarkably fixed. In young animals, the input of circulating T cells 
depends largely on the number of thymic emigrants, while in adults this relies on the 
longevity of mature T cells and their division in the periphery. Both processes, thymic 
emigration and peripheral expansion, determine the initial size of the mature T cell 
pool. Meanwhile, generation of new lymphocytes is balanced by cell loss. In intact 
animals, cell death is the major reason of T cell loss as displacement into other T cell 
subsets is relatively minor. 
 
Each subset of lymphocytes appears to have independent niches for homeostasis. 
For example, loss of T cells is not compensated with increasing B cells, nor is loss of 
CD4 cells compensated by an increase in CD8 cells. Naive and memory T cells also 
have their own niches, with different survival signals, proliferative conditions, and 
death mechanisms. 
 
1.4.2. Factors influencing T cell homeostasis 
 
(1) MHC-peptide complex 
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It has been controversial about the roles of MHC molecules in naive T cell 
survival and homeostatic proliferation. Shimizu’s group first proposed that long term 
survival of naive CD4 cells requires contact with MHC-II molecules (Takeda, S. et al. 
1996). Rocha’s group showed a similar requirement for MHC-I molecules from naive 
CD8 cells by demonstrating that these cells disappeared in the absence of MHC-I 
expression (Tanchot, C. et al. 1997). After that, there were accumulating evidence to 
favour the concept that homeostatic expansion and / or survival of naive T cells 
requires recognition of MHC complex in the periphery (Kirberg, J. et al. 1997; 
Beutner, U. et al 1998; Kieper, WC. 1999; Nesic, D. 1998; Murali-Krishna, K. 1999), 
although there were conflicting reports about whether the peptide ligands were the 
same for thymic selection or from environmental antigens (Ernst, B. et al. 1999; 
Bender, J. et al. 1999). There is also argument about the requirement of MHC for 
naive T cell homeostasis in intact mouse, as most of previous studies were done in 
lymphopaenic hosts which may be affected by altered level of trophic factors like IL-
7, and the inability to monitor both proliferation and persistence in the same 
experiment. 
 
In contrast with naive T cells, memory T cells survive quite well without the 
requirement of peptide/ MHC molecules. Research from different centres all suggest 
that memory CD4 and CD8 T cell homeostasis is independent on peptide/MHC 
complexes (Lau, LL. et al. 1994; Mullbacher, A. 1994; Garcia, S. et al. 1999; Murali-
Krishna, K.1999; Swain, SL. 1999; Hu, H. 2001). However, this seems not the case 
for all memory T cells. John Sprent’s group found that memory CD8 T cells are 
actually composed of the majority of CD122hi and a small proportion of CD122lo 
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cells based on the expression of β subunit of IL-2R/IL-15R recognized by anti-CD122 
(Zhang, X. et al. 1998). Later on, they found that IL-15 is responsible to the survival 
and homeostatic proliferation of CD122hiCD8+ cells, as these cells are absent in IL-
15 KO mice and disappear rapidly after adoptive transfer to IL-15 deficient mice 
(Judge, AD. et al. 2002), while CD122lo memory CD8 cells rely on the contact with 
MHC-I molecules and presumably together with self-peptide ligands as these subset 
of memory CD8 cells failed to proliferate and persist in MHC-I knockout mice 
(Boyman, O. et al. 2006). Others suggest that memory CD8 cells depend on their TCR 
engagement with foreign Ags such as in chronic viral infections (Wherry, EJ. et al. 
2004). 
 
For CD4 memory T cells, it was initially suggested that memory CD4 cell 
generation and survival is independent on MHC-II molecules (Swain, SL. et al. 1999), 
but later evidence showed that TCR ablation reduced homeostatic proliferation of 
memory CD4+ T cells although the initial size of naturally occurring memory CD4 
cell pool was normal (Polic, B. et al. 2001). Furthermore, it was shown that a TCR 
signal from MHC is required for memory CD4 cell homeostasis when the IL-7 signal 
is absent, suggesting peptide MHC complexes do play a role in memory CD4 cell 
homeostasis even though it is not the only factor or the primary governor (Seddon, B. 
et al. 2003). Therefore, at least some proportion of memory T cells rely on TCR 
signals generated from continuous contact with either self or foreign peptide 
complexed to MHC. 
 
Affinity/avidity of TCR engagement by peptide-MHC may influence homeostasis 
by providing weak or intermediate signals to maintain the viability of naïve T cells 
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(Marrack, P. & Kappler, J. 2004). This is supported by the finding that only T cells 
with proper TCR affinity proliferate in T cell deficient mice (Ernst, B. et al. 1999; 
Goldrath, AW. 1999). This is further evidenced by a recent report showing that MHC-
I restricted CD8+ cells carrying low affinity transgenic TCRs have pronounced 
homeostatic proliferation, and that deficiency in a negative regulator of TCR 
signalling, SIT (Src homology domain containing tyrosine phosphatase 2-interacting 
transmembrane adaptor protein), lowers the TCR mediated activation threshold and 
enhances homeostatic proliferation of a range of Ag specific CD8+ cells with a range 
of TCR affinities (Posevitz, V. et al. 2008). 
 
(2) Costimulation 
 
It has been established that costimulatory signals mediated by interactions 
between B7(CD80/CD86)-CD28 is essential for T cell activation in addition to Ag-
TCR binding during a primary immune response (Harding, FA. et al. 1992; Lenschow, 
D.J. et al.1996). The second signal through CD28 enhances T cell activation, 
proliferation, and survival through amplifying TCR signal to lower the threshold of 
activation, upregulating anti-apoptotic proteins, and increasing IL-2 production to 
promote cell survival (Viola, A. et al. 1996; Tuosto, L. et al. 1998; Sperling, AI. et al. 
1996; Kirchhoff, S. et al. 2000; Yu, X.Z. et al. 2003). In spite of the paradigm that 
naïve rather than memory CD8+ cells require CD28 costimulation, evidence suggests 
that costimulatory signals are also required during recall responses of memory CD8+ 
T cells (Bertram, E.M. et al. 2002; Mittrucher, H.W. et al. 2001; Borowski, A.B. et al. 
2007). More recently, Usherwood and colleagues show that vaccinia virus specific 
memory CD8+ cells in CD28 deficient mice have lower expression of differentiation 
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markers CD27 and CD122, suggesting  a role of CD28 in memory CD8+ cell 
differentiation (Fuse, S. et al. 2008). 
 
Bluestone’s group have shown that CD28 costimulation is critical for Treg 
development in thymus and their survival and homeostasis in the periphery (Salomon, 
B. et al. 2000; Tang, Q. et al. 2003). They demonstrated that CFSE labelled 
CD4+CD25+ Tregs cannot proliferate in anti-B7 Ab treated intact hosts and failed to 
survive in CD28 knock out recipients, indicating the requirement of CD28 
costimulatory signal in Treg homeostasis. 
 
However, it is not clear whether or not costimulation affects other subsets of 
mature T cell homeostasis. Although CD28 deficient mice have normal overall T cell 
numbers in peripheral lymphoid tissues (Shahinian, A. et al. 1993; Yu, X. et al. 2000), 
there are reports showing that costimulation may influence thymic negative selection 
(Noel, P.J. et al. 1998; Punt, J.A. et al. 1997) and effector/memory differentiation and 
function (Lenschow, D.J. et al. 1996; Salomon, B. et al. 2000; Mostbock, S. et al. 
2007 a and b). Yu et al examined B7 transgenic and deficient mice and found that 
over expression of B7 result in peripheral T cell hyperplasia and decreased CD4/CD8 
single positive cell ratio in the thymus which depended on TCR and CD28, while B7 
deficiency showed the reciprocal observation, suggesting a substantial role of 
costimulation in regulating T cell development and homeostasis (Yu, X, et al. 2000). 
Costimulatory signals may contribute to T cell homeostasis by modulating TCR 
signalling threshold in TCR ligation with various affinities (Mostbock, S. et al. 2007 
b).  
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(3) Cytokines 
 
In addition to TCR ligation (signal 1) and costimulation (signal 2), a third 
extrinsic signal is from specific cytokine, especially common γ–chain cytokines such 
as IL-7 (and IL-15), for T cell survival, differentiation, memory development, and 
homeostasis (Curtsinger, J.M. et al. 1999; Mescher, M.F. et al. 2006; Boyman, O. et al. 
2007). Cytokine signals have been extensively studied in T cell homeostasis, 
especially the common γ chain family comprised of interleukin-2 (IL-2), IL-4, IL-7, 
IL-9, IL-15, and IL-21. It was named from the common γ chain (CD132) shared by 
the receptors of all these cytokines (Kovanen, P.E. & Leonard, W.J. 2004). The 
heterodimeric receptor of IL-4, IL-7, IL-9, and IL-21 comprises the common γ chain 
and their specific subunits, namely IL-4Rα, IL-7Rα (CD127), IL-9Rα and IL-21Rα 
respectively, while IL-2 and IL-15 receptors are heterotrimeric of the common γ chain, 
shared β chain IL-2/IL-15Rβ (CD122), and their specific α chains, IL-2Rα (CD25) or 
IL-15Rα (Alves, N.L. et al. 2007). 
 
IL-7 is generated by the stromal cells in the lymphoid tissues in a constant rate. It 
is believed that the level of IL-7 in the serum is determined by the rate of 
consumption by the circulating lymphocytes. IL-7 was initially defined as a B cell 
trophic factor, but both IL-7 and IL-7R deficient mice showed additional key roles in 
T cell development in central and peripheral lymphoid organs (von Freedon-Jeffry, U. 
et al. 1995; Peschon, J.J. et al 1994; Maraskovsky, E. et al. 1996). IL-7 acts as a 
growth stimulus to promote T cell proliferation through the JAK/STAT pathway (Yao, 
Z. et al. 2006, Suzuki, K. et al. 2000) as well as a survival factor to prevent T cells 
from death by regulating the balance of anti-apoptotic and pro-apoptotic proteins of 
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the BCL-2 family (Maraskovsky, E. et al. 1997; Pellegrini, M. et al. 2004). Through 
these effects, IL-7 mediates both naïve and memory T cell homeostasis. 
 
Boursalian and Bottomly firstly reported that IL-7 jointly with self-peptide/MHC 
complex is required for naïve T cell survival. They showed that naïve T cell numbers 
decreased following anti-IL-7 Ab treatment in adult thymectomized mice (Boursalian, 
T.E. and Bottomly, K. 1999). More reports after that have set up our current view that 
IL-7 is the primary cytokine for naïve T cell survival and proliferation, and that the 
basal level of IL-7 determines the overall size of naïve T cell pool (Schluns, K.S. et al. 
2000; Tan, J.Y. et al. 2001; Surh, C.D. & Sprent, J. 2005). For memory T cell 
homeostasis, IL-7 seems to have less of a role than IL-15, as over expression of IL-7 
can overcome the dependence of memory CD8+ cells on IL-15 when IL-15 is 
deficient (Kieper, W.C. et al. 2002). It was initially thought that memory CD4+ cells 
do not require IL-7 (Lantz, O. et al. 2000; Tan, J.T. et al. 2002), but new evidence 
suggests that memory CD4+ cells do depend on IL-7 for survival and homeostatic 
proliferation in the absence of TCR signalling (Seddon, B. et al. 2003; Kondrack, R.M. 
et al. 2003). The dependence on IL-7 of naïve and memory T cells is correlated to the 
high expression of IL-7R on these cells. 
 
An “altruism theory” was proposed to explain the observation that IL-7R 
expression can be transcriptionally suppressed by IL-7 or other cytokines like IL-2, 
IL-4, IL-6, and IL-15, to benefit other cells that have not received the limited 
prosurvival cytokines (Park, J.H. et al. 2004). However, the study was mainly 
performed in vitro, and recent in vivo data suggested that IL-7R expression is 
independent of IL-7 itself (Klonowski, K.D. et al. 2006) and may be induced by IL-12 
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(Takemoto, N. et al. 2006) and IL-2 (Dooms, H. et al. 2007). TCR triggering down-
regulates IL-7R expression in double positive thymocytes and peripheral effector T 
cells (Franchimont, D. et al. 2002). Recent studies show that there is interplay 
between TCR signal and cytokine signals. Afred Singer’s group suggested that the IL-
7 signal can transcriptionally increase CD8 coreceptor expression and promote TCR 
signalling in a transgenic mouse model, whereas TCR signals impairs IL-7 signalling 
and downregulates CD8 expression (Park, J.H. et al. 2007). Farrar’s group reported 
the linkage of TCR, costimulation, and cytokine signalling govern the process of Treg 
development (Burchill, M.A. et al. 2008). 
 
IL-15 has overlapping functions with IL-7 in naïve T cell homeostasis. IL-15 
plays a role in supporting naïve CD8+ cell survival but not naïve CD4 cells. This is 
correlated with the expression of IL-2/IL-15R β chain (CD122) on naïve CD8+ but 
not naïve CD4+ cells (Surh, C.D. et al. 2006). As mentioned earlier, IL-15 plays a key 
role in the turnover and survival of CD8+CD122+ memory cells. Low levels but not 
absence of IL-15R β chain expression on CD4+ memory T cells suggests some role of 
IL-15 in regulating memory CD4 cell homeostasis (Ilangumaran S, et al. 2003). 
 
1.4.3. Life and death of peripheral T cells 
 
Life and death of peripheral T cells is determined by the signals received by the 
cells such as TCR triggering, costimulation, and cytokines through several 
mechanisms: extrinsic cell death receptor and caspase dependent apoptosis; intrinsic 
mitochondria and caspase independent apoptosis; or caspase independent cell death. 
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Figure 1.4.1 Two distinct cell death pathways from cytokine withdrawal and 
activation of Fas  
Lymphocyte death occurs either in the contraction phase of immune respones or 
during homeostasis, through death receptors such as Fas (CD95) or Bcl-2 family 
responses to trophic factor deprivation. Ligand binding trimerizes Fas inducing the 
binding of adaptor FADD (FAS-associated death domain protein) to the death 
domain in Fas, resulting in the activation of caspase and eventually rapid apoptosis. 
By contrast, trophic-cytokine withdrawal causes loss of signaling through the JAK–
STAT and PI3K–AKT pathways and disrupts mitochondria through favouring the 
balance of pro-apoptotic Bcl-2 members (Khaled, AR. & Durum, SK. 2002).  
 
The extrinsic apoptotic pathway is triggered by ligand binding to cell surface 
death receptors of the TNF receptor family including TNF receptors (TNFR), CD95 
(FAS or APO-1), TRAIL receptors (TRAILR), and death receptors (DR), which are 
defined by the presence of an intracellular death domain (DD). This results in the 
formation of death inducing signalling complex (DISC) and activation of caspase 
leading to cell death (Green, DR. 2005). The intrinsic apoptotic pathway is induced by 
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a variety of stimuli like TCR stimulation, DNA damage, endoplasmic reticulum (ER) 
stress, and cytokine deprivation that cause break down of the balance of anti-apoptotic 
and pro-apoptotic members of BCL-2 family and permeablization of the 
mitochondrial membrane which consequently release cytochrome C and result in cell 
death (Youle, RJ. & Strasser, A. 2008). 
 
Activated T cells die through either activation induced cell death (AICD) through 
FAS or activated cell autonomous death (ACAD) due to cytokine withdrawal. It is 
still obscure why memory cells die but it is assumed that memory T cells die in 
different ways (Marrack, P. & Kappler, J. 2004). Naïve T cells die through intrinsic 
pathway rather than extrinsic pathway because naïve T cells express lower levels of 
TNFR and FAS, and deficiency in these molecules does not affect naïve T cell 
survival. There is evidence suggesting that naïve T cell viability is controlled by the 
ratio of anti-apoptotic Bcl-2 and pro-apoptotic molecule Bim (Bcl-2 interacting 
molecule) (Wojciechowski, S. et al. 2007). Bim deficiency or Bcl-2 overexpression 
promotes the accumulation of naïve T cells in the periphery (Bouillet, P. et al. 1999; 
Hildeman, D.A. et al. 2002; Strasser, A. et al. 1991). Bim deficiency prevented the 
death of CD127lo CD8+ effector cells during the contracting phase after LCMV 
infection (Wojciechowski, S. et al. 2006). 
 
1.4.4. Survival signalling in naïve T cells 
 
Once a mature single positive thymocytes leaves the thymus, it enters the blood 
stream as a naive T cell and is carried into the peripheral lymphoid tissues which have 
highly organised architecture providing naive T cells the opportunity to interact with 
41 
Chapter 1. INTRODUCTION                                          1.4 T cell homeostasis  
other cell types like dendritic cells and B cells. Naive T cells continually circulate 
through lymph nodes and spleen via lymph and blood until they encounter their 
specific antigens, become activated and differentiate into effectors, or die after a 
period of 4-8 weeks on average.  
 
Recent thymic emigrants continue to undergo peripheral selection through their 
TCR. Strong binding to self-peptide-MHC complex eliminates autoreactive clones (i.e. 
through peripheral deletion), or renders the T cells hyporesponsive. Repeated TCR 
contact with low avidity self/peptide-MHC complexes is required to maintain naïve T 
cells in the peripheral circulation as these cells cannot survive when transferred into 
recipients that lack MHC molecules (Murali-Krishna, K. et al. 1999; Kassiotis G. et al. 
2002).  
 
Mature naive T cells are metabolically quiescent and have infrequent division by 
contact with self-peptide-MHC complex in unstimulated animals; therefore they have 
a prolonged life span (Sprent, J. & Tough, DF. 1994). In the past a couple of decades, 
tremendous efforts have been put in defining T cell functions during activation and 
differentiation. T cells have different functions and biological features at different 
stages of development, characterised by specific cell surface markers and intracellular 
molecules. The comparison of the properties of naive, effector, and memory T cells is 
summarized in table 1.3.  
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1.5  Pre-mRNA alternative splicing  
 
Shortly after exons and introns were discovered in RNA transcript precursors 
(Berget, S.M. and Sharp, P.A. 1977; Chow, L.T. et al. 1977; Gilbert, W. 1978) it was 
found that some exons are variably included in the mature transcript (Early, P. et al. 
1980; Rosenfeld, M.G., et al. 1982). This process is termed pre-mRNA (precursor 
messenger RNA) alternative splicing, referring to the differential removal of introns 
and inclusion of exons (Gilbert, W. 1978). Genome and cDNA sequencing projects 
have revealed that human (and mouse) genes generate complex nascent mRNAs, with 
an average eight exons and large introns making up 90% of the precursor transcript 
(Lander, E.S. 2001).  Recent splicing arrays and bioinformatics studies show that 70% 
~ 80% human genes express multiple mRNA isoforms due to alternative splicing of 
exons or exon segments (Johnson, J.M. 2003; Kampa, D. 2004; Clark, T.A. 2007), 
much larger than initially estimated 5% (Sharp, P.A. 1994) or 35-65% (Mironov, A.A. 
1999; Modrek, B and Lee, C. 2002). 
 
Alternative mRNA splicing expands protein complexity and functional diversity. 
Many protein isoforms encoded by splicing variants have distinct or even antagonistic 
biological activities. It correlates to the disparity between lower number of protein-
coding genes and the large number of proteins in human (approximately 25,000 vs 
900,000) (Woodley, L. and Valcárcel, J. 2002). Comparative analysis shows that most 
human and mouse genes are orthologues sharing the same intron/exon arrangement as 
well as a high degree of conservation in homologous exon sequences and indistinctive 
splicing patterns (Waterston, R.H. 2002; Modrek, B. and Lee, C. 2003). 
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1.5.1. Regulation of alternative splicing 
 
For an individual nascent mRNA, introns must be removed and exons have to be 
precisely joined together to maintain the reading frame. Constitutive exons are 
constantly included in mature transcripts, while there are several types of variable 
exons (Figure 1.5.1a). A cassette exon is one that is either included or excluded 
(skipped) from mature mRNA. As opposed to exon skipping, some introns can be 
variably retained. Two neighbouring exons can be included in a mutually exclusive 
pattern. Differential splice sites at the 5’ or 3’ end can change the exon length. 
Transcript can have alternative initiations and first exons or termination and 3’ exon 
(Smith, C.W. and Valcárcel, J. 2000; Xing, Y. and Lee, C. 2006; Hu, A. and Fu, X.D. 
2007). Exon skipping is the most frequent alternative splicing events in mammals 
(Sugnet, C.W. et al. 2004). 
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Figure 1.5.1a: pre-mRNA splicing patterns and functional complexity  
Splicing regulators, e.g. SR proteins and heterogeneous nuclear 
ribonucleoproteins, modulate alternative splicing of nascent messenger RNAs in 
different patterns in a gene specific, tissue dependent, or cell signal dependent 
manner, which alters the structure of the mature mRNA transcripts as well as the 
function of proteins isoforms (Hu, A. and Fu, XD. 2007).  
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Figure 1.5.1b: Splicing machinery  
Stepwise assemble of spliceosome, a multiple snRNP complex, to the target 
exon-intron boundary to cleave the intron promoted by SR protein binding to the 
exonic splice enhancer (Li, Q. et al. 2007). 
 
Alternative splicing is directed by a complex set of splicing codes consisting of 
consensus sequences of splicing sites at exon-intron boundaries and exonic or intronic 
regulatory elements called exonic splice enhancers (ESE) or intronic splice enhancers 
(ISE), and exonic or intronic splice silencers (ESS/ISS) (Black, D.L. 2003). The 
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splicing sites are critical for all exons and were identified from alignment of intron-
exon boundary sequences (Berget, S.M. 1995). The splice site sequences are 
recognized by small nuclear RNAs (snRNAs) or small nuclear ribonucleoprotein 
particles (snRNPs) through specific base pair interaction (Jurica, M.S. & Moore, M.J. 
2003). During splicing, five snRNA / snRNPs assemble in a stepwise manner to form 
the splicing machinery referred to as the spliceosome. U1 snRNP binds to 5’ splice 
site at a conserved GU dinucleotide, U2AF (U2 snRNP auxiliary factor) recognizes 
the 3’ splice site polypyrimidine tract and a conserved AG dinucleotide with its 65 
and 35 kD subunits respectively (E complex) (Lim, S.R. & Hertel, K.J. 2004; Chiara, 
M.D. & Reed, R. 1995). U2AF65 then recruits U2 which is specific for the branch 
point sequence at the 3’ splice site (A complex). Subsequently the U4/U6-U5 
complex joins (B complex) and remodelling of RNA and protein components in the B 
complex forms an enzymatically active C complex to catalyse the RNA-RNA trans-
esterification reactions to cleave the intron and connect the exons (Martin, A.J. et al. 
2005) (Figure 1.5.1b). 
 
 Conserved sequences at about 10 nucleotides serve as splicing enhancers and / or 
silencers, and occur near the exon/intron boundaries. This directs the spliceosome 
machinery to the right splice site rather than potential cryptic sites of the pre-mRNA. 
The action of two classes of splicing regulatory proteins, Serine/Arginine rich proteins 
(SR proteins) and heterogeneous nuclear ribonucleoproteins (hnRNPs) are best 
studied (Zhu, J. et al. 2001). SR proteins bind to splicing enhancers to initiate exon 
recognition and inclusion (Fairbrother, W.G. 2002; Reddy, A.S. 2007), although they 
may inhibit splicing as well (Barnard, D.C. 2002). SR proteins have two common 
domains: the RNA recognition motif (RRM) and the RS domain with repeated 
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arginine/serine dipeptides. The RRM (also referred to as the RNA binding domain, 
RBD) targets the protein to a particular RNA sequence, whereas the RS domain 
modifies the affinity of RNA binding. SR proteins bind both ESE and ISE to 
positively regulate alternative splicing through recruiting the spliceosome to the 
adjacent exon (Black, D.L. 2003; Graveley, B.R. 2000). SR protein binding sites are 
found in both constitutive and variable exons suggesting their roles in both 
constitutive and alternative splicing (Mayeda A, et al. 1999; Stark, J.M. et al. 1999). 
 
The hnRNP proteins are a large group of proteins associated with mRNA 
precursors that were termed heterogeneous nuclear RNAs (hnRNAs) to describe their 
size heterogeneity and cellular location (Dreyfuss, G. et al. 1993). hnRNPs are highly 
conserved among vertebrates. Most hnRNP proteins have one or more RRMs which 
are also found in many other RNA binding proteins. The RRM domain comprises 
approximately 90 amino acids with two consensus sequences termed, RNP1 and 
RNP2 submotifs. RNP1 is the most conserved octapeptide segment in RRM that is 
comprised of Lys/Arg-Gly-Phe/Tyr-Gly/Ala-Phe-Val-XPhe/Tyr. RNP2 is a less 
conserved hexapeptide sequence of Ile/Val/Leu-Phe/Tyr-Ile/Val/Leu-X-Asn-Leu. The 
aromatic amino acids Phe/Tyr in RNP1 and RNP2 are essential for RNA binding 
(Dreyfuss, G. et al. 1993; Birney, E. et al. 1993). From studies on the best 
characterised hnRNP A1 and PTB (Polypyrimidine Tract Binding protein, or hnRNP 
I), it has been shown that hnRNPs repress spliceosomal assembly either by 
multimerization along exons or by blocking the recruitment of snRNPs to loop out 
exons (Zhu, J. et al. 2001; Tange, T.O. et al. 2001; Sharma, S. 2005; Martinez-
Contreras, R. 2006). Roles of some hnRNPs in alternative exon splicing have been 
established, as well as evidence that hnRNPs regulate constitutive splicing events 
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(Pozzoli, U. and Sironi, M. 2005). Major splice regulators identified so far are listed 
in table 1.4. 
 
  Name Domains Binding Sites targets 
9G8/Sfrs7 
RRM, RS, 
C2HC Znf (GAC)n Tau, GnRH, 9G8 
SC35/Sfrs2 RRM, RS UGCUGUU AChE 
SRp55/Sfrs6 RRM, RS GGCAGCACCUG cTnT, CD44 
SRp75/Sfrs4 RRM, RS GAAGGA FN1, E1A, CD45 
 
SR / SR 
related 
proteins 
  SRm160/Srm1 RS, PWI AUGAAGAGGA CD44 
  
hnRNP A1 RRM, RGG UAGGGA/U Hipk3, Smn2, c-H-ras 
hnRNP H 
RRM, RGG, 
GYR, GY GGGA, G-rich PLP, HIV tat, Bcl-x 
hnRNP I / PTB RRM UCUU, CUCUCU 
nPTB, c-SRC, Fas, cTnt, 
hnRNP A1 etc 
hnRNP L RRM C/A-rich eNOS, CD45 
  
  
hnRNPs 
  
  hnRNP LL RRM ? CD45, Nalp1, etc 
  
TIA1 RRM U-rich Fas, MYPT1, IL-8, etc others 
  Sam68 KH A/U-rich Bcl-x 
 
Table 1.4: Some key alternative splicing regulators (Gabut, M. et al. 2008) 
 
The three dimensional structure of the RRM of many RNA binding proteins has 
been solved by X-ray diffraction and NMR. Most RRM structures consist of similar 
four strands and two helices arranged in an alpha/beta sandwich (β1-α1-β2-β3-α2-β4), 
although in some cases there is a third helix present. The RNP1 and RNP2 submotifs 
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are located in the central β3 and β1 strands with conserved aromatic residues 
contacting RNA (Dreyfuss, G. et al. 1993; Birney, E. et al. 1993). 
 
RRM structure and its binding studies revealed that it can interact with target 
RNA or protein via its β sheet surface; it also interacts with proteins via α2 helix on 
the other side of RRM. The α3 helix of U2AF65’s interaction with the β sheet surface 
of RRM can occlude RNA binding. The α3 helix swings away upon RNA binding, 
facilitating protein dimerization and RNA binding in U1A RRM (Singh, R. and 
Valcárcel, J. 2005) 
 
It has been an interesting issue how hnRNPs and SR proteins specifically bind to 
degenerate nucleic acid sequence and regulate target nascent mRNA splicing 
(reviewed by Singh, R. and Valcárcel, J. 2005). Splicing enhancer and silencer 
sequences have been defined for recognition by major SR proteins and hnRNPs 
respectively. However, these specific regulatory elements are wide spread throughout 
the genome and still provide complex potential high-affinity binding sites for 
alternative usage. Additional protein factors are required to build up the specificity of 
splicing including tissue or cell-type specific expression of RNA binding proteins 
and/or their intracellular localization; effects of their cofactors or interaction with 
other snRNPs; the splicing isoforms of hnRNPs and SR proteins themselves and the 
sensitivities to the specific context comprised of other cofactors; usage of multiple 
RRM domains and KH (hnRNP K homolog), another abundant RNA binding motif, 
and domain tethering; and alternative splicing in responding to specific cell signals 
(Singh, R. and Valcárcel,, J. 2005; Lareau, L.F. et al. 2007; Shin, C. and Manley, J.L. 
2004; Rothrock, C. et al. 2003). 
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Dysregulation of alternative splicing resulting from mutations in splice sites or 
regulatory elements has been implicated in a wide spectrum of human diseases 
including cancer and autoimmune diseases. More than 15% of mutations causing 
genetic diseases affect pre-mRNA alternative splicing (Krawczak, M. 1992). There is 
increasing attention being given to developing therapeutic approaches that modulate 
alternative splicing in target cells. 
 
 
51 
Chapter 1. INTRODUCTION                         1.5 Pre-mRNA alternative splicing 
 
1.5.2. CD45 alternative splicing 
 
CD45 is the prototypic receptor-like protein tyrosine phosphatase. It is abundantly 
expressed on all nucleated hematopoietic cells, occupying up to 10% of the cell 
surface (Thomas, M.L. 1989). This transmembrane glycoprotein consists of an 
extracellular domain with cell-type and developmental-specific isoforms generated 
from alternative splicing of three variable exons, a single transmembrane domain, and 
cytoplasmic tandem phosphatase (PTPase) domains termed D1 and D2.  
 
 
Figure 1.5.2a: Ribbon diagram representations of the CD45 D1D2 domains (from 
Nam, H.T. et al. 2005).  
The D1 and D2 domains are shown in yellow and green, respectively. The viewer is 
looking straight into the D1 active site with the putative “wedge” site marked, and the 
corresponding active site of D2 is facing upward. The acidic and basic loops are 
shown in magenta and blue, respectively.  
 
52 
Chapter 1. INTRODUCTION                         1.5 Pre-mRNA alternative splicing 
From molecular modelling studies based on the crystal structure of PTPα D1 
domain, it has been proposed that a wedge structure in the juxtamembrane region of 
CD45 favours dimerization and inhibition of PTPase activity (Bilwes, A.M. et al. 
1996; Xu, Z. & Weiss, A. 2002). However, three dimensional studies on human CD45 
cytoplasmic domains recently revealed that this may not apply to CD45. Frederick, 
C.A. and colleagues (Nam, H.J. et al. 2005) reported the crystal structure of CD45 
cytoplasmic region containing D1 and D2 domains in native form and in substrate 
interactions. They found that the CD45 D2 domain has the same α1 helix-loop-α2 
helix motif as in D1 domain, suggesting strong D1-D2 interaction and that the steric 
hindrance from the D2 domain prevents D1 dimerisation. This study confirms that 
phosphopeptides only bind D1 active site but D2 may have auxiliary effects. Based on 
these recent studies, structure models of CD45 molecule have been significantly 
changed. The comparison of the two models is shown below. 
            
Figure 1.5.2b: CD45 Models 
Left: old model with wedge structure to D1 domain (Hermiston, M.L. et al. 2003). 
Right: CD45 model based on the 3-D crystal structure study of the cytoplasmic 
regions showing no wedge structure. Short lines and small cycles represent O-linked 
glycoslation in the variable regions and N-linked glycoslation in the Fibronectin type 
III respectively. For more information, please see texts in this chapter. 
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The CD45 extracellular domain contains 3 fibronectin type III repeats and a 
cysteine-rich region that are both heavily N-glycosylated. The membrane distal N-
terminus of CD45 molecule is encoded by 3 variable exons, exon 4, 5, and 6 encoding 
segments A, B, and C that are heavily decorated by O-linked glycosylation. Thus 
through alternative splicing multiple isoforms can be produced depending on the 
developmental stage, and activation status of the cell. The splicing pattern and 
expression of CD45 is highly conserved across species over hundreds of millions 
years of evolution (Hermiston, M.L. et al. 2003; Holmes, N. 2006). 
 
Although alternative splicing of CD45 exon 7, 8, and 10 have been reported in cell 
lines, alternative splicing of exons 4, 5, and 6 is most well established in both human, 
mouse, and other mammals (Chang, H.L. et al. 1991; Virts, E. et al. 1998). Isoforms 
that lack exon 7 (Virts, E. et al. 1998) and a novel exon encoding 41 amino acids 
between exon 3 and exon 4 termed exon D has been reported of the mRNA level (Li, 
D. et al. 2004), but none of these have been detected at protein level in either human 
or mouse. So far only five isoforms have been observed at protein level (Hermiston, 
M.L. et al. 2003): CD45RO (lacks exons 4, 5, 6); RB (exon 5); RAB (exons 4 and 5); 
RBC (exons 5 and 6); and RABC (exons 4, 5, and 6). B cells typically express 
CD45RABC (B220). Naïve T cells primarily express CD45RB, CD45RAB, or 
CD45RBC, whereas activated and memory T cells primarily express CD45RO. 
Variable splicing of CD45 also occurs in other blood lineages such as dendritic cell 
subsets (Lynch, K.W. 2007). 
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Figure 1.5.2c: CD45 pre-mRNA splicing variants  
 
The dependence of CD45 alternative splicing on cell types, developmental stage 
and activation status implies that this process is under the control of both external 
signals and intrinsic regulatory mechanisms (Lynch, K.W. 2007). K.W. Lynch and 
colleagues delimited an exonic splicing silencer to a 60 nucleotide fragment within 
exon 4 designated ESS1 containing an activation responsive sequence (ARS) that is 
responsible partially for basal exon silencing in resting T cells and is sufficient to 
confer activation-induced exon exclusion upon T cell stimulation (Lynch, K.W. and 
Weiss, A. 2001; Rothrock, C. et al. 2003). The ARS sequence has been further refined 
to a minimal sequence of which occurs three times in CD45 exon 4, twice in exon 6, 
and once in exon 5 (Tong, A. et al. 2005). The relative strength of exonic splicing 
enhancers (ESEs) and silencers (ESSs) of each of the three variable exons determines 
the differential expression of CD45 isoforms (Tong, A. et al. 2005).  Recently Lynch 
and co-workers used RNA affinity chromatography with a human CD45 minigene 
template to identify that the hnRNP proteins: hnRNP L, PTB and hnRNP E2 associate 
as a complex to regulate splice site silencing of exon4 of CD45 pre-mRNA in a 
human T cell line (Rothrock, C. et al. 2005). They demonstrated that ESS1 bound by 
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hnRNP L represses exon 4 inclusion by blocking spliceosome assembly after ATP-
dependent exon recognition by U1 and U2 and the formation of spliceosome E-A 
complex, resulting in failure to progress to a final catalytic B-C complex (House, A.E. 
and Lynch, K.W. 2006). Recently, the same group found that cellular stimulation 
causes post-translational modification of hnRNP L in mobility and activity, and more 
importantly, the activation-specific addition of PSF (PTB associated splicing factor) 
with increased activity, suggesting combinatorial control of signal induced alternative 
splicing (Melton, A.A. et al. 2007). This series of studies provides important evidence 
of exonic/intronic regulatory elements in CD45 mRNA as well as identifies some of 
the key trans/cis-acting regulatory hnRNPs/SR proteins that regulate CD45 alternative 
splicing in vivo. One caveat is that most of these results were based on exogenous 
protein expression. Considering the high degree of conservation amongst hnRNP 
proteins, hnRNPs other than hnRNP L may have more important or complementary 
roles in modulating CD45 alternative splicing. More works need to be done to 
elucidate the functions of other hnRNPs in the regulation of CD45 alternative splicing. 
 
CD45 Function 
 
CD45 has been identified as an important regulator of T cell development. Initial 
studies of CD45 deficient T cell lines identified CD45 as a positive regulator of TCR 
signal transduction (Pingel, J.T. et al. 1989; Koretzky, G.A. et al. 1990; Volarevic, S. 
et al. 1993; Hovis, R.R. et al. 1993). Subsequent observations of severe-combined 
immunodeficiency (SCID) were reported in both CD45 deficient mice (Kishihara, K. 
et al. 1993) and humans (Kung, C. et al. 2000) showing  greatly diminished peripheral 
T lymphocytes, unresponsiveness to mitogen stimulation,  and decreased serum 
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immunoglobulin despite normal B-lymphocyte numbers. Molecular studies revealed 
that CD45 deficiency causes dysfunctional pre-TCR and TCR signalling resulting in 
enhanced basal apoptosis and arrest of T cell development at DP to SP transition 
(Byth, K.F. et al. 1996; Kishihara, K. et al. 1993). CD45 deficiency bred into TCR 
transgenic mice proved that CD45 plays a positive role in promoting both positive and 
negative selection of thymocytes and regulates the strength of signal to a fixed Ag 
stimulation (Mee, P.J. et al. 1999). 
 
The earliest event in the TCR signal transduction cascade is the activation of Src 
family protein tyrosine kinases Lck and Fyn. Lck has an inhibitory pTyr505 site that 
is phosphorylated by Csk (C-terminal Src kinase) and dephosphorylated by CD45. 
Lck is the most important substrate for CD45 in T cells as CD45 is the only known 
phosphatase to dephosphorylate the negative regulatory pTyr505 site of Lck, causing 
a conformational change leading to increased kinase activity (Veillette, A. et al. 1992; 
Latour, S. and Veillette, A. 2001). Full activation of Lck requires a second Y394 
residue to be autophosphorylated in the activating loop, displacing the loop to fully 
open the catalytic cleft of the kinase. CD45 dephosphorylates this activatory pTyr394 
site to suppress Lck activity (Doro, U. and Ashwell, J.D. 1999). CD45 thus plays 
opposing roles, both promoting and inhibiting Lck activity (Zamoyska, R. 2007). 
   
57 
Chapter 1. INTRODUCTION                         1.5 Pre-mRNA alternative splicing 
 
Figure 1.5.2d: Antagonistic regulation of Src-family kinase activity by Csk and 
CD45  
 
  Recently Alexander and colleagues generated transgenic mice expressing 
varying amounts of CD45RO and other isoforms, using CD45 mutant mice with low 
or null PTPase activity (Ogilvy, S. et al. 2003; McNeill, L. et al. 2007). They showed 
that only 3% of wildtype CD45RO activity was sufficient to fully restore thymic 
development from DP to SP cells. In the periphery CD45 had a rheostat effect: low 
CD45 activity reduced TCR signalling and intermediate CD45 activity caused 
hyperactivation. They proposed that CD45 differentially dephosphorylates pTyr505 
and pTyr394, such low amounts are sufficient for activating Y505 whereas large 
amounts of CD45 are necessary to dephosphorylate pTyr394 and suppress T cell 
hyperactivity (McNeil, L et al. 2007). Together with an earlier report showing that 
different levels of CD45 expression affects thymic selection (Wallace, V.A. et al. 
1997), these results suggest that titration of CD45 levels or activity may have non-
linear effects on T cell physiological functions.  
 
The functions above apply to all CD45 isoforms but an important unresolved 
question is the role of different CD45 isoforms on T cell function. CD45 isoform 
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expression is tightly and precisely regulated by alternative splicing through the course 
of development and activation. What the exact roles the CD45 isoforms play have 
remained obscure despite several decades of intensive investigation. One reason is 
that it has hot been possible to generate mice or cells with normal CD45 density when 
they are forced to transgenically express different CD45 isoforms. It is quite 
controversial as some reported that CD45RO is more efficient in restoring TCR 
signalling in CD45 deficient cells, whereas others suggested that large isoforms were 
active (Novak, T.J. et al. 1994; McKenney, D.W. et al. 1995; Chui, D. et al. 1994).  
 
Another important aspect of CD45 is the dimerization and its impact on TCR 
signalling. Xu and Weiss. found that three CD45 isoforms (CD45RO, CD45RAB, and 
CD45RABC) can form homodimers in transfected T cells (Xu, Z. & Weiss, A. 2002). 
They found CD45RO isoform was more efficient to dimerise therefore was less active 
to reconstitute TCR signalling than CD45RABC. The process of dimerization of 
CD45 isoforms was independent on their intracellular domains but was modulated by 
sialylation and O-linked glycosylation.  
 
Acuto’s group tested the roles of CD45 ectodomain in TCR signalling using CD45 
chimeras fused with different ectodomains. They found that a large ectodomain can 
rescue TCR signals in CD45 deficient T cells, whereas chimeras with small 
ectodomain were inefficient (Irles, C. et al. 2003). This correlates to the proposal that 
CD45 large isoform (CD45RAB) is more active in PTPase activity than CD45RO. 
The size of CD45 ectodomain as well as the levels of charges from glycosylation may 
have impacts in TCR synapse formation. CD45RAB could be excluded from TCR 
synapses in which the short CD45RO protein may be involved. To some extent this 
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could diminish the activity of CD45. Y394 is most sensitive to decreases in CD45 
activity, this suggests that CD45RABC could enhance Lck activity in the TCR 
synapse, whereas CD45RO would better penetrate the synapse and blunt Lck 
signalling. 
 
Polymorphisms of PTPRC/CD45 that influence differential isoform expression 
has been found in man and linked to various human diseases including multiple 
sclerosis (MS), type 1 diabetes (T1D), Graves’ disease, systemic lupus erythematosis 
(SLE), human immunodeficiency virus (HIV) infections and hepatitis B (Jacobsen, M. 
et al. 2000; Vorechovsky, I. et al. 2001; Johanneson, B. et al. 2002; Vogel, A. 2003; 
Tchilian, E.Z. et al. 2001), although others reported no such linkage to T1D and 
Graves’ diseases (Wood, J.P. et al. 2002; Thude, H. et al. 2004). These 
polymorphisms lie within or near the exon 4 or 6 and reduce their activity. Analysis of 
T cells from individuals with constitutive exon 4 expression showed increased Lck 
activity, decreased Y505 phosphorylation, and increased TCR signalling (Do, H.T. et 
al. 2006), consistent with the idea that CD45RABC has increased activity. 
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1.5.3. Apoptosis controlled by alternative splicing 
 
Members of the Bcl-2 protein family are the central regulators of the intrinsic 
mitochondrial apoptotic pathway. At least 12 core Bcl-2 family proteins which 
contain 3 or 4 Bcl-2 homology (BH) domain are identified in mammals. These are 
classified into 2 sub-groups (Table 1.3) based on their activities either opposing 
apoptosis, like Bcl-2 itself, or promoting apoptosis, like Bax and Bak. A divergent 
group of proteins containing only the BH3 domain includes Bim, Bad, Bik, and makes 
up the third sub-group of the Bcl-2 family (Youle, R.J. and Stasser, A. 2008). Pro-
apoptotic Bax and Bak are essential for inducing permeabilization of the outer 
mitochondrial membrane (OMM) and releasing apoptogenic molecules like 
cytochrome C to activate caspase, whereas anti-apoptotic members like Bcl-2 and 
Bcl-xL inhibit Bax and Bak. The BH1, BH2 and BH3 domains of Bcl-2 members fold 
to line a hydrophobic pocket that can bind BH3-only peptides. The BH3 domain, 
particularly among the BH3-only proteins, mediates interaction between the BH3-
only proteins and core BCL-2 family proteins.  BH3 only proteins may either bind 
and inhibit Bcl-2 anti-apoptotic members resulting in the derepression of Bax and Bak 
(Willis, S.N. et al. 2007; Hinds, M.G. et al. 2007), or, directly activate Bax and Bak 
leading to apoptosis (Youle, R.J. and Stasser, A. 2008).  
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  Name Domains 
Bcl-2 BH1-4, TM region 
Bcl-XL BH1-4, TM region 
Bcl-W BH1-4, TM region 
A1 BH1-2 
 
Anti-
apoptotic 
  Mcl1 BH1-3, TM region 
Bcl-RAMBO BH1-4, TM region 
Boo/Diva/Bcl-b/Bcl2l10 BH1-2 
 Bcl-G BH2-3 
 
Bax BH1-3, TM region 
Bak BH1-3, TM region 
  
Pro-
apoptotic Bok BH3, TM region 
Bid BH3 
Bim/Bod BH3 
Bad BH3 
Bmf BH3 
Noxa BH3 
Hrk/Dp5 BH3, TM region 
Puma BH3 
Bik/Blk/Nbk BH3, TM region 
  
  
  
  
BH3 only 
  
  
  
  Mule BH3, UBA, WWE, HECT 
 
Table 1.5: Bcl-2 family members  
 
Bcl-2, Bcl-xL, Bcl-W, A1 and MCL1 are considered to have anti-apoptotic 
functions in vivo. The three proteins of Bcl-RAMBO, Boo, and Bcl-G are less well 
studied and therefore not categorized. Bax, Bak, Bok, Bid and BH3 only proteins are 
considered pro-apoptotic. MULE contains a ubiquitin-associated domain (UBA), the 
Trp-Trp-Glu interaction module (WWE) and a HECT ubiquitin ligase domain. Bid 
has a unique role as both a Bcl-2 homologue and a BH3-only protein and links the 
intrinsic and extrinsic apoptosis pathways (Youle, R.J. and Stasser, A. 2008).  
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Apoptosis plays essential roles in regulating T cell development. Developing 
thymocytes are subject to apoptosis if they fail to bind self-peptide/MHC with low 
avidity, or bear strongly autoreactive TCR.  
 
Almost every Bcl-2 family member has evidence of multiple mRNA splicing 
variants. The prototypic member, Bcl-2, has two isoforms. The larger Bcl-2α form 
contains a hydrophobic transmembrane domain within the C terminus, enabling it to 
target mitochondrial membranes and prolong cell survival. The short Bcl-2β isoform 
has no transmembrane domain, resides in the cytosol and exerts no effect on survival 
or apoptosis (Tsujimoto, Y. and Croce, C.M. 1986; Tanaka, S. et al. 1993).  
 
Another important anti-apoptotic molecule, Bcl-x, has been reported with 3 splice 
variants. Bcl-xL contains four BH domains and the C-terminal transmembrane 
domain that helps to localise the molecule to the mitochondria and facilitate its anti-
apoptotic function (Boise, L. et al. 1993). Bcl-xS is the smaller isoform lacking the 
BH1 and BH2 domains due to utilising an alternative splice donor site in exon 2. Bcl-
xS also has the transmembrane domain and localises to mitochondria, but antagonises 
cell survival and induces apoptosis (Boise, L. et al. 1993). A third Bcl-x isoform lacks 
the transmembrane domain, but its function has not been defined (Ban, J. et al. 1998). 
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Figure 1.5.3a: Alternative splicing of Bcl-2, Bcl-x and Bax (Akgul, C. et al. 2004; 
Jin, K.L. et al. 2001; Shin, C. and Manley, J.L. 2004;) 
 
The pro-apoptotic gene Bax also has multiple isoforms. Baxα contains BH1, BH2, 
BH3, and the membrane anchor domain and colocalises with mitochondria to prolong 
apoptosis; Baxβ has no transmembrane domain, therefore localises in cytoplasm, but 
still induces apoptosis. Other Bax isoforms have been reported but their functions are 
still not clear ( Oltvai, Z.N. et al. 1993; Wolter, K.G. et al. 1997; Apte, S.S. et al. 1995; 
Zhou, M. et al. 1998; Schmitt, E. et al. 2000). 
 
Among the eight BH3 only proteins Bim exhibits a variety of splice variants 
showing different apoptotic activity (Bouillet, P. et al. 2001; Adachi, et al. 2005; 
Figure 1.5.3b). The best studied isoforms are the three initially identified: BimEL, 
BimL, and BimS (O’Connor, L. et al. 1998). In the human transcript, BimS contains 
exon 2 as the initial transcript site, exon 8 encoding BH3 domain, and exon 11 with 
the stop codon. BimL has an additional exon 4 encoding the Dynein-binding domain; 
BimEL is the largest of the 3 isoforms and includes both exon 4 and exon 3 plus the 
shared regions. Absence of the Dynein-binding domain in BimS results in failure to 
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bind Dynein-light-chain (DLC) proteins and the Dynein motor complex. This could 
be the reason why BimS has the strongest activity to induce apoptosis because 
mutation in BimL abolishing the interaction with DLC1 functions like BimS (Ley, R. 
et al. 2004). BimL has moderate pro-apoptotic activity and BimEL has the weakest 
apoptotic activity. More Bim isoforms have been reported in different cell lines, some 
of them have been demonstrated with pro-apoptotic effect when over-expressed, but 
only BimS, BimL and BimEL are readily detectable at the protein level (Marani, M. et 
al. 2002; Chen, J.Z. et al. 2004; Miao, J. et al. 2007). 
 
 
Figure 1.5.3b: Bim transcript isoforms (Adachi, M. et al. 2005) 
 
The death receptor Fas (CD95/APO-I) is a major player in the extrinsic apoptosis 
pathway in T cells to help mediate activation induced cell death in peripheral T cells.  
Fas mRNA undergoes alternatively splicing to generate two isoforms. Inclusion of 
exon 6 encoding the transmembrane domain encodes membrane bound Fas (mFas) 
which mediates apoptosis upon ligation of Fas ligand (FasL). By contrast, silencing of 
exon 6 generates a soluble Fas (sFas) receptor that can bind to FASL and prevent 
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programmed cell death (PCD) through inhibition of Fas signalling (Krammer, P.H. 
2000; Cheng, J. et al. 1994; Cascino, I. et al. 1995). 
 
Transcriptional and post-translational regulation of the expression and activity of 
apoptotic molecules have been extensively studied, while post-transcriptional 
modification is still poorly understood (Puthalakath, H. and Stasser, A. 2002). 
Transcriptional regulation of Bim is complex, cell-type specific, and responds to 
several signalling pathways. Bim is transcriptionally up-regulated by FOXO3A in 
haemopoietic cells upon cytokine withdrawal. In the presence of survival cytokines, 
FOXO3A is repressed by PI3K/Akt mediated phosphorylation (Dijkers, P.F. et al. 
2000). Bim is also kept low in growth factors stimulated cells by ERK-mediated 
phosphorylation, which targets Bim for ubiquitination and proteasomal degradation 
(Ley, R. et al. 2005).  
 
HnRNPs and SR proteins play critical roles in alternative splicing of apoptosis 
regulators. Garneau demonstrated that hnRNP F/H is responsible for alternative 
splicing of Bcl-x and the shift between anti-apoptotic Bcl-xL and pro-apoptotic Bcl-
xS (Garneau, D. et al. 2005). Massiello identified two cis-elements for Bcl-x exon 2 
splice donor site selection (Massiello, A. et al. 2004) and showed that the splicing 
factor SAP155 can bind to the cis-element 1 at a purine rich sequence which is a 
typical SR-protein dependent ESE (Massiello, A. et al. 2006). 
 
Also implicated in regulating Bcl-X splicing and apoptosis is Sam68, a member of 
Signal Transduction and Activation of RNA (STAR) metabolism family and a target 
of Src tyrosine kinases (Taylor, S.J. and Shalloway, D. 1996; Lukong, K.E. and 
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Richard, S. 2003). Sam68 contains a KH domain (hnRNP K homolog) and a highly 
conserved GSG (GRP33/Sam68/GLD1) domain which is required for sequence 
specific RNA binding and homodimerization (Lin, Q. et al. 1997; Chen, T. et al. 
1999). Sam68 has been shown to induce CD44 exon V5 inclusion (Matter, N. et al. 
2002). It was also shown that Sam68 has a role in inducing apoptosis (Taylor, S.J. et 
al. 2004). Recently, Paronetto, M.P. et al showed that Sam68 modulates apoptosis 
through binding to Bcl-x pre-mRNA and favouring the selection of Bcl-x upstream 5’ 
splice site to produce pro-apoptotic Bcl-xS isoform. Furthermore, interaction with 
hnRNP A1 is required for Sam68’s effect on Bcl-x alternative splicing, whilst 
ASP/SF2 counteracts Sam68’s splicing activity (Paronetto, M.P. et al. 2007). 
 
Fas pre-mRNA alternative splicing involves another RNA-binding protein, TIA1. 
TIA1 recruits U1 SnRNP to a weak 5’ splice donor site in Fas exon 5 and activate 
exon 6 inclusion of Fas transcript, facilitating generation of pro-apoptotic mFas 
isoform (Forch, P. et al. 2000). Izquierdo found that TIA1 and PTB have antagonistic 
effects on regulating Fas exon 6 splicing. TIA1 binds to an intronic splicing enhancer 
to promote U1 SnRNP binding to the adjacent 3’ splice acceptor site of exon 6, 
whereas PTB represses U2AF binding to the polypyrimidine tract upstream of Fas 
exon 6 resulting in exon skipping (Izquierdo, J.M. et al. 2005). 
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1.6  Focus of this thesis 
 
In this thesis I will describe the characterization of a novel ENU variant mouse 
strain called thunder.  The strain was identified through a peripheral blood leukocyte 
screen using multicolour flow cytometry and the affected mice had significantly 
reduced numbers of peripheral CD4+ and CD8+ T cells.  Subsequent mapping 
revealed a mutation in a previously unknown member of the hnRNP protein family, 
Hnrpll.  Further analysis of the thunder mice revealed that the Hnrpll gene is a critical 
trans-acting regulatory factor that coordinates the alternative splicing of the three 
variable exons of CD45 mRNA encoding exons 4, 5 and 6.   
 
The aims of the thesis were: 
1. To characterize the cellular phenotype of the thunder mice to help identify a 
cellular biomarker that would facilitate mapping and identification of the mutant gene. 
2. To map and identify the ENU variant gene responsible for the loss of peripheral 
T cells and the change in CD45 alternative splicing. 
3. To investigate the effect of the Hnrpll mutation on T cell homeostasis in vivo 
4. To investigate if the Hnrpll mutation has any effect on positive selection of 
antigen-specific T cells. 
 
The studies presented in this thesis provide new insights into the regulation of 
mRNA splicing in T cells and the regulation of T cell homeostasis. The thunder strain 
has provided a unique resource that has enabled us to address a fundamentally 
important question within the immune system which until now has been intractable to 
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analysis at the molecular and cell biological level.  The thunder strain has allowed us 
to gain insight into the diversity of alternative splicing and how it is used to control T 
cell homeostasis as well as the generation of T cell effector responses and long lasting 
immune memory. 
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2.1 Mice 
 
Some major mouse strains used in this study are described below: 
 
C57BL/6S (B6): inbred mouse strain was originally obtained from Stanford 
University (CD45.2 or Ly5b).  
 
C57BL/6S:Ly5a: B6 strain congenic for CD45.1 (Ly5a).  
 
CBA: inbred mouse strain. 
 
RAG1-/-:  RAG1 deficient mouse strain were bred on the C57BL/6 background 
and are devoid of mature T and B cells due to a null mutation in the RAG1 gene 
which prevents antigen-receptor rearrangement to occur in immature lymphocytes.   
 
Lochy mice: A CD45 (Ptprc) mutant mouse strain identified by Adele L. Yates 
from an ENU mutagenesis screen carried out to identify mutations that affect 
lymphocyte development and homeostasis (Nelms, K.A. & Goodnow, C.C. 2001). It 
contains a T to A conversion of the intronic nucleotide 93085 of the genomic DNA 
sequence in the 5’ end of exon 17 boundary resulting change of splice site, insertion 
of 5 base pairs to the transcript, shift the open reading frame in the PTPase D1 domain, 
and eventually cause CD45 low expression because of nonsense mediated decay 
(NMD) (Yates, A.L. 2003). 
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Jasmine mice: This is a novel ENU variant strain that was identified in the same 
screen as the thunder and lochy strains.  It was determined that the Jasmine mice have 
a missense mutation in the Transporter of Antigen Presentation 2 (Tap2) gene and 
these mice have been maintained on a C57BL/6 background.   The Tap2 transporter 
plays critical roles in delivering antigenic peptides from the cytoplasm into the 
endoplasmic reticulum where they can be eventually loaded onto MHC class I 
molecule. The Jasmine mice have defective CD8 T cell development because MHC 
class I complexes cannot be formed and presented on the surface of antigen-
presenting cells in the thymus or periphery.  In contrast CD4+ T cell development is 
unimpeded since the Tap2 gene does not affect peptides loaded onto the MHC class II 
molecules. 
 
3A9 TCR transgenic mice: TCRα+β transgenic mice produced in C57BL/6J mice 
were backcrossed more than seven generations to B10.Br/SgSnJ (B10k JAX). It 
expresses a rearranged TCRαβ chain (Vβ8.2 and Vα3) and directs thymocyte 
development towards CD4 lineage bearing transgenic TCR, which is specific for the 
immunodominant peptide of HEL (Hel46-63) complexed with the major 
histocompatibility molecule (MHC) I-Ak. 
 
InsHEL transgenic mice: The ILK-3 transgenic mice express the hen egg 
lysozyme (HEL) protein under the control of the rat insulin promoter and this directs 
expression of the HeEL proteins to pancreatic islet β cells acting as a neo-self antigen. 
The ILK-3 strain produced in C57BL/6J mice was backcrossed more than seven 
generations to B10.Br/SgSnJ (B10k JAX). 
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3A9 TCR:insHEL double transgenic mice are generated by breeding 3A9 TCR tg 
mice x Ilk-3 Hel tg mice.   Most of the Hel-specific CD4+ T cells are deleted during 
negative selection in the thymus and residual circulating transgenic T cells are 
functionally anergic. This mouse model is ideal to study the regulation of organ-
specific autoimmunity (Hoyne, G.F. and Goodnow, C.C. 2006). 
  
All mice were bred and purchased from the Australian Phenomics Facility, 
Australian National University. All mice were housed in specific pathogen free 
conditions and all animal procedures were approved by the Australian National 
University Animal ethics and Experimentation Committee. 
 
2.2 Flow cytometry 
 
2.2.1 Cell surface staining 
Cell suspensions of spleen or thymus were prepared by sieving and gentle 
pipetting. For surface staining, cells were maintained in the dark at 4oC throughout. 
Cells were washed twice in ice-cold FACS buffer (2.5%FCS, 0.02% NaN3 in PBS), 
then incubated with each antibody and conjugate layer for 30 min and washed 
thoroughly with FACS buffer between each layer. Data were acquired on a FACS 
Calibur® flow cytometer, and analysed using FlowJo software (Treestar). Cells were 
sorted on a FACSVantage (BD). 
 
The commercial antibodies were used (all from BD except where otherwise 
indicated):  CD3ε-FITC, CD4-PerCP, CD4-APC, CD4-FITC, CD8-FITC, CD8-PE 
(Caltag), CD8-PerCP, CD44-FITC, CD44-PE, CD44-APC, CD45.2-FITC, CD45.2-
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APC, CD45.1-FITC, CD45.1-PE, CD45RA-biotin, CD45RB-FITC, CD45RC-PE, 
CD62L-biotin, B220-PerCP, B220-APC, B220-PE, B220-biotin, CD19-PE, AA4.1-
FITC, CD19-PE, CD25-APC, CD69-FITC, CD69-biotin, CD90-PE, CD95-PE, CD5-
PE, CD127-PE, CD122-FITC, CD132-PE, anti-TCRβ-FITC, 7AAD (Molecular 
Probes), Ly5a-PE, Ly5a-biotin, Ly5b-FITC. Secondary antibodies and streptavidin 
(SA) conjugates were: rat-anti-mouse IgG1-APC, rabbit anti-rat-IgG-biotin (DAKO), 
SA-PE, SA-APC and SA-Cy-chrome.  
 
The 1G12 monoclonal antibody is a clonotype specific mouse IgG raised 
against 3A9 TCR produced from the 1G12 cell-line that was a gift of E. Unanue and 
D. Peterson from Washington University St. Louis, MO. The cell-line was grown in 
RPMI with 10% FCS and PGS for 3 days post-confluence. The supernatant was 
purified and used at 1 in 5 dilution for cell surface staining. Rat-anti-mouse IgG1-
APC was used as the secondary antibody. 
 
Solutions used for flow cytometry: 
FACS wash: PBS + 2.5%FCS +/- 0.1% azide. 
Red Blood Cell Removal Buffer (Tris-Ammonium Chloride, TAC): 
Tris Base    2.06g 
NH4Cl       7.47g 
MilliQ H2O make up to 1 L before adjust pH to 7.2. 
 
2.2.2 Intracellular staining 
Antibodies include IL-4, IL-5, IL-17, IFN-γ, Foxp3-FITC, Lck-FITC, 
pLck505-FITC, Tyr416 (Cell signalling), and Bcl-2-Biotin. Isotype control and 
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suitable secondary antibodies were performed. Foxp3 intracellular staining kit (BD 
Pharmingen) was used following manufacturer’s instruction. Data were acquired on a 
BD LSRII flow cytometer, and analysed using FlowJo software.  
 
2.2.3 Cell sorting 
The whole spleen cells from 6-8 weeks old female mice were stained with 
CD4-FITC, CD8-PE, and CD44-APC in sterile FACS wash buffer. Naive and 
memory T cells were sorted on a FACS Vantage (BD), gated on CD44lo and CD44hi 
respectively and collected in sterile medium. 2-5 millions of cells were collected from 
a pool of 3 sibling mice with same genotype. Total RNA were isolated immediately 
after sorting for Real-time PCR and exon array experiments. 
 
2.3  Genome mapping and sequencing 
 
2.3.1 Genomic DNA isolation from mouse tails: 
 
Approximately 0.5 cm tails were collected and cut into small pieces in 1.5 ml 
effendorf tubes, add 300 µl tail DNA lysis buffer with 3 µl of 20 mg/ml proteinase K 
(Merck catalog: 1.24568.05000, added before use) and incubated at 56 °C for at least 
2 hours. The samples were centrifuged at 13000 rpm for 10 minutes, and the 
supernatant was transferred to new tubes.  Saturated NaCl (6M) 150 μl per tube was 
added and mixed by inversion till the sample turned uniformly cloudy. The sample 
was centrifuged at 13000g for 10min and the supernatant was added to a new tube to 
which 450uL of ice cold isopropanol. The samples were vortexed and centrifuged as 
above for 1 minute. The supernatant was discarded and the pellet was washed with 1 
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ml 70% ethanol. The DNA pellet was resuspended in 100 µl TE buffer or ddH2O. 
DNA samples were quantitated using Nanodrop Spectrophotometer (ND-1000, 
Nanodrop Technologies, USA). 
 
Solutions: 
 Tissue Lysis Buffer:   
[50mM] 1M Triris pH 8.0   50mL  
[100mM] 0.5M EDTA           200mL 
[0.5%] 10% SDS              50mL 
MilliQH O (Sterile) make up to 1000mL 2
        
  TE buffer:                       1M Tris, pH8           10ml 
0.1M EDTA         1ml 
MQ water make up 1L, use after autoclaved. 
 
2.3.2 Genome linkage screening by PCR using SSLP markers: 
 
DNA from (B6 x CBA)F2 intercross affected mice was analysed by PCR 
amplification of Microsatellite (MS) markers obtained from the MIT database based 
on genomic spacing and reliable discrimination between B6 and CBA strains. PCR 
using MS markers can be used to amplify approximately 6500 different Simple 
Sequence Length Polymorphisms (SSLPs) commonly dinucleotide repeats throughout 
the genome within inbred mouse strains to identify different genomic regions (Rust, S. 
et al. 1993; Schlüter, B. et al. 2002). Figure 2.1 shows an example of a SSLP in a 
particular region between B6 and CBA strain that can be amplified by MS-PCR and 
visualised by different product size when read on gel electrophoresis. 
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CBA
 
Figure 2.1 an example of SSLP between B6 and CBA strain 
 
Whole genome linkage screening was performed by Mr. Adam Hamilton 
(Genotyping and mapping group, IGL) using a set of markers spaced 30-40 cM 
distance from one another. Primers and PCR conditions are listed in below. 
 
Table 2.1 Microsatellite markers (SSLP) used for B6хCBA genome mapping: 
 
B6 
(bp) 
CBA 
(bp) Markers cM F primer R primer 
AGCCTGACTCAACAAGA
CAG 
GTGAACTGTGTACTCTCC
TC D1 Mcg163 35 261 289 
D1Mit42 78 
CTCAGGCACCATTCTAAA
CATG 
ATAGGGCAAAAAACATTC
TTGC 180 200 
D1Mit155 112 ATGCATGCATGCACACGT 
ACCGTGAAATGTTCACCC
AT 252 216 
D2Mit102 52 
TATTTCCCTGTCACTCCT
CCC 
TGTCTTTATGCTCAGACAT
ACACA 162 180 
D2Mit15 50 
ATGCCTTAGAAGAATTTG
TTCCC 
CTTGAAAAACACATCAAA
ATCTGC 145 160 
D2Mit226 96 
TTTTTGCAACTTTGTTAA
GAATTCC 
AAAACACCCTCCCACCCT
T 102 124 
D3Mit268 13.8 
GGGATTTTAAAGCAAAGC
CC 
TCATGCACACACATGAAC
ATG 106 122 
D3Mit120 28 
CAGTCCCCAAGACACAC
ATG 
TACAGGATTGAGGCTAGT
TTTCG 148 160 
D3Mit102 49.7 
GGCTCGCTGGTTGGTTTT
AC 
GGGCTCCTACATGCATGA
AT 152 142 
D3Mit127 70.3 
CCTTCTGACAAGCAGGAT
TTG 
TTTCTAGCATCTCCAAGC
AGG 176 262 
D4Mit172 8.6 
TGCAGGTAGGGGCTCAA
G 
AAGCAGATCTGGCTTCCT
CA 137 123 
D4Mit288 28.6 
TATGCATTAGTCTAGGTG
GTAACAGC 
TTAGCCATGTAGGCAATG
CA 116 100 
D4Mit16 59.1 GATCACCCAAGGCTGGC TCCCCGTGAACTTCCATC 217 235 
D4Mit62 79 
TCCTCTGCCAGCTCTCTC
TG 
CTGCAAGGAGGTGATGTT
CA 190 170 
D5Mit348 8 
CTGACCAGAACACAGCA
TAGTACA 
TTTAAAATAGGAAAAGCAT
TCTTTCC 123 115 
D5Mit391 26 
AATAAGAAAATTCCACCA
AGTCTACA 
CTTGATGGGTCTGATGCC
TT 148 178 
D5Mit7 45 
AAAGGGGGTCTTCTTTG
GAA 
TCTCCTGTAGTGGGTGGT
TT 119 149 
D5Mit320 70 
CTGAGGTGTATGTATGTT
GCATATATG 
TCCGGTCTCAGTACATGT
ACAA 125 111 
D6Mit268 15.6 
AGTCAGAATATGGCAAGT
CAGTG 
TTTCAGAGTCTTTCTTTCA
GTATCTCC 123 110 
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D6Mit61 62.5 
TACAGAGGCTAGAACACT
CCTGG 
CACTTGTTGCTCCTGCTG
AG 135 146 
D7Mit230 24.5 
GGGTTAACTGCTTTTTAA
AAGTGC 
ACTTCTGCATGTTGCCCT
CT 107 91 
D7Mit40 53 
GTCAACAGTCAGGAAAG
CTGG 
CAGATGCTTGTATTTGCA
AAGC 204 228 
D8Mit224 17 
ACGTCCCCAGTGCTTAAC
AC 
TGGTGTAGCATAAAGCAT
ATGTCC 326 454 
D8Mit56 75 
ACACTCAGAGACCATGA
GTACACC 
GAGTTCACTACCCACAAG
TCTCC 160 180 
D9Mit129 26 
TTGTCTTTTAACCTCCTG
GAGC 
TCCCATCTTTCTCCTTGTG
G 132 150 
D9Mit115 56 
TCCAGACTCCTGGGAAC
TACA 
TTTCCCAGCCAGTAAAGG
C 145 137 
D10Mit3 21 
GTTGATAGTCCCACCTCA
CTCA 
TGAGAAATTCCATCTGTG
GC 260 210 
D10Mit70 59 
ACCTTTCTTCCTACCTAC
CTACCT 
TGGCACTTAGAAACTGAT
AAATGG 144 148 
D11Mit21 20 
GAGAGCTCTTTCACACTT
GAAGG 
CAGAAAGGCTCCTACCTC
AGG 156 146 
D11Mit123 58 
AGAAGAAACAAGAGCTG
ATGGC 
GCTTCTTGCCAAGTCAGG
AC 310 335 
D12Mit236 22 
TGTTGCTAATCACAGTCC
ATATCC 
GTTGGCTTCTGGCTTCTG
AC 121 109 
D12Mit132 52 
CCATATACATTTCTAACA
CCCTTGC 
AGAACTTACTTCTAGTGG
AGACAATGC 131 112 
D13Mit88 21 
ACTGATGGCTCATGAGA
CCC 
AAAATTAATAGGAACTGC
AAGGG 170 180 
D13Mit211 58 
TTTGCAAAAGACAAGACT
TATTGC 
AAAAGACATCCAGTTCTC
AATGG 118 126 
D14Mit10 3 
CTCCTCCCCTCCCTACCT
C 
AGCACGGAATTACGGAAC
AC 114 132 
D14Mit115 40 
AACTCTGCACTGTGGCA
GG 
AGTTTGTAAGAAAAGGAA
GCAAATG 113 137 
D15Mit122 34 
ACCCAGTGCAGGTGCTC
TAT 
GGAGAATACAAGTTATGC
CTTAGACC 150 146 
D15Mit108 55.6 
TCCCATGTTACTCAGGAA
TGC 
GCAGAAGACATTCACAGT
CTTAGG 130 140 
D16Mit103 22 
GGTGTGCATACACACAT
GCA 
TGACTAGACTTGACTCCT
CCACC 111 126 
D16Mit6 63.2 
CAGGTCCAAGAGGAGAA
CCA 
TTTGACCTGTGAGCCTGT
GG 191 200 
D16Mit70 57 
GGATCTATATGCTATAGA
ACCATTCA 
GTCATCAATTCCATTTCCT
AATATAGA 189 169 
D17Mit133 10.4 
TCTGCTGTGTTCACAGGT
GA 
GCCCCTGCTAGATCTGAC
AG 180 155 
D17Mit38 45.3 
CCTCTGAGGAGTAACCA
AGCC 
CACAGAGTTCTACCTCCA
ACCC 110 92 
D18Mit202 22 
CCCCTTGCAAAGATGGA
GTA 
CATTTGCTAGTTTAGCAG
GAAGC 111 143 
D18Mit184 41 
CACACATGTGTAGGTAG
GTAGGTAGG 
CGCACAAGGACTACTGAA
ACA 172 127 
D19Mit16 15 
TCTTAGGTAATCTCCCTT
AGGGG 
TGGTAAATGTAAAACTGA
AGCATG 118 136 
D19Mit1 52 
AATCCTTGTTCACTCTAT
CAAGGC 
CATGAAGAGTCCAGTAGA
AACCTC 121 142 
 
PCR mix: 
DNA sample (10-20ng/ul):                    2 µl 
10X Buffer:                                            5 µl 
dNTPs (10mM):                                     1 µl 
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Forward primer (10 µM):                       1 µl 
Reverse primer (10 µM):                          1 µl 
ddH2O:                                                   39 µl 
Taq Polymerase:                                       1 µl 
 
PCR program (optimised in some reactions): 
Steps Temp (oC ) Time (min) # of cycles 
1. Initiation/Melting 94 2 1 
2. Denaturation  94 0:30 
3. Annealing               55 0:20 
35 (steps 2-3-4 will 
cycle in sequence) 
4. Elongation  72 0:30 
5. Finish (i.e., 10oC,) 10 hold 1 
 
Solutions: 
10x buffer: 10X PCR buffer 
2M Tris.Cl pH 8.8  (Tris base Roche # 1 814 273)              3.35 ml 
1M (NH )4 2SO 1.6 ml         4                                                                                                           
2 ME (mercaptoethanol)                                                           70μl 
1M MgCl2  (Final Conc = 2.0mM MgCl  / PCR reaction)     200μl 2
MilliQH O (Sterile):                                                            4.780ml 2
 
2.3.3 Fine mapping 
 
Fine mapping was performed by expanding the Microsatellite marker panel, 
and also by using more markers including Single Nucleotide Polymorphisms (SNPs) 
markers between C57BL/6 and CBA inbred strains, Samples from a larger cohort of 
affected and unaffected F2 mice were used to delimit the locus containing the ENU 
variant gene. During the mapping process the Genotyping lab had moved toward 
using SNP markers routinely for fine mapping of ENU variant genes. The SNP 
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markers were also used to map the polymorphism of distal end of chromosome 17 
between B6 and CBA strains using Ampliflour technology  (Flowgen Bioscience).  
Amplifluor® Universal Systems are based on energy transfer from an excited 
fluorophore to a complex acceptor moiety resulting in quenching of the 
fluorescence.  The quenching is accomplished by linking the fluorophore and the 
acceptor 4-(dimethylamino) azo benzene sulfonic acid (DABSYL) to an 
oligonucleotide primer.  Each reporter UniPrimer™ is composed of a 5' hairpin region 
with a unique energy transfer pair and a different 3' primer sequence.  The primer 
sequences enable the UniPrimer to work with specific unlabelled primers that can be 
used to amplify specific sequence of interest.  The target primers are synthesised with 
a 5' tail sequence complement to the 3' region of a particular Uniprimer™, allowing 
hybridisation of the Uniprimer served as a template for DNA polymerisation. The 
hairpin structure unfolds to double strands and disrupts the energy-transfer between 
the fluorophore and the quencher so as to emit fluorescence (Figure 2.2).  
Figure 2.2 Schematic Amplifluor PCR (Adopted from http://www.flowgen.net) 
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Mrs. Belinda Whittle from the genotyping and mapping group of IGL helped to 
identify SNPs between C57BL/6 and CBA mouse strains from the Wellcome Trust 
Centre for Human Genetics database of mouse SNP genotype set 
(www.well.ox.ac.uk/mouse/INBREDS), and designed Amplifluor primers based on 
SNPs through AmplifluorTM Assay ArchitectTM at http://apps.serologicals.com/AAA/.  
SNP primers and more MS markers used for fine mapping of chromosome 17 were 
listed below in table 2.2 and table 2.3 respectively. 
 
Table 2.2 SNP primers used for fine mapping of distal chromosome 17 
JAX SNP ID 
(chr-position-
source) 
New Chr 
position 
(bp) 
RefSNPs 
ID Allele-specific primer 1/primer 2/reverse primer sequences 
 
GAAGGTGACCAAGTTCATGCTCCAACTACAGCAGCATTTCACTGG 
GAAGGTCGGAGTCAACGGATTCCAACTACAGCAGCATTTCACTGA 
17-
077624509-N rs4231663 76,987,367 
      
      GACTTTCCCACCTCAGAGTCTCAT 
GAAGGTGACCAAGTTCATGCTACTTCTCCCAGTTGGTCCTCACA 
GAAGGTCGGAGTCAACGGATTTTCTCCCAGTTGGTCCTCACG 
17-
080241937-M 79,603,774 rs3676709
      
      CCCTGGCTACAGAAGATTCTGAGAGTCAAT 
GAAGGTGACCAAGTTCATGCTTGCTGGGTTGATTCAGCCAAGACA 
GAAGGTCGGAGTCAACGGATTTGCTGGGTTGATTCAGCCAAGACT 
17-
083294998-M rs3707550 82,660,173 
      
      ATCCCTCACTGCGGAAGGAGAAT 
GAAGGTGACCAAGTTCATGCTGCATCTGTGAGAGTGTGACAGC 
GAAGGTCGGAGTCAACGGATTGTGCATCTGTGAGAGTGTGACAGT 
17-
086110517-N 85,479,538 rs4231722
     
     GTCTTCACATGGAAGGAGGCTA 
GAAGGTGACCAAGTTCATGCTTCAAGCTAACAGCCTAGCACAC 
GAAGGTCGGAGTCAACGGATTTCCTTCAAGCTAACAGCCTAGCACAA 
17-
090405932-M rs3675244 89,770,264 
      
      GGACAGATTTGGTCAGCCATCCTCAA 
GAAGGTGACCAAGTTCATGCTAAACCAGTCAAACAGATATAAATACAGTT 
GAAGGTCGGAGTCAACGGATTAAACCAGTCAAACAGATATAAATACAGTG 
17-
091151542-M 90,508,757 rs3711314
      
      CAAAGCATCACAGTGCTAATTGCTTT 
GAAGGTGACCAAGTTCATGCTAGTACAGACTATCAAAGAATGTGCTTT 
GAAGGTCGGAGTCAACGGATTAGTACAGACTATCAAAGAATGTGCTTC 
17-
093441700-M rs3707114 92,846,090 
      
      CCACTTTGTTACTGAGACATTT 
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Table 2.3 MS markers used for chromosome 17 
MS 
markers cM position (bp) B6 (bp) CBA (bp) 
D17Mit133 10.40 23,455,567 180 155 
D17Mit88 29.50 55,559,823 242 186 
D17Mit38 45.30 72,746,147 110 92 
D17Mit42 47.4 77,603,774 156 162 
D17Mit123 56.7 91,943,428 133 155 
 
Amplifluor PCR reaction: 
DNA (10-20ng/ul)              2ul 
DD H2O                           4.6ul 
dNTP                                0.8ul 
10×Buffer                            1ul 
FAM primer                      0.5ul 
JOE primer                        0.5ul 
Allelic primer                    0.5ul 
Taq DNA polymerase        0.1ul 
 
Amplifluor PCR program: 
 
Steps Temp (oC ) Time (min) # of Cycles 
1. Initiation/Melting 94 2 1 
2. Denaturation  94 0:10 
3. Annealing               55 0:20 
35 (steps 2-3-4 will 
cycle in sequence) 
4. Elongation  72 0:40 
5. Elongation 72 3:00 1 
6. Finish (i.e., 10oC,) 20 hold 1 
 
 
2.3.4 Sequencing 
 
Total RNA were isolated from spleen of individual wildtype and thunder mice 
using Trizol reagent (Invitrogen, Carlsbad, CA). Cells were homogenised or 
82 
Chapter 2.                                                                         Material and methods 
resuspended in Trizol and then chloroform was added for phase separation. RNA was 
precipitated from the aqueous phase with isopropanol and 1ul Linear Acrylamide 
(Ambion, Austin Texas) and washed with 75% ethanol, and the RNA was dissolved 
in DEPC treated water. cDNA were synthesed using SUPERSCRIPT First Strand 
cDNA Synthesis kit (Invitrogen cat: 18080-051) following manufacturer’s instruction.  
 
Transcripts of candidate genes in the linkage interval were amplified by 
reverse transcription PCR using Elongase DNA polymerase kit (Invitrogen, Cat: 
10480-010) following manufacturer’s direction. Primers are listed below in table 2.4. 
 
Table 2.4 Sequencing primers for genes in Chromosome 17 77.6-79.6 Mb 
Genes Forward primer Reverse primer 
Arl6ip2 gtttgacgtcagtggggagt TAGCAGCACAGCCACTTTTG 
Arl6ip2 CAAAAGTGGCTGTGCTGCTA CTCAGCTGTTGCCTGAAGC 
Arl6ip2 GAGAGGAACTACCACACCCAAA TGTTCCCACAGTGTTTCAGC 
Arl6ip2 AGGAGTCCCAGGAAGGTGTT GGAGAGTGGAGTCCATGAGC 
46633 ACTGCCACCTCCTCCAGTT TCAGTGCTTCAGGGGAAAAG 
46633 CCTGACTCCTAAACGGATGG GGCTAACATCACCACATACTCG 
66941 TGACCTTGAACTCACAGAGATCC TGACAACTGTAGGACTGGAGAGA 
Hnrpll ACCGATCAGCGACATCTGAG TCTGCAGCAAATGTCACACA 
Hnrpll AGGCTCTCGTGGAGTTTGAA GAAGACGCTTGTGGTAATGGA 
Hnrpll TGGGCTCTAGAGATACACCTGA GCAAGGCAACATTAGACCAA 
Galm AGAAGCTGCACACCCTGAAC CATCTGCTGCAATGGTGACT 
Galm GCCAGACCACTCCAGTTAATC TAAAGCAAGGCAGGTGAGTG 
Rik aaaaagcccaggatagtgactt TGTAGGCCTGCTTCCAATTC 
Rik TACTGGGAGCTCATGTGGTG cacagaagcacactgggttaag 
sfrs7 GCCTATATAAGCGCGACTCC TCGTGACCTGCTTCTTCTTC 
sfrs7 TCGTCCCTTTGATCCTAATG AGATGGTTGATGATCCTTCCTA 
sfrs7 TCTCAAGTTCACCCGTTAGG CCCTCTAAGCTTGACAATTCC 
sfrs7 GAGTGCATCATGTCAGATCTCTA AGGAGGAAAAACCCAAAACA 
sfrs7 TTCTATTTTGCCAAGCTGGT tcaatctctgcagatttattgaac 
sfrs7 AGTAGCGCGAGGGGAAGAC TGCGGGAGCGAGAGTATC 
sfrs7 atgatgggcgttaagattcg ggtggcctatcaaaacgaga 
sfrs7 cgtcgtccctttgatcctaa ggttgatgatccttcctaggtt 
sfrs7 CTAGATCCCATTCCCGATCC CCCAGTGATTAGGTGGCAGA 
Mopt CCTAGGGGAATCGCAGAGT TGTGGGTGCATGACAACTTT 
Gm941 TTGCATTGTAGGAAGAGCTGA TCAGGATCAGCGAGATGTTG 
Gm941 ACTGTGGCTCTGGAACTGCT ggcaccgtcacaaccttact 
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Q8BSD7 TGCTTCGCGTGCTGTAGA CTGGAGACTGGGAGCTGGAG 
Sos1 GCAGCTGCCTTACGAGTTTT GGTGGAAGGCTCTTCATCAG 
Sos1 TGTGCTGATAAGGTATTGATGG GGGCTGTTATTGCTTGCTTC 
Sos1 CCACTGTCTGCATTACTTTGAA CTCCTCGGAGTCAGGTTCTG 
Sos1 CTGCCCAGTGCTGAAGTGTA TGCTTATGTGCCACTCAACTG 
Sos1 AATGGGTCGAATCCATCACT GCCCTCTTCTGTCTTCAGGA 
Sos1 ACCGTGTGTGCCTTTCTTTG CTTCATCAGTGCCCTTGGAT 
XP-355031.3 caagtcgaccggtacactaaaa CGTGTCTCCCACGAGAAGTT 
XP-355031.3 CACAGACTATGTTGCCACCAG tcacgtggaaaagcagaaaa 
Map4k3 GAACCCGGGCTTCGATCT ATTGTACCCGCCTTTCCTCT 
Map4k3 ACAATTGCCAAACGGAAGTC CCTCTTCAGCGCCAAATATC 
Map4k3 TGTGCCACATCCTGGATAAA AATTGGGATTGACCGTCTCA 
Map4k3 TACCCTCTGGTCTGTGTTGG CTAGGTTCCTGCAGGGTCTG 
54957 acacccaccaggagaggag GCAGTCTGGACGTAATGCTG 
54957 TACGTAGCCGCGACATTACC tcctggaaacttggcttttt 
66934 agcgcagacatcaccagac caatggtggagaagacacca 
M05Rik gaggccaagtGCATTGTGT GGATTGGCTGAGAAAAGTGG 
M05Rik GACATCGACACCCTCATCCT GGATAAGCGATGCAGAGACC 
Thumpd2 TGAGCGCCATGGCTGTAG TCACTCTTCCTGCCTCCTGT 
Thumpd2 CTCAGGACCAGGAGGACTTG ACGCAGCACTCTTTCCATTT 
Thumpd2 TGACATTCCATTTGGGAAAAA CCAAGGCAGGAAGCCTTATT 
NM_178927.2 CCCAGTAGGTGACTTAAGGGTA CTGCTCAAGGCATTCCAAGT 
Slc8a1 ggttggagcagttggaagtc GGCTGCTGTCACAAAGAACA 
Slc8a1 GGTCCCTGATGGAGAGACAA TTCAGCCATTTCCATGTTGA 
Slc8a1 AGCTGATCAAGCAAGGAAGG GAATTCGAGCTCTCCACAGG 
Slc8a1 CAAAACTATTGAAGGCACAGC GGCAAACAGAACCTTCCAGA 
Slc8a1 AGAAGCTGCCCTCCTGTTTT ttgttcctTTAGAAGCCCTTT 
ENSMUSG000006932 AAATCTCAGGTTTGTAGCATCC ATGATGAGAAGGAAAGGAGTTG 
66931 AAAGCCTAGGGAATGAAAGGA AAGCTGGTTCCCAGTCTTCA 
AW494914 GAACCTTGCATGACTAGGTGAA AGAAACACTGGCGGAGAAGA 
AW494914 GGCCCTGAGGATCTGTGAT GGCCTTGCCATAAAGGAACT 
AW494914 CCTACCTCTGGCTTGTCGTT TCCCACATCCAGTCATACCA 
AW494914 CAAGCACCAAGTGGTTGTCA GCTCCCGTCCTGTAACACAT 
AW494914 CAGTTTTTCCTGGAGGATGC CTCAGCAATGTTGGTGGAAA 
AW494914 TGAAACCTCCAATGGGTGTA GGGAGACACAAAAGGGGACT 
AW494914 GGACCCTGCTCTCACCATT TAGGGGCTGTCGAAGTGTCT 
AW494914 ATGTCCACATTCACCCTTCC CAGTCTTCCGTGGGAGGTAG 
Gmin6 cGGCGTGTGAGCTAAGTAGA ATTGGAGCTGCTGCAGTTTT 
Gmin6 AAATGGCTGGAGAAGAACCA ccacccaggaaaaaccaata 
 
PCR mix to amplify transcripts of candidate genes: 
ddH2O                                                                                 34 ul 
5x buffer B (or a mix of A and B for Mg+ titration)          10 ul 
dNTPs (10 mM)                                                                    1 ul 
Amplification primer A (Forward) (10 uM)                      0.5 ul 
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Amplification primer B (Reverse) (10 uM)                       0.5 ul  
Elongase DNA polymerase                                                  2 ul 
cDNA (10-20ng/ul)                                                              2 ul 
Programs:  94°C, 3 minutes, 1 cycle. 
94°C, 30 seconds, 
59°C, 60 seconds, (variable from primers) 
72°C, 90 seconds, 36 cycles. 
72°C, 5 minutes, 1 cycle. 
 
Amplified cDNA products were then electrophoresed in 1.5% agarose gel, 
stained with EtBr, cut under UV light, and purified with Gel Purification kit (Qiagen) 
following manufacturer’s instructions. cDNA were quantitated with Nanodrop 
Spectrophotometer and sequenced using BigDye terminator mix performed by Mr. 
Carmarone in the Biomedical Research Facility, JCSMR. 
Sequencing reaction: 
5x buffer (BRF)                                                                      3ul 
Clean DNA (can use less if DNA product is short)          25-50 ng 
Sequencing primer (10 uM)                                                  1 ul 
Big Dye mix (BRF)                                                         2 ul  (1/4x) 
ddH2O to 20 ul 
Program:  
1. 94C – 5 min 
2. 96C - 10 s 
3. Ramp 1C/sec 
4. 50C 5 sec 
5. Ramp 0.5C/sec 
6, 60C 4 min 
7. Ramp 0.5C/sec 
8. GOTO 2, 30 times 
9. 10C hold 
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Sequencing were performed in both directions (forward and reverse), using the 
same primers for RT-PCR amplification of gene of interest. Sequencing results were 
analysed using Sequencher software. 
 
2.3.5 Genotyping thunder mutation 
 
Mrs. Belinda Whittle designed allele specific primers for distinguishing 
wildtype and thunder mutation in the Hnrpll gene to genotype the Thunder mice using 
mutagenically separated PCR (MS-PCR) strategy (Rust, S. et al. 1993; Schlüter, B. et 
al. 2002). Introduction of mutations into the PCR-primer binding regions in an allele 
specific manner prevents the formation of products by the error elongation of the 
wrong primer in subsequent cycles. The allele-specific primers introduce additional 
deliberate differences into the allelic PCR products in one reaction that can be 
identified by gel electrophoresis.  
 
Table 2.5 Primer sequences for thunder genotyping 
Primers Sequence 
F' Wt GTCCATGTTCGAGGGCTCTGTGAATCTCT 
thu F' Mut CTGTTTCCCCTGTTCACCATGTTCGAGGGCTCTGTGAATGTGA 
thu Rev CATATTGTCCCAAATTTCTCCAGTGCC 
Table 2.6 PCR mix of thunder genotyping: 
Reagent/ Constituent Volume (uL) 
DNA Sample (ear punch) 0.5 
2x  Qiagene Multiplex Master Mix 5 
Q solution 0.25 
ddH2O 3.5 
Primer 1 (10 uM) Name: thunder F’WT 0.30 
Primer 2 (10 uM) Name: thunder F’Mut 0.15 
Primer 2 (10 uM) Name: thunder Rev 0.30 
   TOTAL VOLUME OF REACTION 10 ul 
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Table 2.7 MS-PCR program of thunder genotyping: 
oC ) Temp ( # of Cycles 
Steps Time (min) 
1. Initiation/Melting      95 15 1 
2. Denaturation  95 0:20 35 
3. Annealing               60 0:20 steps 2-3-4 will cycle in 
sequence 4. Elongation  72 0:30 
5. Finish 10 hold 1 
 
The PCR products were separated by gel electropheoresis in 3% agarose gel 
that was ran at 400mV for about 10 minutes before staining and visualising wildtype 
band of 77bp and thu/thu band of 91bp of size using EtBr. 
 
2.4 RT-PCR and real time PCR 
 
2.4.1 Total RNA isolation, cDNA synthesis, and RT-PCR verifying 
alternative spliced transcript variants 
 
Total RNA were isolated from thymus and lymph nodes of 3 individual 
wildtype and thunder mice using TRIZOL and chloroform, precipitated with 
isopropanol and 75% ethanol, and resuspended in DEPC treated water. cDNA were 
synthesised using SUPERSCRIPT First Strand cDNA Synthesis kit (Invitrogen) 
following manufacturer’s instruction. CD45 transcripts were amplified with a forward 
primer (5’-GGC AAA CAC CTA CAC CCA-3’), and a reverse primer (5’-GCT TGC 
AAG GCC CAG AGT GGA TGG TGT AAG-3’) both at 10uM reaction 
concentration using Elongase polymerase kit (Invitrogen). PCR was performed by 
heating the samples to 94°C for 3 minutes, followed by 36 cycles of 30 seconds at 
94°C, 60 seconds at 59°C, and 90 seconds at 72°C, and finished with 5 minutes at 
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72°C. PCR products were electrophoresed in 1.5% agarose gel, stained with EtBr, and 
filmed with GeneSnap software from SynGene Company. 
 
Some other genes were also tested including Nalp1, Bim, Fas, Mapk4, CD44, 
CD3τ, Thada, etc. Primers were listed in figure 2.8. 
 
Figure 2.8 Primers for validation of alternative splicing variants: 
Primers Sequence 
Bim F GCCAAGCAACCTTCTGATGT 
Bim 1R ACATCGACACAGTGCAGAGC 
Bim 2R AGGACTTGGGGTTTGTGTTG 
Bim 3R CCATTTGAGGGTGGTCTTCA 
Bim 4R GGCATCACCGTGGATATTTT 
CD44 F TCTTTATCCGGAGCACCTTG 
CD44 R CGCACTTGAGTGTCCAGCTA 
Mapk7 F ATACCAAAGCAGCCCTCAAA 
Mapk7 R TGGAGTGCCAGAGAACACAG 
Nalp1 F CGTGGCTGCCAACTAAAGAC 
Nalp1 R GATTGTCACTGCCCTTGTCA 
Thada F AGCTTCTACTGCTGGCGATG 
Thada R GGGCGAGTGAATCTTTGTTC 
CD3z F GCACGATGGCCTTTACCAG 
CD3z 1R CCTTCTTTGAGCCACCTCTG 
CD3z 2R TATATCCGACGGGCTTTCTG 
CD3z 3R GTCATCACCAGAGCTGAGCA 
CD3z 4R TTTGCTGCACAGTGTGTTAGG 
 
 
2.4.2 Real time RCR 
FACs sorted peripheral B cell and T cell subsets (naive and memory, CD44lo 
vs CD44hi) were sorted as described before. Total RNA was extracted using 
MiniRNA column (Qiagen) following manufacturer’s instruction. RNA was 
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quantitated using the Nanodrop spectrophotometer. First strand cDNA was 
synthesised using SuperScript® First-Strand Synthesis System from Invitrogen (cat: 
11904-018). Before cDNA synthesis, contaminating genomic DNA were removed by 
DNase treatment. 
 
5× first strand buffer          2ul 
RNA (50ng/ul)                7.5ul (~375ng) 
DNase                              0.5ul 
Total                                  10ul 
Incubate at 37°C for 20 minutes and then inactivate at 75°C for 5 minutes. 
 
Then reverse transcript to cDNA using oligo dT primers: 
RNA                                               10ul (~375ng) (at final conc. ~20ng/ul) 
Oligo dT                                           1ul 
DEPC treated H2O                          3ul 
5× first strand buffer                        2ul 
DTT [0.1M]            2 ul 
dNTP [10mM]           1 ul 
RNase Inhibitor [40u/ul]         0.5ul 
Superscript III [200U/ul]         0.5ul 
Total                                                 20ul 
Incubate at 41°C for 1 hour and then inactivate at 90°C for 10 minutes. 
 
Quantitative real-time PCR was performed using the TaqMan Gene 
Expression Assays system from Applied Biosystems (Foster City, CA), Hnrpll and 
Hnrpl expression was examined relative to a housekeeping gene Ube2d1 for T cells. 
 
TaqMan Universal Master mix                            5ul 
20× TaqMan Gene Expression Assay mix        0.5ul 
cDNA                                                                1ul (20ng) 
DEPC treated H2O                                            3.5ul 
Total                                                                    10ul 
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 PCR reaction was performed following manufacturer’s instruction with ABI 
SDS qPCR7900 machine in the Biomedical Research Facility in John Curtin School 
of Medical Research, using the universal thermal cycling parameters (Hold 2 minutes 
at 50°C, 10 minutes at 95°C, then melt at 95°C for 15 seconds and anneal/extend at 
60°C for 1 minute for 40 cycles). Gene expression assays for Hnrpll, Hnrpl, and 
Ube2d1 are shown as below in figure 2.3. 
 
Assay ID Details: Mm00804896_m1 (Hnrpll primer) 
 
 
Assay ID Details: Mm00624101_m1 (Hnrpl primer) 
 
 
Assay ID Details: Mm00461037_g1 (Ube2d1 primer) 
 
Figure 2.3 Realtime-PCR assays for Hnrpll, Hnrpl, and Ube2d1. 
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2.5 Retrovirus based gene transfer 
 
2.5.1 Retrovirus vector 
Retroviral vector p-IRES-KMV is modified from pIRES bicistronic expression 
vector from Clontech laboratories, Inc. It contains the internal ribosome entry site 
(IRES) of encephalomyocarditis virus (ECMV) allowing translation of two open 
reading frames from a single mRNA. Ribosomes can enter the bicistronic mRNA 
either at the 5’ end of the inserted gene of interest or at the ECMV IRES to translate 
the reporter gene GFP. The single cassette express both the gene of interest and GFP 
so all transduced cells expressing GFP also express the gene of interest. Another 
antibiotic resistant gene (β -lactamase) included in the vector has its own promoter so 
that the transfected colonies can be selected for ampicillin resistance (Figure 2.4).  
 
 
Figure 2.4 Schematic diagram of retroviral vector pIRES-KMV and bicistronic 
mRNA translation. 
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PCMV IE: Human cytomegalovirus (CMV) major immediate early promoter 
enhancer; IRES: The internal ribosome entry site; GFP: Green Fluorescent Protein; 
Amp+: Ampicillin resistance; Ψ: packaging signal; Coli E1 ori: Coli E1 origin of 
replication. 
Polylinkers:       AccI               ClaI        BglII DpnI  XhoI     SalI HincII        BspDI 
AGATCTCTCGAGGTCGACGGTATCGATAAGCTTGATATCGAATTCCGCCC 
                               EcoRI 
CCCCCCCTAACGTTACTGGCCGAAGCCGCTTGGAATAAGGCCGGTGTGCG 
 
2.5.2 Clone Hnrpll EST 
 
Hnrpll transcript including EST was downloaded from Ensembl mouse 
genome database (http://www.ensembl.org/Mus_musculus/index.html).  
GAAGACCGGAAGCCACGGCCCGGCCCCATCCTTACTTTCGCGTCCCCCCCGGGGCTGGGA 
............................................................ 
 
GCCGCGAAGCTGGCGGAGGGAGAGGCTGGAGGCTGGCTGAGAGATAAAGGGAAGCGTCCC 
............................................................ 
 
CTCAGCCCGCGCTCCCTTCTCAGTCACGGGCTCCTGGAGCGCGCCGCGGAGGACGCCGGG 
............................................................ 
 
CCAGCTCAGACCCGCGCCGAGGAGGCGCAGCCCGCGGCGGGGACCGATCAGCGACATCTG 
............................................................ 
                                    1                      24 
AGGCCCGTCTCCCGCGCCGTCTCCACCGCCGCCGCCATGTCCTCCTCCTCCTCCTCCTCC 
....................................-M--S--S--S--S--S--S--S- 
25                                                         85 
CCCAAGGAGGAGACGTACGAGGAGGACCGGGAGTTCGAGAGCCAGGCCAAGCGCCTCAAG 
-P--K--E--E--T--Y--E--E--D--R--E--F--E--S--Q--A--K--R--L--K- 
86                                                        145 
ACCGAGGAGGGAGAGATCGTCTACTCGGCCGAGGAGAGCGAGAATCGCCAGGAAGCGACG 
-T--E--E--G--E--I--V--Y--S--A--E--E--S--E--N--R--Q--E--A--T- 
146                                                       205 
CCTCAGGCGGGGAGCGATAGCGACAGCGGCGGCGGCGACGGAGGCGACGGAGACGGAGGC 
-P--Q--A--G--S--D--S--D--S--G--G--G--D--G--G--D--G--D--G--G- 
206                                                       265 
AGCGGCGGCGGCGGCGACGGCGAGGAAGGCGAAGGTGGAGAAGAAGGCGACGAAGGCGAC 
-S--G--G--G--G--D--G--E--E--G--E--G--G--E--E--G--D--E--G--D- 
266                                                       325 
GGCGATGAGGGAGGGAGCGGCGGCGACGAAGGTGGCAGCGGCGGTGGCCCTCGGAGCATG 
-G--D--E--G--G--S--G--G--D--E--G--G--S--G--G--G--P--R--S--M- 
326                                                       385 
CCCCTGTCCACGGAGGGAGGTGGAAGTCATCATAAAGTTTCTGTTTCCCCTGTTGTCCAT 
-P--L--S--T--E--G--G--G--S--H--H--K--V--S--V--S--P--V--V--H- 
386                                                       445 
GTTCGAGGGCTCTGTGAATCTGTTGTGGAAGCTGACCTTGTGGAGGCACTGGAGAAATTT 
-V--R--G--L--C--E--S--V--V--E--A--D--L--V--E--A--L--E--K--F- 
446                                                       505 
GGGACAATATGCTATGTGATGATGATGCCATTTAAACGACAGGCTCTCGTGGAGTTTGAA 
-G--T--I--C--Y--V--M--M--M--P--F--K--R--Q--A--L--V--E--F--E- 
506                                                       565 
AATATAGATAGTGCCAAAGAATGTGTGACATTTGCTGCAGATGTGCCTGTGTACATTGCT 
-N--I--D--S--A--K--E--C--V--T--F--A--A--D--V--P--V--Y--I--A- 
566                                                       625 
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GGCCAGCAGGCTTTCTTCAACTATTCTACAAGTAAAAGAATCACTCGGCCAGGAAATACC 
-G--Q--Q--A--F--F--N--Y--S--T--S--K--R--I--T--R--P--G--N--T- 
626                                                       685 
GACGATCCATCAGGGGGCAACAAAGTGCTCTTGCTCTCTATTCAGAATCCTCTTTACCCA 
-D--D--P--S--G--G--N--K--V--L--L--L--S--I--Q--N--P--L--Y--P- 
686                                                       745 
ATTACGGTGGATGTTCTGTATACTGTATGCAACCCTGTTGGAAAAGTACAGCGTATTGTT 
-I--T--V--D--V--L--Y--T--V--C--N--P--V--G--K--V--Q--R--I--V- 
746                                                       805 
ATCTTCAAGAGAAATGGGATACAAGCAATGGTTGAGTTTGAGTCAGTCCTTTGCGCCCAG 
-I--F--K--R--N--G--I--Q--A--M--V--E--F--E--S--V--L--C--A--Q- 
806                                                       865 
AAGGCTAAAGCAGCACTCAATGGAGCTGATATATATGCCGGATGTTGCACACTAAAAATT 
-K--A--K--A--A--L--N--G--A--D--I--Y--A--G--C--C--T--L--K--I- 
866                                                       925 
GAATATGCAAGGCCAACTCGTCTAAATGTTATTAGGAATGACAATGACAGTTGGGACTAC 
-E--Y--A--R--P--T--R--L--N--V--I--R--N--D--N--D--S--W--D--Y- 
926                                                       985 
ACTAAACCTTATTTGGGAAGACGAGATAGAGGAAAGGGTCGCCAGAGACAAGCCATTTTG 
-T--K--P--Y--L--G--R--R--D--R--G--K--G--R--Q--R--Q--A--I--L- 
986                                                       1045 
GGAGACCATCCTTCTTCGTTTAGACATGATGGCTATGGATCGCATGGTCCGCTACTGCCT 
-G--D--H--P--S--S--F--R--H--D--G--Y--G--S--H--G--P--L--L--P- 
1046                                                      1105 
TTACCAAGTCGTTATAGAATGGGCTCTAGAGATACACCTGAACTTGTTGCTTATCCATTA 
-L--P--S--R--Y--R--M--G--S--R--D--T--P--E--L--V--A--Y--P--L- 
1106                                                      1165 
CCACAAGCGTCTTCCTCTTACATGCATGGAGGCAGTCCGTCTGGCTCCGTTGTAATGGTT 
-P--Q--A--S--S--S--Y--M--H--G--G--S--P--S--G--S--V--V--M--V- 
1166                                                      1225 
AGTGGATTACATCAGCTCAAAATGAATTGTTCAAGAGTCTTCAACCTGTTCTGCTTGTAT 
-S--G--L--H--Q--L--K--M--N--C--S--R--V--F--N--L--F--C--L--Y- 
1226                                                      1285 
GGAAATATTGAAAAGGTAAAGTTTATGAAGACCATTCCTGGCACAGCACTCGTAGAAATG 
-G--N--I--E--K--V--K--F--M--K--T--I--P--G--T--A--L--V--E--M- 
1286                                                      1345 
GGTGACGAGTACGCTGTGGAAAGAGCTGTCACCCACCTTAATAATGTCAAACTCTTTGGG 
-G--D--E--Y--A--V--E--R--A--V--T--H--L--N--N--V--K--L--F--G- 
1346                                                      1405 
AAAAGACTTAATGTTTGTGTGTCTAAACAGCACTCAGTTGTTCCCAGTCAAATATTTGAG 
-K--R--L--N--V--C--V--S--K--Q--H--S--V--V--P--S--Q--I--F--E- 
1406                                                      1465 
CTAGAGGATGGTACGAGCAGCTACAAAGATTTTGCAATGAGCAAAAATAATCGCTTTACA 
-L--E--D--G--T--S--S--Y--K--D--F--A--M--S--K--N--N--R--F--T- 
1466                                                      1525 
AGTGCTGGACAAGCATCTAAGAATATAATCCAGCCACCGTCATGTGTGCTGCATTATTAC 
-S--A--G--Q--A--S--K--N--I--I--Q--P--P--S--C--V--L--H--Y--Y- 
1526                                                      1585 
AATGTTCCGCTGTGTGTCACAGAAGAGACCTTCACAAAGTTGTGTAACGACCACGAAGTT 
-N--V--P--L--C--V--T--E--E--T--F--T--K--L--C--N--D--H--E--V- 
1586                                                      1645 
CTTCCGTTCATCAAATATAAAGTGTTTGACGCGAAAGCTTCCGCGAAAACTCTGTCTGGG 
-L--P--F--I--K--Y--K--V--F--D--A--K--A--S--A--K--T--L--S--G- 
1646                                                      1705 
CTATTGGAGTGGAAGTGCAAAACTGATGCCGTGGAAGCTCTCACTGCGCTCAATCACTAC 
-L--L--E--W--K--C--K--T--D--A--V--E--A--L--T--A--L--N--H--Y- 
1706                                                      1765 
CAGATACGAGTCCCGAATGGATCCAACCCCTATACGTTGAAGCTTTGCTTTTCTACATCA 
-Q--I--R--V--P--N--G--S--N--P--Y--T--L--K--L--C--F--S--T--S- 
1766                                                      1825 
TCCCATTTATAAGAAGAGAAGAGCATGTTAGAATTTATGTTCATCTTTATTGCAGTTTTA 
-S--H--L--*-................................................ 
 
AAGCTATACTTCATCCATAATAATCTAAAATGGTTGGTCTAATGTTGCCTTGCTTACTAT 
............................................................ 
 
AAGATCCTGTTCTGTAATAAACATATTTTGCCTC 
.................................. 
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Figure 2.5 Mouse Hnrpll transcript and translation 
 
In order to choose appropriate endonucleases for cloning, Hnrpll EST was 
analysed for restriction enzyme recognition by testing the sequence in the online 
restriction map program (http://rna.lundberg.gu.se/cutter2/). XhoI and EcoRI which 
are among the polylinkers of the pIRES-KMV vector do not cut Hnrpll EST sequence.  
 
Primers were designed by inputting the transcript sequence to the online primer 
design resource (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) to 
amplify Hnrpll EST.  The 5’ end primer GCCGCCATGTCCTCCAC right start 6 bp 
in front of transcription initial site, while the 3’ end primer TAA 
ATGGGATGATGTAGAAAAGCA site just before the stop codon TAA. The second 
pair of primers adopted XhoI target sequence CTCGAG to the 5’ end of forward 
primer whereas EcoRI recognised sequence GAATTC was added to the 3’ end of 
reverse primer with poly A tag to both primers, maintaining the sequence in reading 
frame. 
 
Hnrpll cDNA was amplified by PCR: 
ddH2O                                                                    32 ul 
5x buffer B                                                             10 ul 
dNTPs (10 mM)                                                       1 ul 
HnrpllXhoIF primer (Forward) (10 uM)                 2 ul 
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HnrpllEcoRIR primer (Reverse) (10 uM)               2 ul  
Elongase DNA polymerase                                     2 ul 
cDNA                                                                       1 ul 
 
Programs:  94°C, 3 minutes, 1 cycle. 
94°C, 30 seconds, 
55°C, 60 seconds,  
68°C, 2 minutes, 36 cycles. 
72°C, 5 minutes, 1 cycle. 
 
Amplified Hnrpll cDNA were verified by electrophoresis and sequencing, 
double digested with XhoI and EcoRI restriction enzymes: 
NE buffer for EcoRI                            2ul 
XhoI                                                  0.9ul 
EcoRI                                                0.9ul 
Hnrpll cDNA/pIRES-KMV vector    500ng 
DDH2O                                      up to 20ul 
 
Samples were mixed and incubated at 37°C for one hour and the cDNA was gel 
purified by running samples by gel electrophoresis. The cDNA was excised from the 
gel and purified using Qiaquick PCR purification kit (Qiagen: 28104). The cDNA 
concentration was quantitated  and the linearized vector and cDNA were mixed at 
1:3~1:10 ratio for connection. 
pIRES-KMV                           4 ul 
Hnrpll cDNA                          4 ul 
Roche 10× ligation buffer       1ul 
Roche T4 DNA ligase             1ul 
 
Samples were incubated at 16°C over night. The ligated plasmid was used to 
transform competent E. coli. by heat shock by mixing 2ul of plasmid with 20ul of 
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competent E. coli and cells were incubated on ice for 5-30 minutes. The samples were 
transferred to 42°C for 30 seconds without shaking, and immediately incubated on ice 
for 10 minutes. 200ul of pre-warmed SOC media (at room temperature) was added to 
the cells  and these were, shaken  at 200rpm at 37°C for 1 hour, and spread to pre-
warmed selective plates. After 10-12 hours growth, ampicillin resistant colonies were 
picked and inoculated into 5ml LB media with 0.1% ampicillin and rotate at 200rpm 
overnight. The following day plasmids were extracted and purified from E. coli using 
the PureLink™ Quick Plasmid DNA Miniprep Kits (Invitrogen K2100-11). The 
constructors were verified by double digestion with XhoI and EcoRI and checking the 
size of insertion and vector. 
 
2.5.3 Retrovirus package 
 
Colonies with appropriate pIRES-KMV-Hnrpll plasmid were grown in a 2L 
flask so that the plasmid can be yield and extracted in large scale. The Pheonix 
packaging cell line was grown in T75 flasks to about 50-60% confluence in a 10mL 
volume, add 5ul of 50mM chloroqine , 155ul of 2M CaCl2 solution to 40ug plasmid 
in 1095ul volume. 60 minutes after adding chloroquine, add 1250ul of pH7.35 2×HBS 
was added to the cells by bubbling, immediately add the mixture to the cells, and 
agitate the culture gently to ensure uniform distribution. After 9 hours incubation in 
37°C, the culture media was replaced with fresh full media and to the cells were 
incubated at 32°C. 48 hours post-transfection, the retroviral supernatant was collected. 
A second round of transfection was obtained by adding10 ml of fresh media to the 
Pheonix cells and returns the flask to 32°C incubator and 48h later the supernatant 
was collected. 
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2.5.4 Calcium Phosphate gene transfection of primary T lymphocytes 
 
Spleen CD4+ T cells purified from C57BL/6J mice or thu/thu mice by magnetic 
sorting were added into 6 well culture plates with 3 million cells per well,  stimulated 
with anti-CD3 and anti-CD28 for 24h and then added in 3 ml retroviral supernatants 
(1ml/1million cells) with 3 ul of 1000× polybrene (4mg/ml) to each well. Spin the 
plates 3000rpm at 30°C for 60-90 minutes, incubate the plates at 30°C for 30 minutes, 
then remove the viral supernatants and add in 3 ml of fresh complete media. Culture 
the cells in 37°C for 2 days, check CD45 isoforms by FACs. 
Media and solutions: 
2× HBS:  NaCl                  2g 
 HEPES              6.5g 
Na2HPO4        10ml (5.25g Na2HPO4 dibasic in 500 ml H2O, pH 7.35)  
Growth Medium for Phoenix cell: 
DMEM                                                    440ml 
Hi FCS                                                      50ml 
Penicillin/Strep and L-glutamine              10ml 
Complete RPMI for splenocytes: 
RPMI                                                        440ml 
Hi FCS                                                      50ml 
Pen/Strep and L-glutamine                       10ml 
β-mercaptoethanol (50uM)                       500ul 
HEPES (1M)                                               5ml 
100× nonessential A.A. (0.1mM)                5ml 
100× Na puryvate                                        5ml 
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2.6 In vitro culture 
 
Flat bottom 24 well plates were coated with anti-CD3 in PBS over night at 
serial dilutions of anti-CD3 starting from 10ug/ml. Single cell suspensions of 
lymphocytes were prepared in ice-cold RPMI using cell strainer from fresh tissues of 
spleen and lymph nodes. Cells were sorted through MACS beads by deleting red 
blood cells, B cells, granulocytes, macrophages, NK cells and dendritic cells. Cells 
were resuspended at 5.0 x 107/ml in warm RPMI 1640 and incubated for 10 min at 
37oC with 5μM CFSE (Carboxyfluorescein succinamide ester, Molecular Probes). 
Labelling was quenched with three washes of ice-cold RPMI/10% FCS. Cells were 
resuspended in warm RPMI+10% FCS at 1×106 cell/ml with soluble anti-CD28 
(1ug/ml), added 1 ml to each well, cultured at 37oC for 3-4 days, stained with 
appropriate antibodies including 7AAD, and analysed by Flowcytometry. 
 
2.7  Adoptive cell transfer 
 
Thymocytes and splenocytes from wild type CD45.1 and thu/thu (CD45.2) 
mice were prepared from 6-8 week old mice and cell suspensions were prepared and 
washed, either labelled with CFSE or not. The labelled lymphocyte populations were 
mixed at a 50:50 ratio and 2 x 107 cells were injected into the tail vein per recipient 
mouse including RAG-/-, irradiated TAP1-/- and C57BL/6 mice, in different 
experiments.  Mice were bled at different time points after the transfer from the retro-
orbital plexus. The peripheral blood leukocytes were lysed of red blood cells, stained 
with antibodies to CD4, CD8, CD45.1, CD45.2 etc and the samples were analysed by 
FACS. Recipient mice used in these experiments were at 6-8 weeks of age. The 
irradiation dosage in the experiments was a single 1.5 Gy dose. 
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2.8 All exon array 
 
2.8.1 Cell sorting and RNA isolation 
 
3-6 female mice at 6-8 weeks of age, either wildtype or thu/thu, were 
sacrificed and lymphocytes from the spleen and lymph nodes were pooled to two 
groups in according to the genotype. The cells were stained with anti-CD4, CD8, and 
CD44 antibodies and were sorted to 8 samples in sterile ice-cold RPMI + 10% FCS 
from FACS Vantage DIVA option and FACS Aria  (Becton Dickinson), wt naïve 
CD4 (CD44lo), wt memory CD4 (CD44hi), wt naïve CD8 (CD44lo), wt memory 
CD8 (CD44hi) and their thu/thu mutant counterparties. 2- 5 millions cells were 
collected for each sample.  Total RNA was immediately extracted after cell sorting 
using RNeasy plus Mini kit (Qiagen #74134) to eliminate genomic DNA 
contamination. At least 1.5ug total RNA of each sample was prepared for exon array 
experiments with good quality that was tested with Agilent Bioanalyzer Chips in 
Biomedical Research Facility in John Curtin School of Medical Research. Each RNA 
sample has 3 biological triplicates for statistic purpose. RNA from CD4 and CD8 
single positive thymocytes were also prepared in the same method. 
 
2.8.2 Chips, hybridization, and data analysis 
 
Exon arrays are powerful tools for the discovery and study of mRNA 
transcript isoforms derived from pre-mRNA alternative splicing. Affymetrix 
GeneChip® Mouse Exon 1.0 ST (Sense Target) Array is a single array with more than 
4.5 million unique 25-mer oligonucleotide features constituting approximately 1.2 
million probe sets that can be grouped into 1 million exon clusters and over 80, 000 
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transcript clusters. With about four probes for each exon and average 40 probes per 
gene, this array provides detection of both the whole transcript expression and the 
differential expression of each exon within a gene. Exon array chips were provided by 
Dr. Alan Aderem and were performed by Mr. Bruz Marzolf and Ms. Katherine 
Kennedy in the System Biology Institute in Seattle, WA, USA. 
 
A total of 1ug RNA was in vitro transcripted to cRNA. 10 ug cRNA was 
amplified in the second round used. A hybridization cocktail including 5.5 ug of 
fragmented end labelled ssDNA was applied to Affymetrix Mouse Exon 1.0 ST Array 
chips. Hybridization was performed using F450-001 fluidics wash and stain script 
using the Affymetrics Gene Chip Fluidics station 450. The arrays were then scanned 
using Affymetrix GCS3000 7G and Gene chip operating software to produce CEL 
files. Detection of each exon in the mRNA enables examination of individual exon in 
the transcript isoforms.  
 
Array data were analysed with Partek Genomics Suite 6.3 using the core probe 
sets defined by Affymetrix. A two way ANOVA of genotypes/cell subsets versus 
probeset ID was calculated in a given mutant cell type in comparison to their wildtype 
counterpart or memory T cells in comparison to the naive cells. Alternative splicing 
was evaluated by the p values of different probeset intensities between different 
genotypes or cell subsets. Approximately 15,000 genes were analysed and the 
candidate gene views were created and linked to known transcript sequences in the 
USSC Bioinformatics database for validation. 
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Introduction 
 
Mature T cells are generated in thymus. The recent thymic emigrants will 
circulate through the peripheral blood and secondary lymphoid tissues where they 
encounter APCs presenting a specific peptide/MHC complex for the clonally 
restricted TCR. T cells in the peripheral circulation are considered naive before they 
encounter their specific antigen and display a characteristic expression of a range of 
cell surface markers including CD44lo, CD25-, CD43lo, CD62Lhi, and CD127hi 
(Surh, C. and Sprent, J. 2003). The life span of naïve T cells in the peripheral 
circulation is around 6 weeks if they fail to encounter their specific antigen. Once they 
die they will be replaced by other mature cells arising from the thymus that expand to 
fill the empty niche (Surh, C. and Sprent, J. 2003).  T cell homeostasis refers to the 
status of relatively stable cell numbers through the life and death cycle of T cells. 
Each subset of T cells has independent niche and different factors contributing to their 
homeostasis. The immune system maintains the peripheral T cell repertoire at a 
relatively constant size throughout the lifetime of an individual despite varying 
thymic production of T cells and the response of T cells to environmental antigens. 
 
The homeostatic mechanisms that are used by the immune system to maintain the 
numbers of peripheral T cells is slowly being understood. These include extrinsic 
factors that influence naïve and memory T cell homeostasis (e.g. peptide/MHC 
recognition and the cytokines IL-7 and IL-15) (Takeda, S. et al. 1996; Tanchot, C. et 
al. 1997; Zhang, X. et al. 1998; Boursalian, T.E. and Bottomly, 1999), our knowledge 
of how these are integrated to control T cell repertoire size and composition is still 
rudimentary.  Some intrinsic factors like Bim, Fas/FasL, APO2L/TRAIL, c-FLIP, and 
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FOXO3a etc were also reported playing important roles in memory T cell homeostasis 
in mouse or human (Bosque, A. et al. 2005; Sabbagh, L. et al. 2006; Wojciechowski, 
S. et al. 2007; Riou, C. et al. 2007; Weant, A.E. et al. 2008; Williams, M.A. et al. 
2008). 
 
Upon Ag stimulation, naive T cells quickly expand and differentiate to become 
effector cells which play an important role to control the spread of pathogens. A 
subset of primed T cells is selected from the expanding repertoire to differentiate as 
memory T cells of the same specificity as the effector population.  The memory cells 
are long lived and display a more rapid and heightened response following secondary 
antigen stimulation. Naïve and memory T cells have distinct cellular niches and these 
are controlled by different homeostatic processes. One of the most widely used 
markers defining memory T cell differentiation in human arises from a regulated shift 
in the alternative splicing of Ptprc mRNA encoding CD45, such that memory T cells 
silence the inclusion of three exons encoding the CD45RA, RB and RC isoforms 
present on unprimed naïve T cells, and hence become CD45RO (Hermiston, M.L. et 
al. 2003). While this memory-associated change in splicing is a highly conserved 
marker across the animal kingdom, its functional significance is unclear and the 
factors that bring it about have remained obscure. Moreover, it is not known whether 
or not the change in CD45 splicing is part of a more global reprogramming of mRNA 
splicing in memory T cells that might change the longevity and responsiveness of 
memory T cells.   
 
Primary mRNA alternative splicing is a ubiquitous phenomenon of post-
transcriptional modification that helps to increase protein diversity and complexity 
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from the same gene (Modrek, B. and Lee, C. 2003). Splicing variants normally have 
different extent activity or even antagonistic effects that are important in regulating 
protein functions (Rothrock, C. et al. 2003). Yet little is known about the mechanisms 
of how pre-mRNA alternative splicing is regulated and how differential splicing 
influences immunological functions.  
 
In this chapter, we report a mouse strain, thunder, carrying an ENU induced 
mutation that was identified through a screen for mice with defective T cell 
homeostasis. Thunder mice were identified by flow cytometric analysis with a 
reduction in peripheral CD4+ and CD8+ T cells. As we report in this chapter we 
identified the mutation was in a novel splicing silencer protein that leads to a defect in 
pre-mRNA alternative splicing. 
   
3.1    Screening and identification of the thunder strain 
 
A male C57BL/6S (B6) mouse was injected with standard dose of ENU and bred 
with a wild-type female B6 mouse. Subsequent breeding followed a typical 3 
generation screening strategy for recessive traits (Nelms & Goodnow, C.G. 2002). 
The founder G1 male mouse (#19) of the ENU 126 pedigree was backcrossed to a 
wild-type B6 female to generate G2 offspring. Since there was only 50% chance of 
any G2 female carrying the thunder mutation, the original G1 male (#19) was rotated 
past four separate G2 daughters to generate a total of 19 G3 mice from 4 litters 
(Figure 3.1). It is expected that the G3 generation is the first time a recessive mutation 
would come to homozygosity. For a recessive trait we would expect 25% of G3 
offspring to show a phenotypic trait.  G3 offspring were bled around 8 weeks of age. 
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Figure 3.1 Pedigree of the ENU126 ‘thunder’ strain
4 G3 breeder pairs produced by breeding a G2 
daughter-G1 father breeders from ENU treated C57BL/6S 
offspring produced 4 litters. Two G3 female mice had a 
significant reduction in peripheral blood T cells.
Male mice = squares,  female mice = circles.  
Affected mice filled symbols, unaffected mice = open 
symbols, carries=half filled
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Peripheral blood leukocytes were analysed by multicolour flow cytometry for changes 
in T and B cell proportions.  Two G3 female mice from the ENU126 strain were 
identified with reduced CD3+ T cell percentages (Fig. 3.1 and 3.2.1 a). A significant 
reduction in both CD4+ and CD8+ T cells was observed and many of the cells 
expressed high levels of the CD44 marker indicative of a memory cell phenotype (Fig. 
3.2.1 b, c, and d). The strain was named “thunder” for “T helper cells under 
represented”.  
 
Homozygous mutant mice on the B6 background were either out-crossed to the 
mapping strain of CBA to increase genetic polymorphisms to facilitate mapping of the 
ENU-induced mutation. F1 hybrid carriers were intercrossed to produce F2 progeny 
with a quarter of the offspring being homozygous mutants that could be used to map 
the mutant locus. Thunder homozygous mutant mice were also maintained on a 
C57BL/6 background to facilitate further biological studies.  Most studies of this 
project were performed on the C57BL/6 background. 
 
3.2    Thunder mutation encodes a recessive trait that involves the loss of 
naive T cells in the peripheral lymphoid tissues 
 
3.2.1   T cell lymphopenia with hyperactivation by bleed screening 
 
An identical cellular phenotype was observed with the thunder homozygous 
mutant on the mixed B6/CBA F2 background compared to the mutants on C57BL/6 
background. Homozygous thu/thu mice have significantly lower percentages of CD3+ 
T cells in the blood that affect both the CD4+ and CD8+ subsets (Fig. 3.2.1a and b). 
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Figure 3.2.1  Thunder mutation leads to a loss of peripheral T cells. 
Representative FACS dot plots of (a) CD3 versus B220 expression 
and (b) CD4 versus CD8 on peripheral blood leukocytes for individual 
+/+, thu/+ and thu/thu mice.  Representative histograms of CD44 
expression on (c) CD4+ and (d) CD8+ T cells. 
e.
Figure 3.2.1  Thunder mutation leads to a loss of peripheral T cells. 
(e). Accumulative data showing the frequency of T cells versus B cells 
and naïve versus memory T cells in CD4+ and CD8+ cell 
compartments as determined by flow cytometry. Each symbol 
represents a single animal.
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Mutant T cells show an increased CD44hi memory T cell frequency while CD44lo-mid 
naive percentages are decreased (Fig. 3.2.1 c and d). Dot plots comparing the T cell/B 
cell ratio vs naive/memory T cell ratio generated from flow cytometric analysis of 
peripheral blood samples from individual B6/CBAF2 mice show a clear segregation 
of thu/thu homozygotes from wild-type and heterozygotes (Figure 3.2.1 e). This 
indicates that thu/thu mice have a reduced frequency of T cells in the peripheral blood 
and there is a significant reduction in naïve T cells compared to memory CD4+ and 
CD8+ cell populations.  
  
3.2.2   Normal T cell development in the thymus 
 
T cells originate from common lymphoid progenitor cells that arise from the bone 
marrow and migrate into the thymus and follow a well characterized pattern of 
cellular differentiation. We sought to determine whether the thunder mutation 
influences thymic development or whether it only affects the survival of T cells in the 
periphery. Wild-type, heterozygous and homozygous mutant mice were taken down at 
8 to 12 weeks of age. The numbers of T cells present in the thymus, spleen, and 
lymph nodes were enumerated using flow cytometry.  
 
Figure 3.2.2 shows that the thunder mutation has no effect on T cell 
differentiation in the thymus with normal percentages of immature double negative, 
double positive and mature single positive cells being present (Figure 3.2.2 a). Also 
there is no change in the absolute cell numbers of mature CD4 and CD8 single 
positive cells in wild-type or thu/thu mice at any stage of postnatal development 
ranging from 2 weeks to 18 weeks of age (Figure 3.2.2 d). 
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Figure 3.2.2 Normal T cell development
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Figure 3.2.2 The thunder mutation does not affect T cell 
development in the thymus.
Representative FACS dot plots of thymocytes from +/+, thu/+ and 
thu/thu mice showing (a) CD4 versus CD8, (b) B220 v Thy1.2 
(CD90) and (c) contour FACS plots of thymocytes showing B220 
versus CD3 expression. 
Figure 3.2.2 The thunder mutation does not affect T cell development 
in the thymus. 
d. The absolute numbers of mature CD4+ and CD8+ single positive 
thymocytes were enumerated from individual mice .  Each point on
the graphs represents an individual mouse
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However, most thu/thu thymocytes show constitutive high level of expression of 
the CD45R isotype (B220) at the cell surface (Figure 3.2.2 b). Both CD3hi (mature 
thymocytes) and CD3lo (immature thymocytes) cells display elevated levels of the 
B220 marker (Figure 3.2.2 c), although it appeared to be extinguished in most mature 
SP thymocytes and in peripheral T cells. This may reflect changes in glycosylation, 
since B220 epitope is carbohydrate dependent as well as requires the CD45RABC 
backbone. The constitutive expression of the B220 marker on thunder thymocytes 
suggests the mutation must affect the alternative splicing of the CD45 mRNA during 
T cell development. 
 
3.2.3   Loss of naïve T cell in the peripheral lymphoid tissues 
  
As T cell numbers and maturation were normal in thymus of thunder mutant mice, 
we examined the numbers of T and B cells in the spleen and lymph nodes (LN). 
Spleen cells from 8 week old mice were analysed by flow cytometry. As shown in 
Figure 3.2.3 a, there is a clear reduction in the frequency of CD3+ T cells in the 
spleen of thu/thu mice compared to wild-type and heterozygous mice and this 
corresponded with a decrease in both CD4+ and CD8+ T cells (Fig. 3.2.3 b).  
 
The T cell populations were further subdivided into naïve (CD44lo) and memory 
(CD44hi) cells based on FACS staining. The numbers of naive and memory subsets 
were enumerated at different ages after birth. The numbers of naive T cells (CD44lo-int) 
in wild-type mice increased in the spleen after birth until about 8 weeks of age due to 
increased thymic output of mature T cells to help fill the T cell compartment. The 
107 
Figure 3.2.3 Loss of thu/thu naive T cells in the periphery
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Figure 3.2.3 The thunder mutation results in a loss of naïve T cells 
in the periphery. 
Representative FACS dot plots of splenocytes from +/+, thu/+ and 
thu/thu mice showing (a) B220 versus CD3, (b) CD4 v CD8 
staining.
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Figure 3.2.3 The thunder mutation results in a loss of naïve T cells 
in the periphery. 
(c) CD4+ and (d) CD8+ T cells were enumerated from the spleen. 
Naïve (CD44lo) and memory (CD44hi) subsets were enumerated 
separately. Each point on the graphs represents an individual 
mouse. 
Figure 3.2.3  Loss of thu/thu naive T cells in the periphery
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Figure 3.2.3 The thunder mutation results in a loss of naïve T cells in 
the periphery. 
(e,f). Representative FACS dot plots of lymph node cells from +/+, thu/+
and thu/thu mice showing (e) B220 versus CD3 and (f) CD4 v CD8 
expression. 
(g) Absolute numbers of naive and memory CD4+ and CD8+ T cells 
were enumerated from  lymph nodes including cervical, anterior, and 
superficial inguinal nodes. The data showing the mean and standard 
deviation were collected from 6 mice/group.
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numbers of peripheral T cells in wild-type mice then remain at a relatively constant 
level (Fig 3.2.3.c and d). In thu/thu mice there was no significant difference in the 
numbers of naïve and memory T cells at 2 weeks of age, but, by 4 weeks of age, 
CD4+ T cells were decreased by 3 fold and there was a 2 fold reduction in naïve 
CD8+ T cells by 8 weeks of age (Figure 3.2.3 c and d). In contrast, the numbers of 
memory phenotype T cell (CD44hi) numbers were indistinguishable between wild-
type and thu/thu mice at any of the time points (Figure 3.2.3 c and d). There was also 
a significant reduction in the number of naïve CD4+ and CD8+ T cells in the lymph 
nodes (LN), whereas there was no difference in the number of  memory phenotype T 
cells between wild-type and thu/thu mice (Figure 3.2.3 e-g). 
 
3.3    Aberrant CD45 pre-mRNA alternative splicing 
 
3.3.1   Multiple CD45 transcript variants in thu/thu T cells 
 
As mentioned in chapter 3.2.2, thu/thu thymocytes constitutively express the B220 
(CD45RABC) receptor, which is recognized by a monoclonal antibody (RA3-6B2) 
that binds an epitope on the extracellular domain of the CD45 glycoprotein (Coffman, 
R.L. & Weissman I.L. 1981; Asensi, V. et al. 1989). The binding of this antibody to 
the T cell surface is dependent on the expression of exon 4, 5, 6 and specific 
carbohydrate residues, indicating higher expression of variable exons in thu/thu mice, 
the expression of which is normally silenced during T cell development and upon T 
cell activation in the periphery. 
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Figure 3.3 CD45 pre-mRNA alternative splicing
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Figure 3.3 The thunder mutation leads to disruption of alternative splicing 
of CD45 in multiple cell types.
(a) RT-PCR of thymocyte RNA purified from thymocytes of wild type and 
thu/thu mice.  Arrows on the left indicate the predicted sizes of the 
different CD45 isoforms. Data shows representative results from 3 
mice of each genotype (predicted size: RO 71bp; RB 218bp; RAB 
347bp; RBC 359bp; RABC 488bp).
(b) Representative histograms of CD4+, CD8+ T cells and B cells in the 
spleen of wild type (red line), thu/+ (green line), and thu/thu (blue line) 
mice stained with CD45R segment-specific antibodies and a pan-
CD45.2 antibody.
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To demonstrate that thu/thu thymocytes undergo aberrant CD45 pre-mRNA 
alternative splicing, total RNA was isolated from thymocytes of wild-type and thu/thu 
mutant mice and reverse transcribed to cDNA using oligo-dT primer. CD45 transcript 
variants were amplified by RT-PCR using a pair of primers complementary to exon 3 
and exon 7. Thymocytes from wild-type mice predominantly express the CD45RO 
isoform and some CD45RB, in contrast with thymocytes from thu/thu mice which 
exhibit expression of multiple transcript variants including CD45RO, RB, RAB, and 
RBC, suggesting defective CD45 pre-mRNA alternative splicing during thymocytes 
development in thunder mice (Figure 3.3 a). 
 
3.3.2   T cells from thunder mice cannot silence the variable exons of CD45 
 
A panel of monoclonal antibodies specific to epitopes in the CD45RA, B, and C 
segments was used to examine the cell surface expression of various CD45 isoforms 
by T and B cells using flow cytometry. T and B cells from different lymphoid tissues 
including thymus, spleen, LN, and blood were examined from adult wild-type, 
heterozygous and homozygous mutant mice. The data shown in Figure 3.3 b and c 
shows that B cells cannot silence the variable exons 4, 5 or 6 of CD45 and therefore 
constitutively express high levels of CD45RA, RB and RC epitopes. In contrast, wild-
type CD4 T cells have low expression of CD45RA and RC but maintain an 
intermediate level of CD45RB isoform expression. The levels of the different CD45 
isoforms increases 2-4 fold after CD4+ cells leave the thymus and enter the periphery 
(Fig 3.3c). Also there is a 10 fold increase in the expression of CD45RA and RC 
segments after CD8+ cells migrate from the thymus to the periphery (Fig. 3.3c). 
CD8+ T cells in the spleen of wild-type mice have approximately 10 fold higher 
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Figure 3.3 The thunder mutation leads to disruption of alternative 
splicing of CD45 in multiple cell types.
(c). Bar graphs representing the geometric mean fluorescence of 
different CD45R epitopes and total CD45 on the surface of DN, DP
CD4SP and CD8SP thymocytes, as well as CD4+, CD8+ and 
CD19+ spleen cells. Data showing the mean and standard deviation
of data were collected from n=6 mice/group. Wild type mice (open
bars), thu/+ (hatched bars), thu/thu (filled bars).  
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levels of CD45RA, RB and RC compared to CD4+ T cells (Fig. 3.3 b and c). Thus in 
wild-type mice the expression of CD45 isoforms changes with cell types and T cell 
development and maturation state of the cells. 
 
  When we examined the expression of the CD45R epitopes on thymocytes and 
spleen cells from thunder homozygous mutant mice, the thu/thu T cells display 
constitutive high level expression of all 3 segments, equivalent to the levels expressed 
by B cells (Fig. 3.3 b and c). In heterozygous mice the expression of all three CD45R 
epitopes in CD4+ cells  (and CD45RA & RC in CD8+ cells) was intermediate to that 
observed in homozygous mutant mice (Fig. 3.3 b and c) suggesting a dose-dependent 
effect of the mutation on CD45 alternative splicing. The only exception was the 
CD45RB isoform on CD8+ T cells which showed little effect with the thunder 
mutation mainly because this exon is not normally silenced in CD8+ cells.  However, 
quantitating the levels of expression of CD45 RB on multiple animals indicated that 
there was still a 1.5-2 fold increase in CD45RB levels on thunder homozygote mutant 
CD8+ cells compared to wild-type CD8+ cells (Fig. 3.3 c).  These results indicate that 
the thunder mutation has an essential role in CD45 pre-mRNA alternative splicing in 
T cells, disruption of thunder gene causes failure in silencing CD45 variable exons 4, 
5, and 6, and leading to the constitutive expression of high molecular weight isoforms 
of CD45 at the surface of T cells regardless of status of development and activation. 
 
3.3.3   Aberrant CD45 alternative splicing in other hematopoietic cells 
 
We were interested to know if the defects in CD45 alternative splicing were 
restricted to just T cells so we examined the expression of the different CD45 
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Figure 3.3 The thunder mutation leads to disruption of alternative splicing of 
CD45 in multiple cell types.
Representative histograms comparing CD45RA and CD45RC expression on 
(d) NK and TCRγδ+ cells in the thymus and (e) Gr-1+ cells, CD11c+ DCs 
and CD11b+ macrophages in the spleen. (red lines = +/+ cells, blue 
line=thu/thu cells)
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isoforms expression on a range of other hematopoietic cells in the thymus and spleen 
including NK cells, γδ T cells, dendritic cells, macrophages, and granulocytes. As 
shown in Figure 3.3 d and e, dysregulation  of CD45 splicing was observed in all 
leukocyte populations as all the cell types tested constitutively expressed the  high 
MW isoforms of CD45 containing the CD45RA and/or CD45RC epitopes. This 
suggests thunder mutation has a broad role in regulating CD45 pre-mRNA alternative 
splicing in all nucleated haematopoietic cells. 
 
3.4 Discussion  
 
Homozygous thunder mice display normal T cell development in thymus in terms 
of both cell percentages and absolute numbers  but there is a significant reduction in 
total CD4+ and CD8+ T cell numbers in the periphery only after 4-6 weeks of age.  
Detailed phenotypic analysis of thymocytes at different stages of development failed 
to reveal any significant differences between wild-type and thu/thu thymocytes, 
despite the fact that the mutant cells constitutively express the high MW isoforms of 
CD45 which are thought to be the most active protein tyrosine phosphatase in 
leukocytes. The CD45 protein is essential in T cell development because mice and 
humans that lack CD45 develop severe combined immune deficiency (SCID) 
(Tchilian, E.Z. et al. 2001). CD45 deficiency causes a significant arrest of T cell 
development at the DP stage leading to a severe reduction in mature single positive 
thymocytes and peripheral CD4+ and CD8+ T cells (Kishihara, K. et al. 1993).  In the 
case of B cells, loss of CD45 does not affect the development of B cells in the bone 
marrow but they do display an arrest in development in transitional stages in the 
spleen (Kishihara, K. et al. 1993). 
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The CD45 protein is thought to be recruited to the immunological synapse to help 
initiate TCR signalling and to control the threshold of TCR signalling (Zhang, M. et al. 
2005). Thus in the absence of CD45 the threshold becomes very high resulting in a 
failure of positive selection of thymocytes. The high molecular weight isoforms of 
CD45 (i.e. RA, RB, RC) are believed to have the highest enzymatic activity (Xu, Z. & 
Weiss, A. 2002). The most important substrate for CD45 is the Src tyrosine kinase 
p56Lck in T cells, and p59Fyn can also act as a target. CD45 plays a critical role in 
dephosphorylating two key tyrosine residues of Lck, tyrosine 394 and tyrosine 505 
(i.e. Y394, Y505) as discussed in section 5 of the introductory chapter 1 (Zamoyska, 
R. 2007). However there is still no clear understanding of the roles of the different 
CD45 isoforms in the regulation of TCR signalling or the functional maturation of T 
cells.  
 
A study by Weiss and colleagues showed that a point mutation in the assumed 
wedge domain of CD45 which maintains the continuous phosphatase activity of the 
CD45 can disrupt negative selection in the thymus and mice are predisposed to 
developing autoimmunity (Majeti, R. et al. 2000). Despite the established roles for 
CD45 in regulating T cell development the studies presented here can find no 
significant effect of CD45 differential splicing on T cell development. As will be 
discussed later (Chapter 6) similar findings are also observed when the thunder 
mutation is bred onto a TCR transgenic background. Thus despite the obvious 
changes in CD45 isoform expression the thunder thymocytes somehow are able to 
control potential changes in TCR signalling strength during positive and negative 
selection and this leads to a normal T cell maturation in the thymus. 
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 At birth the peripheral immune system is devoid of mature T and B cells and 
therefore the immune system relies on the production of mature T and B cells from 
the thymus and bone marrow respectively. Analysis of mice at different ages during 
postnatal development identified that the production of mature T cells in the thymus 
of thunder mice is normal throughout postnatal life. During the first 4 weeks of life 
thymic output of mature T cells reaches a maximum. Because the peripheral immune 
system is initially devoid of T cells, the recent thymic emigrants will undergo 
homeostatic and Ag-induced proliferation to fill the memory compartment. It is 
during this period that the naïve T cells rely on extrinsic signals from self-peptide 
MHC and cytokine signals from IL-7/IL-7R signals that promote their expansion. The 
naïve T cells still require self-peptide MHC and cytokine signals from IL-7/IL-7R 
signals for their long term survival and persistence in the periphery in order to 
maintain a diverse T cell repertoire (Surh, C.D & Sprent, J. 2005).   
 
The data presented in this chapter clearly identifies that the thunder mutation does 
not affect T cell development.  Instead the thunder mutation severely disrupts the 
ability of mature naive T cells to accumulate in the periphery.  These results highlight 
that the thunder mutation has a critical role in the persistence of mature T cells in the 
peripheral circulation and therefore has an important role in the regulation of T cell 
homeostasis in vivo. Despite the development of T cell lymphopaenia the thunder 
mice remain healthy and have a normal lifespan. This is intriguing considering that 
there is evidence from different mouse models that the development of T cell 
lymphopaenia can predispose to autoimmunity (King, C. et al. 2004).  
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Despite a significant loss of the naïve cell compartment, memory T cells in 
thunder homozygous mutant mice appear not to be affected significantly. This 
indicates that there is a specific defect in the ability of naïve T cells to persist in the 
peripheral circulation and in secondary lymphoid tissues. The thunder strain was 
identified on the basis of low numbers of T cells in the peripheral blood and most of 
the cells were of a CD44hi (memory) phenotype.  The phenotypic analysis of the 
thunder strain presented in this chapter begins to explain why there is an 
accumulation of memory cells in these mice.  The greatest loss of T cells affects the 
naïve compartment. It is easy to see these changes because in young wild type-mice 
(e.g. 4-16 weeks of age) the number of naïve T cells should outnumber memory 
phenotype cells by almost 2:1.  However the reverse ratio is observed in the thunder 
mice. We hypothesize that the increased frequency of memory phenotype T cells in 
thunder mice is caused by the constant homeostatic proliferation of T cells in 
response to the lymphopaenic environment resulting from constant attrition of mature 
T cells. 
 
Although memory T cells can form in thunder mice it would appear that the long 
term survival of both naïve and memory T cells in thunder mice are affected because 
the number of mature T cells (i.e. both naïve & memory) in the secondary lymphoid 
tissues never reaches the same level as that achieved in wild-type mice with 
increasing age.  This could be because the size of the memory compartment is much 
smaller than the naïve compartment. Once naïve cells differentiate and adopt a 
memory phenotype they cannot re-enter the naïve cell niche because of changes in the 
pattern of cell surface integrins, selectins, chemokine receptors etc. Alternatively the 
memory cells may persist for a slightly longer half life in the circulation but 
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eventually they are destined to die and to be replaced by a new population of memory 
cells. 
 
A defining feature of the thunder mouse strain is that T cells fail to silence the 
three variable exons of CD45. The failure in exon silencing was identified both at the 
level of mRNA in thymocytes as well as at the level of protein expression using a 
panel of well characterised isoform specific monoclonal antibodies. CD45 is the most 
abundant membrane tyrosine protein phosphatase in T cells but still remains one of 
the most enigmatic proteins expressed by leukocytes (Hermiston, M.L. et al. 2003).  It 
has been known for almost 30 years that CD45 protein undergoes alternative splicing 
and this feature is conserved throughout the animal kingdom. CD45 is an important 
component of TCR signalling cascade with a role in initiation of TCR signal 
transduction upon Ag stimulation. However there is still no clear understanding of the 
role of the different CD45 isoforms in the regulation of TCR signalling or the 
functional maturation of T cells.  
 
Loss of naïve T cells and aberrant CD45 pre-mRNA alternative splicing are key 
features of thunder strain, however, they show different heritability. The loss of naïve 
T cells is strictly a recessive trait as heterozygotes share the same phenotype as wild-
type with normal numbers of naïve CD4+ and CD8+ T cells in the thymus and 
periphery. In comparison the CD45 variable exon expression shows evidence of a 
gene dosage dependent semi-dominant effect such that heterozygote mice express an 
intermediate level of CD45RA, RB & RC in CD4+ and CD8+ T cells. These results 
raise the possibility that the changes in CD45 isoform expression may not account for 
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the defect in homeostasis of naïve T cells.  However this line of work will be followed 
up in more detail in chapter 5. 
 
3.5 Chapter Summary  
 
We have identified a novel mouse strain generated by ENU mutagenesis which is 
characterised by the selective reduction of naïve CD4+ and CD8+ T cells in the 
peripheral lymphoid tissues and aberrant CD45 pre-mRNA alternative splicing 
causing constitutive expression of CD45RA, RB and RC isoforms in T cells. The 
association between expression of the high molecular weight CD45 isoforms and 
naïve T cell homeostasis is unclear and will be a focus of later chapters in this thesis. 
This novel ENU variant mouse strain provides an ideal model and a unique entry 
point to investigate the role of pre-mRNA alternative splicing and some important 
aspects of naïve T cell biology, such as homeostasis, survival, activation, and immune 
memory cell transition. 
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Introduction 
 
Protein encoding genes are transcribed to messenger RNA with genetic 
information and then translated into proteins to perform biological functions. Nascent 
mRNAs, also called primary mRNA (pre-mRNA), undergo splicing to remove introns 
so that only continuous sequence of codons exists in mature mRNAs. There are 
specific sequences near exon-intron boundaries called exonic/intronic splicing 
enhancer/silencer (ESE/ISE or ESS/ISS) that respectively bind either splicing factors 
(SR proteins) or heterogeneous nuclear ribonuclear proteins (hnRNP) to initiate or 
suppress exon recognition by the core splicing machinery (splicesome). About 30 
hnRNPs have been identified playing multiple roles in RNA processing. hnRNP L has 
been suggested to repress the inclusion of CD45 variable exons via regulated ESS 
(Rothrock CR, et al. 2005), but the complete mechanism of CD45 pre-mRNA 
alternative splicing is still obscure. In this chapter, we reveal the identification of the 
thunder mutation and its essential role in regulating CD45 variable exon splicing. 
   
4.1   Genome mapping and sequencing thunder mutation 
 
4.1.1 Genome screening for chromosome linkage 
Several generic mapping approaches have been successfully used in the 
Immunogenomics laboratory to efficiently localise ENU mutations to a particular 
chromosomal region by cosegregation of the mutation with genetic markers 
throughout the genome. A homozygous thu/thu mouse (C57BL/6S background), 
which was confirmed by flow cytometry to have low numbers of peripheral T cells 
and constitutive expression of the CD45 isoforms by flow cytometry, was outcrossed 
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to an inbred mapping strain, CBA, to produce heterozygous F1 progeny with one set 
of B6 and CBA chromosomes each. Each F1 mouse will carry one mutant allele and 
one wild-type allele of the gene responsible for the low T cell trait in thunder mice. 
During a meiosis in the F1 animals meiotic recombination shuffles the parental 
chromosomes. Intercrossing F1 carrier mice by brother-sister pairings generated F2 
progeny of which 25% are homozygous for the recessive thunder mutation. 
Comparing a group of homozygous mutants with wildtype or heterozygous mice 
using B6/CBA polymorphic genetic markers across all chromosomes distinguishes 
the chromosomal regions closely linked to the mutation, as the affected mice will all 
bear homozygous B6 alleles in the mutant locus whereas unaffected mice will have 
CBA or heterozygous alleles (Figure 4.1 a). Once the linkage region is narrowed 
down to a reasonable size (usually < 2Mbp), candidate genes can be sequenced to 
verify the mutation (Figure 4.1 b) (Nelms KS, Goodnow CC. 2001). 
To map the thunder mutation F2 mice were screened by flow cytometry to 
identify mice with low numbers of peripheral T cells and those which show 
constitutive expression of CD45 RA, RB and RC on peripheral T cells. Genomic 
DNA was prepared from a cohort of 15 affected F2 mice and 4 unaffected F2 mice 
and these were tested individually with 50 independent microsattelite markers spaced 
at about 30-40 cM intervals across the genome.  Genome scanning showed that the 
thunder mutation was linked to the distal end of chromosome 17 near the micro-
satellite marker D17Mit38 at about 74.1 Mb, as 11/15 individual affected mice 
showed a homozygous B6 allele plus 3/15 had heterozygous B6/CBA allele in 
contrast with ¾ unaffected siblings showing homozygous CBA allele at the same 
region. Chi square test showed that χ2=7.34 (χ20.05(1)=3.84),  indicating P<0.05 and 
significant statistic difference between the two groups (Figure 4.2).  
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Figure 4.1 Genome mapping and sequencing to identify recessive thunder 
mutation. 
(a) Intercross breeding strategy used to map recessive mutation by genetic 
linkage analysis. Mutant C57BL/6 mice are backcrossed to a mapping strain 
(CBA) to produce F1 hybrid mice that carry the mutation and these are 
intercrossed to produce F2 mice where 25% of offspring should be homozygous 
mutant for the mutation.  DNA from the affected F2 progeny can be pooled and 
analyzed by microsatellite markers.  The B6 and CBA alleles can be separated by 
size of PCR fragments in gel electrophoresis.  Markers closely linked to the 
mutation will yield on B6 homozygous alleles, whereas unlinked markers will 
show both B6 and  CBA alleles in F2 mutant mice. DNA from the F1 progeny 
should give both B6 and CBA alleles.  (b) If the linked region is <2Mb then all in 
the interval are resequenced and the mutation in the coding region can be 
identified.
Adapted from Nelms KA, Goodnow CC. Immunity. 2001, 15 (3), 409-18.
b.
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Figure 4.2 Genome scan for linkage to distal end of chr 17
Figure 4.2 Linkage of 
thunder mutation with 
microsatellite markers to 
the distal end of 
chromosome 17.(a) 
Representative RT-PCR 
results for 2 markers used 
to define the linked region 
on chromosome 17. The 
allelic differences between 
B6 and CBA are indicated 
on the right of each gel. (b) 
Results of linkage analysis 
using DNA from 15 
affected F2 mice and 4 
non affected F2 mice 
using the same two 
markers as shown in (a).
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4.1.2 Fine mapping 
In order to confirm and delimit the linkage region and accurately define the 
location of the mutation, more genomic samples were tested to find  affected 
individuals that might have an informative recombination event that would help 
define more closely the region containing the ENU variant gene responsible for the 
thunder phenotype. This involved the use of additional markers within the linked 
region using DNA from 60 affected F2 mice to help in fine mapping. The linked 
interval was further reduced in size down to a  2.1 Mb region defined by the two 
microsatellite markers D17Mit42 and a SNP marker at the position of 17-080241937, 
which are localised at 79.2 and 81.3 Mb of chromosome 17 (Figure 4.3 a-b).  
According to the Ensembl mouse genome database, there are 21 transcription 
units within the linked interval as listed in Figure 4.3 c.  Among them there are 
several genes particularly involved in RNA processing based upon protein sequence 
motifs, including Hnrpll belongs to hnRNP family, sfrs7 is related to known SR 
protein splicing factors, Arl6ip2 has homologs to nucleotide binding and AW494914 
has motifs featured in RNA helicases. 
 
4.1.3 Sequencing thunder mutation: 407T→A transition in Hnrpll 
 
cDNAs were amplified from the thymus mRNA of both unaffected and affected 
mice and were sequenced in priority based on a candidate gene approach, but 
eventually all the coding region of genes in the linkage interval was  resequenced.  
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Figure 4.3 Fine mapping of the Thunder mutation to a 2.1Mb interval. 
(a) Fine mapping on independent cohort of 60 F2 mice was performed using a 
number of microsattellite markers using the amplifluor technology.  (b) An 
informative recombination  was identified between 79.2 and 81.3 Mb on chr 17. (c) 
The table shows the list of 21 genes contained within the 2.1 Mb linked interval.
s
D17Mit88 56.9 B6 Het Het Het B6 CBA
D17Mit38 74.1 B6 B6 B6 Het B6 CBA
D17Mit42 79.2 B6 B6 B6 Het B6 B6
17-0802 81.3 B6 B6 B6 B6 Het B6
D17Mit123 91.9 B6 B6 B6 B6 Het CBA
Marker 17-080241937 (rs3676709)
B6
CBA
solute carrier family 8 (sodium/calcium exchanger), member 1 2823Slc8a121
expressed sequence AV344025 (AV344025), mRNANM_178927.220
THUMP domain containing 21848Thumpd219
RIKEN cDNA 2810417M05 gene16902810417M05Rik18
248UNKNOWN17
UNKNOWN16
mitogen-activated protein kinase kinase kinase kinase 3 3382Map4k315
PREDICTED: similar to cyclin-dependent kinase-like 4 984XP_355031.314
Son of sevenless homolog 1 (Drosophila)4747Sos113
12 days embryo embryonic body between diaphragm region and neck cDNA, 324Q8BSD7_MOUSE12
gene model 941, (NCBI) 1207Gm94111
protein containing single MORN motif in testis 647Mopt10
expressed sequence AW494914 (ATP dependent RNA helicase)4101AW4949149
gem (nuclear organelle) associated protein 6 1086Gemin68
PREDICTED: hypothetical protein LOC677374930560E09Rik7
splicing factor, arginine/serine-rich 7 2272Sfrs76
galactose mutarotase2245Galm5
heterogeneous nuclear ribonucleoprotein L-like3002Hnrpll4
UNKNOWN3
UNKNOWN2
ADP-ribosylation factor-like 6 interacting protein 2 (nucleotide binding)2842Arl6ip21
DescriptionCDS (bp)Gene ID
b. 
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Chapter 4                                                                                                       Mutation 
The only identified mutation was a 407T→A transition in the transcript of Hnrpll, 
resulting in a valine to aspartic acid substitution in the protein (Figure 4.4 a). The 
mutation was confirmed by resequencing genomic DNA samples of other affected 
mice. 
 
Hnrpll belongs to the hnRNP family which consist of a class of diverse RNA 
binding proteins associated with nascent mRNA processing and was named 
heterogenous nuclear ribonuclear protein L-like as it shares 58% homolog to hnRNP 
L. HnRNPs are highly conserved proteins and hnRNP LL has more than 97% residue 
identity between mouse and human (Black, D.L. 2003). A common feature of hnRNP 
proteins is that they contain at least one RNA recognition motif (RRM) also called 
RNA binding domain (RBD). So far there are more than 30 hnRNP proteins identified. 
hnRNP A/B can block splicing factor binding to splicing enhancer to promote exon 
silencing during alternative mRNA splicing, and hnRNP I (PTB) can bind to the 3’ 
splicing site of pyrimidine-rich sequence (Domsic JK, et al. 2003;  Lou, H. et al. 1999; 
Hall-Pogar T, et al. 2007). 
 
Comparison of the primary structure of hnRNP LL and hnRNP L shows the 
similarity of the two proteins (Figure 4.4 b). They both have 3 RRM domains but 
hnRNP LL has an additional coiled-coil domain at the N-terminus and the related 
hnRNP L protein has a proline-rich region between the RRM2 and 3 domains. The 
mutation in the thunder strain is located within the RRM1 domain (Figure 4.4 b). 
 
The RRM motif is the major domain of many eukaryotic RNA binding proteins 
binding to single-stranded RNA and consists of about 90 amino acids (Black, D.L. 
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Figure 4.4 sequencing thunder mutation. 
(a) Genes involved in RNA processing in the linkage region of chr 17 
and T–›A transition in Hnrpll base 407. 
(b)    Primary structure of Hnrpll and Hnrpl. The numbers indicate the 
location of the domains within the primary amino acid sequence 
for each gene. 
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Figure 4.4 sequencing thunder mutation. 
(C) Conservation of Val 136 residue in the hnRNPLL RRM1 domain across 
several species. The mutated valine in thunder mice is indicated in red and as 
can be seen this residue is completely conserved across the species and is also 
conserved in related hnRNP proteins such as hnRNPL and PTB.  Above the 
sequence alignment are the locations of the residues relative to the secondary 
protein structure. The brown arrows indicate β-pleated sheets, whereas the green 
boxes indicate the α-helices. The brown boxes indicated on the sequence 
alignment identify the RNP1 and RNP2 motifs, and within these domains the key 
conserved H and Q residues are highlighted in the square. 
(d) NMR structure of the wild type hnRNPLL RRM1 domain. The mutated valine 
136 residue lies beneath the RNP1 and RNP2 motifs and depicted on the 
diagram are the two key RNA contact points H128 and Q162 (NMR model from 
RIKEN database).
d. 
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2003). RRMs are found in a variety of RNA binding proteins, including 
heterogeneous nuclear ribonucleoproteins (hnRNPs) and protein components of small 
nuclear ribonucleoproteins (snRNPs). The RRM domain contains two consensus 
sequences known as the RNP1 and RNP2 motifs which are highly conserved 
octapeptide and hexapeptide sequences respectively. The RNP1 and RNP2 motifs 
form the core of the binding site for a target RNA. In particular there are two highly 
conserved amino acids,  a glutamine within the RNP1 motif and a histidine in the 
RNP2 motif, that provide essential contact points to the RNA target (Dreyfuss G. et al. 
1993). The X-ray or NMR structures of several hnRNP proteins has been solved and 
these have helped to define a general RRM structure that consists of four β strands 
and two α helices arranged in an alpha/beta sandwich. Recently the RRM1 domain of 
hnRNP LL was solved in collaboration with Prof Gottfried and colleagues at the 
Research School of Chemistry at the ANU.  The conserved valine residue mutated in 
thunder mice is located within loop1 between the β1 sheet (RNP2) and the α1 helix 
highlighted in red in Figure 4.4 c. The conserved RNA contact residues are 
highlighted on the structure as Glutamine (Q162) within the RNP1 domain and 
histidine (H128) in the RNP2 domain. These residues are boxed in the amino acid 
alignment of the RRM1 domain (Figure 4.4 c) and the conserved valine (V136) is 
indicated in red. NMR structural model of RRM1 domain is shown in Figure 4.4 c 
with H128, V136, and Q162 labelled. 
 
4.2   Hnrpll is a novel pre-mRNA alternative splicing regulator  
 
Retrovirus based gene transfer: over-expression of Hnrpll can down-
regulate CD45 exon 6 expression in Hnrpllthu/thu CD4 T cells 
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a. RT-PCR amplify Hnrpll and Hnrpl cDNA
b. Recombinant vectors digested with restriction enzyme XhoI and EcoRI
Hnrpll EST: 
1.8kb
Hnrpl EST: 
1.6kb
Hnrpllthu/thu
KMV
Hnrpl
KMV
Polylinkers:             AccI ClaI
AGATCTCTCGAGGTCGACGGTATC
BglII DpnI XhoI SalI HincII BspDI
GATAAGCTTGATATCGAATTCCGCC
EcoRI
CCCCCCCCTAACGTTACTGGCCGAAG
CCGCTTGGAATAAGGCCGGTGTGCG
c. 
Hnrpll+/+
Hnrpllthu/thuHnrpll+/+
Figure 4.5 Retrovirus based gene transfer rescue of CD45 alternative splicing by 
expression of wild type Hnrpll. (a) RT-PCR amplification of wild type and mutant 
Hnrpll and wild type Hnrpl cDNA. (b) Restriction enzyme digestion to confirm the 
cloning of the relevant cDNAs. (c) Plasmid map of the KMV retroviral vector used 
to over express the wild type cDNA in mutant T cells.  
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To prove that the mutation in Hnrpll was responsible for the defect in CD45 pre-
mRNA alternative splicing, a retrovirus based gene transfer experiment was carried 
out. In theory, if the 407T→A Hnrpll mutation causes CD45 pre-mRNA splicing 
defects in Hnrpllthu/thu T cells, expression of wild-type Hnrpll cDNA should restore 
silencing of CD45R exons and epitopes. 
 
Both wildtype Hnrpll and Hnrpllthu/thu cDNA were amplified (Figure 4.5 a), 
confirmed by sequencing, and cloned into a bicistronic retroviral vector (p-IRES-
KMV) (Figure 4.5 a, b and c). Retroviral vector p-IRES-KMV is modified from 
pIRES bicistronic expression vector from Clontech laboratories, Inc. It contains the 
internal ribosome entry site (IRES) of encephalomyocarditis virus (ECMV) allowing 
translation of two open reading frames from a single mRNA. Ribosomes can enter the 
bicistronic mRNA either at the 5’ end of the inserted gene of interest or at the ECMV 
IRES to translate the reporter gene GFP. The single cassette expresses both the cDNA 
of interest and GFP so all transduced cells co-express GFP and the gene of interest 
(Figure 4.5 c). Successful constructs were cloned with the correct size of the vector 
and the correct expected sizes of the Hnrpll, Hnrpllthu/thu, or Hnrpl cDNAs (Figure 4.5 
b, c). Successful constructs were then amplified by large scale culture of the positive 
colonies. Plasmids were extracted and transfected into a phoenix packaging cells 
expressing ectopic env gag virus coating proteins. The supernatants containing 
infective retroviral particles were used to transduce mouse primary T cells activated 
with anti-CD3 and anti-CD28 and cultured for 3 days in vitro. At the end of the 
culture the cells were harvested, stained with CD45RC antibody and analysed by flow 
cytometry to compare CD45RC expression on GFP+ and GFP- cells.  
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Hnrpllthu/thu
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Figure 4.5 Retrovirus based gene transfer rescue of CD45 alternative splicing 
by expression of wild type Hnrpll. 
(d) Thunder CD4+ T cells were transduced with an empty vector retrovirus 
and stained for CD45 RC expression.  The GFP- and GFP+ cells show 
constitutive expression of the CD45RC epitope at the cell surface. (e) Wild 
type CD4+ T cells were transduced with a Hrnpll expressing retrovirus and the 
cells were stained with CD45RC and analyzed by FACS. Data shows that wild 
type T cells normally have low expression of CD45RC and there is no 
difference in CD45RC expression in GFP+ cells (red line) expressing the wild 
type Hnrpll gene and non-transduced cells (green line). The blue line shown 
on the graph represents the level of CD45RC expression on thunder CD4+T 
cells (f) Thunder CD4+ T cells were transduced by a retrovirus encoding the 
wild type Hrnpll gene. The data show that thunder T cells forced to express 
the wild type Hrnpll gene (GFP+ cells, red line) downregulate CD45RC 
expression as a result of alternative splicing.  In contrast non transduced 
thunder T cells that fail to silence CD45RC expression (GFP- , Green line).
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The results show that when thunder CD4+ T cells are transduced with an empty 
vector, these GFP+ cells retain constitutive expression of the CD45RC protein at the 
cell surface that is indistinguishable from non-transduced GFP- cells in the same 
culture (Figure 4.5 d). By contrast when the vector also expresses wild type Hrnpll 
cDNA there is a marked decrease in CD45RC expression selectively on the GFP+ 
cells (Figure 4.5 f).  As an internal control, the non-transduced thunder T cells in the 
culture fail to silence CD45RC expression and maintain high levels of CD45RC on 
the cell surface (Figure 4.5 f).  Wildtype CD4 T cells transfected with p-IRES-KMV-
Hnrpll virus did not change CD45 splicing as CD45 variable exons have been 
silenced with endogenous Hnrpll (Figure 4.5 d). This gene complementation 
experiment establishes that the mutation in Hnrpll is responsible for the loss of CD45 
exon silencing in thunder mice. 
 
4.3   Thunder mutation destabilizes RRM1 domain of hnRNP LL protein 
 
Structural studies were carried out in collaboration with Prof. Gottfried Otting 
and his PhD student Xinying Jia in the Research School of Chemistry ANU to 
understand how the mutation affects the RRM1 domain of hnRNP LL. NMR solution 
structures of bacterially expressed wild-type and mutant RRM1 revealed that both 
adopted a classic RRM fold, however, the non-polar valine mutated to a positive 
charged aspartic acid in the hydrophobic core of the protein destabilized the domain 
above 25 oC (Figure 4.6 a). The protein is coloured from blue (N-terminus) to red (C-
terminus). The surface with the most positive charge potential is on the top 
representing RNA binding site. Below 15 oC the resonance assignment of the 15N-
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Figure 4.6 Thunder mutation destabilizes RRM structure of 
hnRNP LL protein
Fig.4.6 b. DSC thermograms of RRM1 wild type (—) and RRM1 V136D 
mutation (—). Heating rate is  1.5℃/min. Prescan thermostat is 5 min. 
Postscan thermostat is 0 min. RRM wild type was analyzed at concentration of 
0.0725 mM and RRM V27D mutation was analyzed at concentration of 
0.126 mM (Data from Mr. Xinying Jia and Dr. Gottfried Otting). 
Fig.4.6 a. NMR structure of RRM1 combined with resonance assignment of 15N-
HSQC spectrum. The protein is colored from N-terminus in blue to C-terminus in 
red. Q162 and H128 residues are marked in grey and light blue representing 
RNA binding site. V136 is marked in yellow underneath and the mutation to 
D136 results in the missing of some amide protons shown in red spheres and 
significantly shifted peaks shown in orange. (Data from Mr. Xinyin Jia and Dr. 
Gottfried Otting).
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HSQC spectrum of the wild-type and the mutant RRM1 domain showed that wild-
type peaks are selectively altered as missing from the spectrum of the α1 helix 
(Figure 4.6 a). The respective amide protons in the structure have been highlighted as 
spheres. Red spheres mean missing peaks; orange spheres mean significantly shifted 
peaks. The side chain of Val136 is shown in yellow underneath the RNA binding 
surface composed of RNP1 and RNP2 domains marked by Q162 in grey and H128 in 
light blue..  
 
The stabilities of the wild-type and mutant RRM1 domains were assessed by 
differential scanning calorimetry. The mutation resulted in a much lower melting 
temperature and a significant degree of unfolding above 25 oC of the mutant RRM1 
domain, whereas the structure of the wild-type domain was stable until 45 oC (Fig. 4.6 
b). The combined NMR and DSC data indicate that the V136D mutation is likely to 
interfere with RNA binding indirectly by producing a thermolabile structure which is 
mostly unfolded at 37 oC. 
.  
4.4   Hnrpll expression in lymphocyte subsets 
  
To determine Hnrpll expression in lymphocytes, CD4SP and CD8SP from thymus 
and CD4+ T cells, CD8+ T cells, and CD19+ B cells from spleen were sorted by flow 
cytometry. Total RNA was isolated and quantified to use equal amount of RNA for 
realtime-PCR. The results show that Hnrpll is highly expressed in both CD4+ and 
CD8+ T cells but lowly expressed in B cells, in contrast with Hnrpl is expressed in all 
lymphocytes. This is consistent with the observation that mouse B cells cannot silence 
the 3 variable exons of CD45 (exon 4, 5 and 6) and provides further evidence for the 
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non-redundant role for the Hnrpll gene to allow T cells to silence the three variable 
CD45 exons. Furthermore, Hnrpll is more highly expressed in memory T cells than 
naïve T cells, suggesting Hnrpll is developmentally regulated and is up-regulated as T 
cells differentiate to become memory cells. It is also well established that memory T 
cells predominantly express CD45RO isoform due to activation induced silencing of 
the 3 variable exons in CD45 molecule (Bell, E.B., Sparshott, S.M., 1990; Beverley, P. 
1991). Hnrpllthu/thu naïve T cells have more Hnrpll transcripts than wildtype 
counterparts. This may be due to loss of Hnrpll function in Hnrpllthu/thu mutants and 
the compensation of relative higher expression (Figure 4.7). 
 
4.5 Discussion  
 
HnRNP proteins are important regulators of pre-mRNA alternative splicing. 
Several members of the hnRNP protein family such as hnRNP A, PTB (hnRNP I) 
have been demonstrated to play multiple roles in pre-mRNA processing (Wang, Z. et 
al. 2004; Oberstrass, F.C. et al. 2005; Paradis, C. et al. 2007). Here we have identified 
a mutation in a previously uncharacterized member of the hnRNP protein family 
hnRNP LL.  Like other members of this diverse protein family. Based on analysis of 
the thunder mutation and complementation with wild-type protein expressed from a 
retroviral vector, hnRNP LL plays an important role in regulating alternative splicing 
of at least one known target gene in CD4+ and CD8+ T cells and that is the Ptprc 
gene which encodes the tyrosine phosphatase CD45.  
 
Although the detailed mechanism of pre-mRNA splicing is still poorly understood, 
it is generally accepted that the major function of hnRNP proteins is to bind to 
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ESS/ISS sequences (Black, D.L. 2003). In this way, they repress recognition of the 
consensus cis-acting exon splicing enhancer sequences by splicing factors of the 
Serine –arginine rich (SR) protein family that promotes recruitment of the 
spliceosome to the intron/exon boundary and to promote exon inclusion on the mRNA 
target. When hnRNP proteins are bound to the ESS/ISS cis regulatory sequences of 
exons this thereby prevents the recruitment of the spliceosome and leads to exon 
silencing/skipping (Black, D.L. 2003).  
 
Although alternative splicing of the Ptprc gene has been known for more than 20 
years the critical trans-acting factor(s) that mediates exon silencing during alternative 
splicing have remained elusive. In recent years there has been considerable effort 
placed into understanding the molecular regulation of CD45 splicing. Although the 
three variable exons of CD45 exons 4, 5 and 6 are variably included in the CD45 
mRNA depending on the state of maturation and activation, it has been shown that 
exons 4 and 6 are most tightly regulated (Lynch, K. 2004). Exon 5 usage appears 
more stochastic or leaky. Regulation of alternative splicing of CD45 is an important 
issue because it is a key marker of memory T cells. Dysregulation of CD45 splicing 
may predispose susceptible individuals to autoimmune diseases such as multiple 
sclerosis and to infections (Lynch, K.W. & Weiss, A. 2001; Boxall, S. et al. 2004). 
The cis- acting regulatory sites in these variable exons that have been implicated in 
disease etiology are the same that govern the isoform switch in activated T cells.  
 
Several splicing factors of the SR family have been implicated in CD45 
alternative splicing.  Many of these studies have been performed at a biochemical 
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level because gene knockouts of the ubiquitously expressed SR proteins lead to 
embryonic lethality (Wang, H.Y. et al. 2001).   
 
Previous studies by Lynch and colleagues have focused on the cis-acting ARS 
elements that regulate exon 4 silencing of CD45, since this is regulated in an 
activation dependent manner (Rothrock, C., et al. 2003; Rothrock, C. R., A. E. House, 
and K. W. Lynch. 2005; House, A. E., and K. W. Lynch. 2006; Melton, A.A. et al. 
2007).  They performed RNA affinity chromotagraphy to elute the proteins bound to a 
RNA oligonucleotide probe containing the ESS1 cis-regulatory sequence of variable 
exon 4 that mediates partial exon repression in resting cells and increased exon 
skipping upon activation. They identified that multiple hnRNP proteins could 
associate with the ESS1 sequence including PTB, hnRNP E2 and hnRNP L (Rothrock, 
C. et al. 2005; Melton, A.A. et al. 2007). hnRNP L shares 58% homology with 
hnRNP LL. Within the RRM1 domain hnRNP L shares 66% identity with the hnRNP 
LL protein and the key conserved residues such as Val136, His128 and Q162 are 
completely conserved (Figure 4.4).  
 
T cells from thunder mice have normal expression of the Hnrpl gene but the 
mutant cells still cannot splice CD45 correctly.  We conclude from this finding that 
hnRNP LL must play a critical and non-redundant role in the regulation of CD45 
alternative splicing in mouse T cells.  Although hnRNP LL was not identified in the 
complex purified in human Jurkat cells these experiments are technically demanding 
and may not necessarily pull down all the relevant proteins in vitro.  Another 
possibility is that the requirements for hnRNP L and hnRNP LL are reversed and so 
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the hnRNP L assumes a more dominant role in CD45 splicing in human T cells. 
Further studies should hopefully provide an answer to this question. 
 
The NMR structure of the RRM1 domain of hnRNP LL shows that this previously 
uncharacterized protein shares many of the structural properties of other hnRNP 
proteins. The RRM1 domain of the hnRNP LL protein is conserved across the species, 
as are the location and structure of the RNP1 and RNP2 motifs. The valine mutated in 
thunder cells highlights the important roles of this residue for the first time that it 
plays in maintaining the stability and function of the RRM1 domain.  Previous studies 
have identified the critical role that the conserved His and Glu residues play within 
the RNP1 & 2 motifs to contact the RNA template. The NMR structural studies 
performed on the wild type and mutant RRM1 domain of hnRNP LL revealed that 
introducing a non conserved amino acid renders folding of the whole domain 
temperature-sensitive.  
 
Although hnRNP LL has three RRM domains it is clear from the phenotype of the 
thunder mouse and the disruption caused to CD45 splicing that the RRM1 domain of 
hnRNP LL must play an important and critical role in contacting the RNA template to 
allow exon silencing to occur. The hnRNP proteins usually have multiple RRM 
domains and it is not understood exactly how the multiple RRM domains facilitate in 
binding RNA. Binding data showed that RRM1 has micromolar affinity for ARS 
motif RNA (not shown, from Gottfried Otting’s recent collaboration). It is possible 
that one RRM domain may provide a major contact site and the other domains could 
help stabilize the protein bound to the ESS/ISS cis regulatory sequences. Alternatively, 
129 
Chapter 4                                                                                                       Mutation 
it is possible that unfolding of the RRM1 domain leads to degradation of mutant 
hnRNP LL. 
 
The data shown in Chapter 3 and 4 shows that hnRNP LL has a non-redundant 
role in regulating alternative splicing of CD45 in T cells.  Thus the related hnRNP L 
protein although expressed cannot substitute the functional role for hnRNP LL when 
it is mutated in thunder T cells.  FACS staining showed evidence of a dose 
dependency in exon 4 & exon 6 silencing in both CD4+ and CD8+ T cells. These two 
exons are the most tightly regulated in T cell activation, whereas silencing of exon 5 
is more stochastic. Although FACS staining does reveal some role for hnRNP LL in 
regulating efficient silencing it is likely other splicing regulators could be involved in 
this exon.  Recently it was shown that the splicing factor U2AF26 and the Gfi1 
proteins could regulate exon 5 usage in T cells (Heyd, F. et al. 2006). 
 
The Hnrpll gene is developmentally regulated in T cells and appears to be low or 
absent in B cells. It is expressed by thymocytes and its expression is significantly 
upregulated as T cells differentiate from a naïve to memory cell.  In contrast the Hnrpl 
gene does not show developmental regulation and is expressed equivalently between 
naïve and memory T cells and B cells. The differential expression of Hnrpll and 
Hnrpl between B cells is consistent with the pattern of CD45 splicing in B cells 
observed by flow cytometry.  Normally B cells do not silence CD45RA, B, and C and 
the lack of Hnrpll expression in B cells may explain this.  As T cells differentiate 
between the naïve and memory states they are believed to alter their program of gene 
expression that somehow changes their functional behaviour and allows for their long 
term persistence in the peripheral circulation without the need for persistent antigen.  
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A key feature of memory T cells is that they can proliferate more rapidly upon 
reactivation and can differentiate rapidly to become effector cells with increased 
secretion of cytokines.  Exactly how this global change in gene expression is achieved 
remains poorly understood.   
 
4.6   Chapter Summary  
 
The data presented in this chapter identifies that the hnRNP LL protein is a novel 
trans-acting factor that regulates CD45 splicing in T cells.  The phenotype of the 
thunder mouse suggests that hnRNP LL through its ability to regulate alternative 
splicing directly impacts on the process of T cell homeostasis.  CD45 is clearly a 
target of the hnRNP LL protein in murine T cells but we hypothesize that this 
represents just the tip of the iceberg and that hnRNP LL is likely to control a much 
wider program of alternative splicing in T cells that may involve hundreds of genes.  
This is an area of work which will be expanded more on later in the thesis. 
 
The data presented in chapters 3 and 4 of this thesis also provides further support 
for the important role that ENU mutagenesis programs can have in phenotype driven 
approaches to identify novel genes that regulate lymphocyte development and 
homeostasis in the immune system. Since the mutagenesis screens are non biased i.e. 
they make no prior assumptions for the role of genes in biological or cellular 
processes, this allows the identity of novel genes that regulate fundamental processes 
in the immune system to be discovered.  Since the hnRNP proteins are ubiquitous in 
their expression this has made study of these proteins in vivo, especially in the 
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immune system, extremely difficult since mutations in these proteins normally result 
in an embryonic lethal phenotype.   
 
Currently there are no known mutations in any of the hnRNP proteins in mice or 
humans as most of them have only been studied at a biochemical level. This makes 
the thunder strain an extremely valuable and unique resource that should allow us to 
gain important insights into: (i) how changes in alternative splicing affect the long 
term survival of naïve T cells and the generation of memory cells (ii) to explain how 
CD45 signalling influences T cell homeostasis, (iii) how changes in alternative 
splicing affects the generation and homeostasis of antigen-specific effector and 
memory T cells and (iv) generally provide new insights into the genetic regulation of 
T cell homeostasis. 
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Introduction 
 
The immune system aims to maintain a diverse repertoire of T cells in the 
peripheral circulation so it can fight off infections. It allows the rapid expansion and 
contraction of antigen-specific cells during an immune response. Some existing 
memory cells are destined to die and replaced by the new memory cells. Similarly 
naïve T cells have a defined life span and as one cell dies it is quickly replaced by a 
thymic emigrant that expands in number to fill the void. Studies over the last 10 years 
have begun to define the signals that regulate T cell homeostasis in vivo. There is 
ample evidence that naïve and memory CD4+ and naïve CD8+ T cells depend upon 
pro-survival signals mediated by IL-7/IL-7R signalling and TCR signals delivered by 
recognition of self-peptide/MHC interactions. In contrast, the long term survival of 
CD8+ memory cells is independent of TCR signals and relies upon IL-15 (Sprent, J. 
& Surh, C.D. 2002). 
 
Memory T cells can be generated from either homeostatic proliferation (IL-7 
dependent) or antigen-induced proliferation (TCR signal dependent) pathways. CD45 
is an important molecule to initiate TCR signalling by modulating Lck activity 
(Hermiston, M.L. et al. 2003). In this chapter we explore the association between T 
cell homeostasis and CD45 expression and splicing in thunder mice. We further 
characterize changes in other cell surface markers that are known to influence T cell 
survival in the peripheral immune system, so that we can gain an insight into the 
homeostatic defects of Hnrpllthu/thu naive T cells. 
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5.1   Defective T cell homeostasis in thunder mice: failure in persistence 
 
5.1.1 Normal proliferation of Hnrpllthu/thu T cells with anti-
CD3/anti-CD28 stimulation in vitro 
 
The failure of mature Hnrpllthu/thu naive T cells to survive in the periphery could be 
due to defective TCR signalling.  To test this we cultured wild-type CD45.1+ 
congenic T cells with Hnrpllthu/thu (CD45.2+) T cells in vitro. The T cells were 
prepared from the spleen and were purified by MACS separation to deplete NK cells, 
B cells, granulocytes, red blood cells, macrophages and dendritic cells.  The T cells 
were labelled with the membrane dye CFSE and cultured on plates coated with 
various concentrations of anti-CD3 and soluble anti-CD28 in the culture medium. At 
the completion of the assay cells were harvested, stained with antibodies to CD4 and 
CD8 and 7AAD and analysed by FACS.  As shown in Figure 5.1.1, there was no 
difference in the proliferative response of wild-type or Hnrpllthu/thu T cells in vitro as 
assessed by the rate of CFSE dilution to any of the concentrations of anti-CD3 used.  
 
5.1.2 Normal homeostatic proliferation of Hnrpllthu/thu naïve CD4 
and CD8 cells with or without MHC restricted peptide 
presentation in irradiated B6 and Tap2 mutant mice 
 
When T cells are placed into a lymphopaenic environment they can sense the 
empty lymphoid compartment and spontaneously proliferate in response to TCR-
pMHC signals and pro-survival signals from IL-7.  We wanted to determine if 
thunder T cells could undergo homeostatic proliferation when transferred to a 
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Figure 5.1.1 Normal T cell proliferation of thunder T cells in vitro
CD4 CD8
Anti-CD3 0.25ug/ml
+ Anti-CD28 0.5ug/ml
No stimulation
Anti-CD3 0.5ug/ml
+ Anti-CD28 1ug/ml
Anti-CD3 1ug/ml
+ Anti-CD28 2.5ug/ml
Anti-CD3 2.5ug/ml 
+ Anti-CD28 5ug/ml
Anti-CD3 5ug/ml
+ Anti-CD28 10ug/ml CD45.2 (thu/thu)
CD45.1 (+/+)
Fig. 5.1.1 Mixture of wild-type (CD45.1, red) and thu/thu (CD45.2, green) 
splenocytes were labelled with CFSE and co-cultured in medium 
containing different concentrations of anti-CD3 and anti-CD28. Data 
showed comparable proliferation of thunder T cells in response to anti-
CD3 and anti-CD28 stimulation.
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lymphopaenic host. Two different experimental models have been widely used to 
study homeostatic proliferation of T cells in vivo. One is to transfer T cells into 
Rag2null mice carrying a mutation in the Rag2 gene, in which lymphocyte precursors 
are unable to rearrange their antigen receptors resulting in the arrest of lymphocyte 
maturation and failure to make T or B cells (Mombaerts P, et al. 1992). A second 
experimental model involves transferring T cells into wild-type mice that have first 
been conditioned with a sublethal dose of γ-irradiation which kills off lymphocytes. 
This treatment creates “space” to allow donor T cells to homeostatically expand and 
fill the lymphoid compartment.   
 
In the experiments described below we have used both types of animal model to 
examine the capacity of Hnrpllthu/thu T cells to undergo homeostatic proliferation and 
to persist in the circulation once the lymphocyte compartment has been filled.  
Previous studies have used naïve T cells usually from the spleen or lymph node as 
donor cell populations but in thunder mice the majority of mature T cells in the 
periphery are of a memory phenotype (see Figure 3.2.1c). Therefore to have a starting 
population of naïve T cells for these experiments we chose to use thymocytes as the 
donor cell population since only the mature single positive cells in the thymus will 
survive in the recipient and these cells will initially be of a naïve T cell phenotype 
(Fig 5.1.2 a). 
 
First we wanted to examine if Hnrpllthu/thu naive T cells are defective in their 
ability to undergo homeostatic proliferation. The thymocytes were prepared from 
either wild-type CD45 .1 congenic mice or thu/thu (CD45.2) mice and were labelled 
with CFSE to monitor their proliferation in vivo. Prior to the injection wild-type and 
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+/+ donor T cells
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Figure 5.1.2 T cell Homeostatic proliferation in irradiated hosts
b. Procedure of adoptive cell transfer experiment:
i.v.
CD4SP 
thymocytes
+/+ thu/thu
CD44
Naïve phenotype of donor 
CD4SP thymocytes
Fig. 5.1.2 T cell homeostatic proliferation in irradiated hosts.
a. To study the responsiveness of thu/thu naive T cell to pMHC, thymocytes 
were transferred to lymphodepleted recipients. CD4/CD8 SP act as naive 
T cells and proliferate in the presence of IL-7 and self-peptide/MHC.
b. Mixture of wild-type (CD45.1) and thu/thu (CD45.2) thymocytes were 
labelled with CFSE and injected to irradiated B6 or Tap2 mutant mice. 7 
days after injection, thu/thu T cells were distinguished from wild-type 
donor and residual host cells from CD45.2 and CD45RC staining. Cell 
division was analysed by CFSE dilution.
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Hnrpllthu/thu cells were mixed in a 50:50 ratio. The mixture was then injected 
intravenously into recipient C57BL/6 mice that had been irradiated with a single dose 
of 6 Gy (Fig 5.1.2 a and b). 
 
 The recipient mice were taken down 7 days after the injection. The spleen and 
peripheral blood lymphocytes were stained with antibodies to CD4, CD8, CD45RC, 
CD45.1 and CD45.2 and analysed by flow cytometry. The donor wild-type and 
thunder T cells could be distinguished based on the difference in allelic expression of 
the CD45 markers (i.e. CD45.1 vs CD45.2), whereas the residual T cells of the 
irradiated host can be distinguished from donor Hnrpllthu/thu T cells by the constitutive 
expression of CD45RC in the mutant cells (experimental procedure is shown in 
Figure 5.1.2 b).  
 
Also we wanted to determine if the homeostatic proliferation of wild-type or 
Hnrpllthu/thu CD8+ T cells may be impeded as a result of a lack of peptide/MHC I 
complexes in vivo. The recipient jasmine mouse strain was identified from an ENU 
mutagenesis screen by a lack of peripheral CD8+ T cells (Fahrer, A. Goodnow, C. 
unpublished). Through genetic mapping the mutation was identified in the Tap2 gene, 
encoding an essential transporter for loading MHC class I-restricted peptides into the 
endoplasmic reticulum. In Tap2 deficient mice MHC-I fail to be loaded with antigenic 
peptides, are unable to present the peptides, and remain unstable, thus only low levels 
of MHC1 is present on the cell surface (de la Salle H, et al. 1994). This abolishes the 
differentiation of mature CD8+ T cells in the thymus, and causes a lack of mature 
CD8+ T cells in the peripheral circulation. 
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Figure 5.1.2 T cell Homeostatic proliferation in irradiated hosts
Figure 5.1.2 c. 
Blood CD4 vs CD8 profile of recipient mice prior and  post  irradiation and 
mixed cell transfer showing lower % CD8+ cell in TapJas/Jas mice
d. Comparable proliferation of wild-type and  thu/thu T cells in irradiated 
B6 and Tap2Jas/Jas hosts.
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Figure 5.1.2 c shows that CD4+ and CD8+ cell percentages in the host blood prior 
to and after irradiation and cell transfer. Tap2Jas/Jas mice have very few mature CD8+ 
cells. One week after adoptive transfer of thymocytes, the CD8+ cell percentages in 
the blood are 50% less in the Tap2Jas/Jas recipient mice, compared to the wild-type 
recipients (Fig. 5.1.2 c). However, there was no difference in the rate of proliferation 
as measured by CFSE dilution for either wild-type or Hnrpllthu/thu CD4+ or CD8+ T 
cells in wild-type C57BL/6 recipients, as shown in Figure 5.1.2 d, and the cells 
convert to a memory phenotype (CD44hi) at a similar rate for the wild-type and 
Hnrpllthu/thu T cells (Figure 5.1.2 e).   
 
The homeostatic proliferation of wild-type and Hnrpllthu/thu naïve CD8+ T cells 
both appeared to be reduced as a result of lack of peptide/MHC I complexes 
expressed on peripheral APCs in jasmine recipient mice. As shown in Fig. 5.1.2 f 
CD8+ T cells displayed weaker and delayed proliferation in Tap2Jas/Jas recipient mice 
compared to that in B6 hosts, and again there is no difference in the proliferation rate 
of wild-type and Hnrpllthu/thu naïve CD8+ T cells in wild-type B6 and Jasmine 
recipient mice respectively. 
 
5.1.3 Hnrpllthu/thu T cells fail to persist after adoptive transferring in 
RAG-1null hosts   
 
Next we examined the capacity of wild-type and Hnrpllthu/thu T cells to expand in 
RAG-1null hosts. Wild-type and Hnrpllthu/thu thymocytes were mixed at a 50:50 ratio 
and injected intravenously into RAG-1null recipients and bled on days 7 and 21 after 
the transfer (Figure 5.1.3 a). The peripheral blood samples were stained with anti-
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f. Failure in MHC I restricted peptide presentation results in impeded CD8+ cell proliferation
Figure 5.1.2 T cell Homeostatic proliferation in irradiated hosts
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e. Normal proliferation and naïve to memory transition of thu/thu T cells
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Fig. 5.1.2 e. Both +/+ and thu/thu donor T cells were segregated from B6 and 
TapJas/Jas recipients and analysed for CFSE dilution and CD44 expression.
f. Histograph overlays showing CFSE dilution in wild-type and thu/thu T cells in B6 
and TapJas/Jas recipients 7 days after transfer, 
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CD4. CD8, CD45.1 and CD45.2 to distinguish the two donor cell populations.  As 
shown in Figure 5.1.3b at the start of the experiment both CD4+ and CD8+ T cell 
populations started at 50:50, and the T cell compartment expands rapidly during the 
21days.  When we analysed the T cells to identify their origin we found by the end of 
the first week the wild-type CD4+ T cells represented 60% of the peripheral CD4+ T 
cells while Hnrpllthu/thu derived CD4+ T cells represented 40% of the peripheral CD4+ 
population. By 3 weeks after the transfer there was a significant difference between 
the proportion of wild-type and Hnrpllthu/thu derived T cells, where wild-type cells 
constituted about 80% of the CD4+ cells and 90-95% of the CD8+ cell populations, 
whereas Hnrpllthu/thu cells represented just 20% of CD4+ and <10% of CD8+ T cells 
in the peripheral blood (Figure 5.1.3b).   
 
We conclude from these data that the Hnrpllthu/thu mutation does not affect the 
ability of T cells to undergo homeostatic proliferation as they show effective cell 
division compared with wild-type T cells and can expand at a similar rate to that of 
wild-type T cells in response to TCR stimulation in vitro and pro-survival cytokine 
signal in vivo. However, Hnrpllthu/thu T cells fail to persist in the circulation. The most 
possible explanation is due to increased cell death but it does not rule out the 
possibility of different homing potency. 
 
5.1.4    Hnrpllthu/thu T cells fail to persist in lymphoreplete hosts  
  
When T cells are transferred to a lymphoreplete host, the peripheral T cell 
compartment is already “full” and there is limited space to be occupied by donor T 
cells. In the case of transferring T cells to a lymphoreplete host, donor T cells cannot 
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Fig. 5.1.3  T cell persistence in RAG-1 KO recipients
a. Mixture of wild-type and thu/thu thymocytes were adoptively transferred to 
RAG1 deficient mice and bled fortnightly to monitor the persistence.
b. Top: Blood CD4 and CD8 cell percentages in RAG1 KO recipients after 
transfer. Blue dots: CD4; pink dots: CD8. Bottom: proportion of wild-type 
(blue dots) and thu/thu (pink dots) in RAG1-/- recipients during a 5-weeks 
course. Each pair of dots represents data from one recipient.
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proliferate but instead should be able to persist albeit at a low frequency, since they 
would receive the necessary signals (i.e. p/MHC and IL-7) to promote their survival. 
The data from the preceding experiment indicated that Hnrpllthu/thu mutation 
selectively affects the ability of Hnrpllthu/thu T cells to persist in vivo.  Therefore a 
prediction is that when Hnrpllthu/thu T cells are transferred to a lymphoreplete host they 
would fail to persist and would die off rapidly.  
 
 To test this hypothesis a 50:50 mixture of wild-type CD45.2+ (CD45RClo)  and 
Hnrpllthu/thu CD45.2+ (CD45RChi) thymocytes or splenocytes (at 4 weeks of age so 
mostly naïve T cells) were injected intravenously  into intact CD45.1 hosts to monitor 
the persistence of donor cells (Figure 5.1.4 a). The recipient mice were bled 
fortnightly after the injection and we analysed the proportion of CD45.2+ T cells that 
were retained in the mice. The data showed that donor CD4+ T cells had a declined in 
the blood from 2 weeks to 4 weeks post transfer (Figure 5.1.4 b).  The wild type and 
Hnrpllthu/thu T cells could be distinguished based on the difference in CD45RC 
expression. As shown in Figure 5.1.4 c and d, whether thymocytes or splenocytes 
were used as the source of donor cells, the Hnrpllthu/thu derived CD4+ T cells failed to 
persist in the peripheral blood compared to wild-type cells. This result confirms a cell 
autonomous effect of the Hnrpllthu/thu mutation on T cell persistence in vivo. 
 
Through a series of adoptive cell transfer experiments, we found that Hnrpllthu/thu 
naïve T cells have normal proliferation rate in response to TCR stimulation either in 
vitro or in vivo. They can compete with wild-type T cells during the homeostatic 
expansion phase, in contrast to wild-type T cells the Hnrpllthu/thu naïve T cells cannot 
be sustained in the peripheral circulation once the T cell compartment is filled. 
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5.2. Hnrpllthu/thu naive T cells show multiple phenotypic changes  
 
The homeostasis of naïve T cells is dependent upon TCR signals and exposure to 
the cytokine IL-7 (Sprent, J. & Surh, C.D. 2002).  The TCR of mature naïve T cells 
recognize self peptide/MHC complexes in the periphery that are thought to mimic 
those peptides presented in the thymus and provide a tonic signal to promote cell 
survival rather than allowing full activation.  Exposure to IL-7 is critical for the 
survival of naïve T cells in the periphery (Fry, T.J. & Mackall, C.L. 2005).  We 
hypothesized that decreased survival of Hnrpllthu/thu naïve T cells could be due to a 
cell intrinsic problem that affected the ability of Hnrpllthu/thu T cells to respond to 
peptide/MHC complexes or to IL-7.  Lymphotrophic IL-7 signaling is transduced 
through binding to the IL-7R in T cell surface, which is composed of a multimeric 
complex including the IL-7Rα (i.e. CD127), IL-2Rβ (CD122) and the common γ 
chain (CD132). Monoclonal antibodies exist to all three components and their 
expression at the cell surface can be quantitated by flow cytometry. 
 
5.2.1    Lower expression of IL-7R on Hnrpllthu/thu naïve T cells 
 
We compared the expression of CD127 (IL-7Rα) on the surface of naïve (CD4+ 
or CD8+, CD44lo) or memory (CD4+ or CD8+, CD44hi) spleen T cells of wild-type, 
Hnrpllthu/+ and Hnrpllthu/thu mice by flow cytometry. The data in Figure 5.2.1a shows 
that the majority of Hnrpllthu/thu CD44lo T cells have relatively low expression of 
CD127 fluorescence compared to wild-type or Hnrpllthu/+ naïve T cells. The 
histogram overlay of gated CD44lo cells shows a clear shift to the left for IL-7Rα 
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Fig. 5.2.1 a. Representative dot plots of spleen CD4 and CD8 T cells 
from wild-type, thu/+, and thu/thu mice showing CD127 (IL-7Ra) 
expression in CD44lo naïve and CD44hi memory compartments.
Figure 5.2.1  Lower IL-7R expression on Hnrpllthu/thu naive T cells
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b. Histograph overlay of naïve T cells showing IL-7Ra expression in 
wild-type (red line), thu/+ (green line), and thu/thu (dark line) mice.
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expression on naïve Hnrpllthu/thu T cells, and this shift was more obvious on naïve 
CD4+ cells than CD8+ cells (Figure 5.2.1 b). A similar pattern of staining for IL-7Rα 
was also observed on naïve T cells in the peripheral blood of Hnrpllthu/thu mice,  The 
data in Figure 5.2.1c shows the geometric mean expression of CD127 on  CD4+ and 
CD8+ naïve and memory T cell subsets in the peripheral blood obtained  from a 
cohort of wild-type, Hnrpllthu/+ and Hnrpllthu/thu mice. There is a statistically 
significant difference in IL-7Rα expression on Hnrpllthu/thu naïve CD4+ and CD8+ 
cells but not in the memory T cells (Figure 5.2.1 c). 
 
We have also observed a significant decrease of IL-7Rα mRNA in Hnrpllthu/thu 
naïve CD4+ and CD8+ T cells compared to their wild-type counterparts from exon 
array experiments, whereas memory T cells showed no difference in IL-7R expression 
(Figure 5.2.1d). Thus it appears that IL-7R expression is decreased in Hnrpllthu/thu 
naïve T cells at both the level of mRNA and protein. 
 
5.2.2 Bone marrow chimeras show T cell autonomous defects in 
CD45 splicing and IL-7R expression in naive T cells 
 
The lower expression of IL-7R on the surface of Hnrpllthu/thu naïve T cells could 
be due to a cell extrinsic effect caused by the lymphopaenia such as elevated IL-7.  To 
confirm that the Hnrpllthu/thu mutation affects T cell persistence in a cell autonomous 
manner and to examine if the decrease in IL-7R on Hnrpllthu/thu T cells is due to a cell 
autonomous effect of the Hnrpllthu/thu mutation, we generated mixed bone marrow 
chimeras. Two different 50:50 bone marrow chimeras were set up, a control group 
reconstituted with the mixture of wild-type CD45.1 and wild-type CD45.2 bone 
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marrow cells, and a test group with wild-type CD45.1 and Hnrpllthu/thu CD45.2 donor 
marrow. The irradiated recipients were bled initially 7 weeks after the reconstitution 
and were bled every 2 weeks for a further 6 weeks to monitor the proportions of T 
cells in the peripheral blood and the level of IL-7R expression on T cells by flow 
cytometry.   
 
At 7 weeks we could confirm that the defect in CD45 alternative splicing is T cell 
intrinsic effect due to Hnrpllthu/thu mutation, as Hnrpllthu/thu T cells maintained the 
CD45RChi phenotype irrespective of whether they grow in the presence of wild-type 
cells (Figure 5.2.2 a). Analysis of the T cell populations in the CD45.1 (+/+) and 
CD45.2 (+/+) chimeras revealed that by the end of the 16 week period the CD4+ and 
CD8+ T cells were approximately 50:50 derived from the two marrow donors (Fig. 
5.2.2 b and data not shown). By contrast, in the CD45.1 (+/+) and CD45.2 
(Hnrpllthu/thu ) chimeras, by 7 weeks after reconstitution Hnrpllthu/thu derived T cells 
represented just 25% of the peripheral CD4+ T cell pool.  Over the remaining 6 weeks 
of the experiment the Hnrpllthu/thu T cells failed to increase in number and remained at 
just 20% of the peripheral CD4+ pool (Fig. 5.2.2 b).  
 
Analysis of the IL-7R expression on T cells from the two different chimeras was 
also informative.  Whereas IL-7R expression decreased over time on CD4+ cells in 
the CD45.1 (+/+) and CD45.2 (+/+) chimeras there was no significant difference in 
the geometric mean of CD127 for either the CD45.1+ or CD45.2+ derived cells.  In 
contrast the Hnrpllthu/thu derived T cells showed a lower level of IL-7R expression 
throughout the course of the experiment and this was statistically significant at 
p<0.002 (Fig. 5.2.2 c). Therefore the results of these experiments confirm that the 
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Fig. 5.2.2 a. Two groups of bone marrow chimeras were set up in irradiated CD45.1 
mice. One with mixture of CD45.1 and CD45.2 wild-type cells, the other with CD45.1 
wild-type and CD45.2 thu/thu cells. Cells derived from the first group of BM cells can be 
distinguished by CD45.1/CD45.2 markers whereas cells in the second group are 
different in CD45RC expression as well as CD45.1/CD45.2.
b. Blood CD4 cell composition of wild-type CD45.1vs CD45.2 and wild-type vs thu/thu.
c. IL-7Ra GeoMeans of CD4 cells in the chimeras. Each pair of lines represent data
from one host.
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Figure 5.2.3 Common γ chain (CD132) expression in wild-type and 
thu/thu T cells in the peripheral blood of intact mice. Naïve and memory 
T cells were gated on the level of CD44 staining.
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Hnrpllthu/thu mutation acts in a cell autonomous manner to regulate IL-7R expression 
and also to influence T cell homeostasis in vivo.  
 
5.2.3 Normal common γ-chain cytokine receptor 
 
In contrast to the IL-7R expression there was no difference in expression of the 
common γ chain (CD132) on naïve and memory T cells from either wild-type, 
Hnrpllthu/+ or Hnrpllthu/thu intact mice (Figure 5.2.3). 
 
5.2.4 Change of IL-7R expression is not due to alternative splicing 
 
Alternative splicing of pre-mRNA is frequently observed in cytokines and 
cytokine receptors that generate complex regulation of cytokine signalling (Atamas, 
S.P. 1997). It is not surprising that receptor abnormalities or a pathological ratio of 
different isoforms may contribute to the defects in T cell homeostasis by 
circumventing normal growth factor control or altering the balance of proliferation 
and differentiation. IL-7Rα has been reported with alternatively spliced transcripts 
coding truncated receptor proteins and potentially modulating IL-7 signalling in 
patients with leukaemia (Korte, A. et al. Cytokine. 2000). So we decided to examine 
if the change in IL-7R expression in thunder naïve T cells is caused by or 
accompanied with a change in alternative splicing of the receptor. 
 
CD4+ and CD8+ single positive thymocytes and naive and memory peripheral 
CD4+ and CD8+ T cells were FACS sorted to isolate total RNA. It was then 
hybridized to Affymetrix mouse all exon array chips to screen splicing targets of 
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b. Exon array data from mRNA of wild-type and thu/thu peripheral 
naïve and memory CD4 and CD8 cells showing IL-7R transcripts 
in the four cell subsets. The exon level detection of IL-7R 
transcript shows no evidence of alternative splicing in the mutant 
cells, but the overall expression of IL-7R in thu/thu naïve T cells 
(in blue) is lower than that of wt naïve cells (in purple).
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Figure 5.2.4 IL-7R is not alternative spliced in thunder T cells
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Hnrpllthu/thu mutation throughout the genome (further details in chapter 7). IL-7Rα 
(CD127) transcripts were analysed and viewed using Partek Genomic Suite software. 
The data showed no evidence of alternative splicing of the IL-7R in the Hnrpllthu/thu 
thymocytes (Figure 5.2.4 a) or peripheral T cells compared to wild-type cells (Figure 
5.2.4 b). 
 
5.2.5 Lower expression of TCR/CD3 complex and coreceptors 
 
In addition to changes in IL-7R expression, Hnrpllthu/thu naïve T cells showed 
reproducible changes in TCR, CD3 and CD5 expression at the cell surface detected by 
flow cytometry. The data in Figure 5.2.5 shows a significant decrease in the geometric 
mean of TCR and CD3 expression in Hnrpllthu/thu CD4+ and CD8+ T cells, compared 
to the wild-type and Hnrpllthu/+  litter mates (Figure 5.2.5 a and b).  
 
Lower expression of the coreceptors CD4 and CD8 were also observed in 
Hnrpllthu/thu CD4+ and CD8+ T cells respectively (Figure 5.2.5 c).  
 
Naïve CD4+ and CD8+ T cells in Hnrpllthu/thu mice showed higher expression of 
CD5 compared to T cell subsets from wild-type or Hnrpllthu/+ mice, while there was 
no difference in CD5 expression on memory CD4+T cells from any genotype (Figure 
5.2.5 d and e). In contrast both naïve and memory Hnrpllthu/thu CD8+ cells have higher 
CD5 expression than their wild-type counterparts (Figure 5.2.5 d and e).  
 
Collectively the phenotypic changes observed in TCR, CD3, CD5, and 
coreceptors CD4 and CD8 expression in Hnrpllthu/thu T cells are equivalent to changes 
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that would normally occur when T cells display enhanced levels of TCR signalling in 
response to chronic antigen stimulation (Berg, L. et al. 2000). 
 
5.2.6 Increased apoptosis in Hnrpllthu/thu naive T cells 
 
In response to chronic TCR signalling T cells can upregulate the Fas receptor 
(CD95) which binds to FasL. This interaction can trigger apoptosis of the Fas 
expressing cells.  We examined the expression of Fas on the surface of wild-type, 
Hnrpllthu/+ and Hnrpllthu/thu peripheral blood T cells and found that naïve CD4+ T cells 
in thunder mice had  higher levels of Fas expression compared to wild-type or 
Hnrpllthu/+ mice (Figure 5.2.6 a and b). There was no difference in Fas levels on 
memory T cells and mature single positive thymocytes (Figure 5.2.6 b & c).   
 
Exposure to IL-7 provides a pro-survival signal mediated by AKT and PI3K and 
this leads to an increase in the expression of the Bcl-2 proteins that prevent apoptosis 
(Marrack, P. & Kappler, J. 2004).  We stained naïve and memory T cells from wild-
type, Hnrpllthu/+ and Hnrpllthu/thu mice and found that naïve CD4+ T cells from 
Hnrpllthu/thu mice have lower expression of Bcl-2 protein as detected by intracellular 
staining by flow cytometry. In comparison there was no difference in Bcl-2 
expression in memory T cells or in thymocytes (Figure 5.2.6 d, e and f).   
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Figure 5.2.6 T cell apoptosis
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Fas expression on T cell subsets
0
5
10
15
20
25
G
eo
M
ea
n
CD4+ CD44lo:
CD4SP 
thymocytes: CD4+ CD44hi:
thu/thu
Naive CD4 Naive CD8
Memory 
CD4
Memory 
CD8
p<0.05
c. +/+
thu/+
thu/thu
Bcl-2
CD44
+/+ thu/thuthu/+
CD4 gate:
Bcl-2
isotype
isotype
thu/thu
wt
CD4+ CD44lo:
d
e.
d. Dot plots showing Bcl-2 expression on naïve (CD44lo) and memory (CD44hi) 
CD4+ subsets in wild-type, thu/+, and thu/thu mice in the spleen.
e. Histograph overlays showing Bcl-2 expression in CD4SP thymocytes, naïve 
and memory CD4+ splenocytes. (isotype control=red and green, wild-
type=blue, thu/thu=brown).
f. Bcl-2 GeoMean of spleen T cell subsets. P value from a Student’s t-Test.
CD4SP 
thymocyte : CD4+ CD44hi:
Bcl-2 Expression on T cell subsets
0
20
40
60
80
100
120
G
eo
M
ea
n +/+
thu/+
thu/thu
isotype
Naive CD4 Naive CD8Memory CD4
Memory 
CD8
p<0.05
f.
Chapter 5                                                                            Defective T cell homeostasis  
 
5.3 Investigating the role of CD45 in regulation of T cell homeostasis in 
thunder mice 
 
CD45 is the most abundant membrane bound protein tyrosine phosphatase in 
lymphocytes playing important roles in initiating TCR signalling by 
dephosphorylating and activating tyrosine kinase p56Lck. Lck can then phosphorylate 
ITAMs (immune tyrosine activation motifs) of the TCR/CD3 complex, promote TCR 
signal transduction, and lead to cell activation and proliferation (Hermiston ML, Xu Z, 
Weiss A. 2003). It remains obscure how CD45 splice variants affect TCR signalling. 
The high molecular weight isoforms of CD45 (i.e. CD45RABC) which are expressed 
constitutively on the surface of Hnrpllthu/thu T cells have been shown to have the 
highest level of phosphatase activity and therefore should be efficient in promoting 
TCR signalling (Chui, D. et al. 1994).  We hypothesized that the phenotypic changes 
in TCR, CD3, CD5 and CD95 in naïve T cells of thunder mice might be contributed 
by increased CD45 enzymatic activity which could increase the strength of TCR 
signalling.   
 
CD45 controls one of the earliest events in TCR signalling by dephosphorylating 
two critical tyrosine residues of the Lck protein (Hermiston ML, Xu Z, Weiss A. 
2003). Antibody reagents have been generated to these phospho-peptides of the Lck 
protein and can be used to quantitate the level of phosphorylation in resting versus 
activated T cells by flow cytometry. 
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5.3.1. CD45 reduction in a previous identified ENU mutant lochy 
strain 
 
To address the question of whether the defect in CD45 alternative splicing is 
correlated to loss of Hnrpllthu/thu T cells, we crossed the Hnrpllthu/thu mutation to a 
previously identified ENU mutant mouse strain, lochy, which has a point mutation (T 
to A conversion) of the intronic nucleotide in the 5’ splice donor of exon 17 of the 
Ptprc gene (Yates, A.L. & Goodnow, C. unpublished). The mutation causes an 
alternative cryptic splice site adding 5 base pairs to the mRNA, causing a shift in the 
reading frame and introducing a premature stop codon. The premature termination of 
the CD45 mRNA leads to nonsense-mediated decay of the Ptprc mRNA and a 20-fold 
reduction in the total amount of CD45 expressed at the cell surface of lymphocytes 
(Yates, A.L. PhD thesis. 2003). The residual protein may arise from correctly spliced 
mRNA. It shows representative flow cytometric histograms of low CD45 expression 
on homozygous Ptprcloc/loc CD4+ T cells compared to Ptprc+/+ and Ptprcloc/+ T cells 
(Figure 5.3.1 a), detected using a pan-CD45 antibody (anti-CD45.2). The relative 
expression of total CD45 is measured where the geometric mean expression of CD45 
on Ptprc+/+ T cells is normalised to a value of 1.0 and Ptprcloc/+ mice have half the 
amount of CD45 at the surface of CD4+ cells, while the homozygous Ptprcloc/loc mice 
have just 5% CD45 expression compared to wild-type T cells (Fig. 5.3.1 b). 
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a. Total CD45 expression in the CD4+ T cells in a CD45/Ptprc
mutant mouse strain, lochy, stained with a pan-CD45 antibody 
CD45.2. (Ptprc+/+=red, Ptprclloc/+=green, ptprcloc/loc =blue). , 
loc/loc encode CD45 reduction (not null).
Figure 5.3.1  Reduced CD45 expression on T cells in an ENU 
mutant strain lochy
Ptprc+/+ Ptprc loc/+ Ptprc loc/loc
a
b
b. Relative expression of CD45 on CD4+ T cells in +/+, loc/+, and 
loc/loc littermates compared to normal B6 mice. Relative expression was 
calculated using CD45 GeoMean measured on the T cells divided by the 
average CD45 GeoMean of CD4+ T cells from a group of B6 mice.
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5.3.2. Introducing Hnrpllthu/thu mutation to lochy mouse shows similar 
CD45 splicing defects on T cells  
 
To investigate if the changes in CD45 splicing might influence the loss of naïve T 
cells in the periphery of thunder mice, we bred the thunder mutation onto the 
Ptprcloc/loc background and examined T cell numbers of wild type, the Ptprcloc/lo 
Hnrpll+/+, Ptprcloc/loc Hnrpllthu/+ and the Ptprcloc/loc Hnrpllthu/thu mice in the thymus, 
spleen and peripheral blood of mice at 8-10 weeks of age by flow cytometry. As 
shown in Fig 5.3.2, it was still possible to observe different expression of the 
CD45RA, RB, and RC isoforms on the surface of T cells from the Ptprcloc/loc 
Hnrpllthu/thu double mutant mice compared to the Ptprcloc/loc Hnrpll+/+ T cells. 
Although the expression of the CD45 isoforms on the double mutant T cells was 
relatively low it was still detectable and confirms that the residual CD45 mRNA in 
Lochy mice can still undergo alternative splicing which has not been previously 
documented. 
 
5.3.3 CD45 reduction can not repress the action of thu/thu on 
peripheral T cell numbers  
 
We have previously shown that the thunder mutation does not affect T cell 
development and thu/thu mutant mice have equivalent numbers of mature CD4 and 
CD8 single positive T cell numbers in the thymus compared to wild-type mice but 
reduced numbers of T cells in secondary lymphoid tissues. In correlation to the 
reports on CD45 deficient mice, the Ptprcloc/loc mice have defects in T cell maturation 
in the thymus resulting in decreased numbers of mature T cells in the thymus and 
149 
Red: ptprcloc/loc hnrpll+/+
Green: ptprcloc/loc hnrpllthu/+
Blue: ptprcloc/loc hnrpllthu/thu
B cell
Figure 5.3.2 Histograph overlays of CD45RA, 
RB, and RC epitope specific staining in CD4, 
CD8, and B cells in Ptprcloc/loc Hnrpll+/+ (red),
Ptprcloc/loc Hnrpllthu/+ (green), and Ptprcloc/loc
Hnrpllthu/thu (blue) mice.
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Figure 5.3.2  Alternative splicing with diminished CD45 in 
Ptprcloc/loc Hnrpllthu/thu mice 
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reduced numbers of CD4+ and CD8+ cells in the spleen (Figure 5.3.3 a and b), 
consistent with the reduced activity of CD45 signaling in these mutant cells 
(Kishihara, K. et al. 1993; Stone, J.D. et al. 1997; Seavitt, J.R. et al. 1999; Baker, M. 
et al. 2000).   
 
If the decrease in T cell numbers observed in the peripheral circulation of thunder 
mice is caused directly by the dysregulated splicing of CD45 then one prediction is 
that the thunder mutation would not affect T cell numbers in CD45-deficient mice. 
Thymus, spleen and peripheral blood samples were collected from Ptprcloc/loc 
Hnrpll+/+,  Ptprcloc/loc Hnrpllthu/+ and Ptprcloc/loc Hnrpllthu/thu double mutant animals and 
stained for flow cytometry analysis. The cell numbers were evaluated. As shown in 
figure 5.3.3 b Hnrpllthu/thu mutant mice have normal thymic development and a 
decrease in peripheral CD4+ and CD8+ T cell numbers which we have shown in 
chapter 3. Ptprcloc/loc mutation causes a 5-6 fold reduction in mature CD4+ and CD8+ 
SP thymocytes and reduced peripheral T cells as well (Figure 5.3.3 b). Importantly, 
CD4+ T cell numbers were significantly lower in the Ptprcloc/loc Hnrpllthu/thu double 
mutant mice compared to Ptprcloc/loc mice without the thunder mutation, 
demonstrating that the thunder mutation still affect T cell numbers when CD45 was 
almost absent. As in the thu/thu single mutant mice, the thunder mutation had its 
greatest effect in loc/loc animals on the naive CD4 compartment (Figure 5.3.3 c and 
d).  
 
Similar results were also observed in the blood of the Ptprcloc/loc Hnrpllthu/thu 
double mutant mice suggesting that the disruption to T cell homeostasis caused by the 
thunder mutation is independent of CD45 signals. Importantly the thunder mutation 
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Figure 5.3.3  CD45 reduction can not repress the action of thunder 
mutation on loss of naïve CD4+ but CD8+ T cells
a
b
Figure 5.3.3 a. FACs plots showing CD4 and CD8 cells in the thymus and 
spleen of Ptprc+/+ Hnrpll+/+ , Ptprc+/+ Hnrpllthu/thu, Ptprcloc/loc Hnrpll+/+, and 
Ptprcloc/loc Hnrpllthu/thu mice.
b. top: Total CD4 and CD8 SP thymocyte numbers in the wild-type (blue bar), 
thu/thu (red bar), loc/loc (yellow bar), and loc/loc thu/thu (green bar) mice.
Bottom: Spleen CD4 and CD8 T cell numbers in the thunder and lochy mice. 
P values were calculated by a Student’s t-Test.
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Figure 5.3.3  Alternative splicing with diminished CD45 in Ptprcloc/loc
Hnrpllthu/thu mice 
Figure 5.3.3 c. Histographs showing CD44 staining of CD4 and CD8 cells 
in the spleen of Ptprc+/+ Hnrpll+/+ , Ptprc+/+ Hnrpllthu/thu, Ptprcloc/loc Hnrpll+/+,
and Ptprcloc/loc Hnrpllthu/thu mice.
d. Naïve and memory T cell numbers in the wild-type (blue bar), thu/thu
(red bar), loc/loc (yellow bar), and loc/loc thu/thu (green bar) mice. P 
values were calculated by a Student’s t-Test.
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does not change the total amount of CD45 expressed at the cell surface by CD4+ and 
CD8+ T cells (Fig. 3.3, chapter 3). These results do not rule out of the possibility that 
thunder mutation acts through CD45, since the Lochy mutant mice still have a low 
level of functional CD45 protein expression on the cell surface. A recent study has 
shown that as little as 3% of the total CD45 expression is required to allow normal T 
cell differentiation in mice and to dephosphorylate Lck505 (McNeill, L. et al. 2007). 
However, data from lochy mice showed that reduction of CD45 amount do not 
suppress the effect of thunder mutation in loss of peripheral T cells. We are currently 
breeding the thunder mutation with a CD45-/- null mutation to address this remaining 
possibility. 
 
5.3.4 CD45 splicing isoforms show different phosphatase activities 
when CD45 is reduced 
 
As CD45 is the only known membrane bound protein phosphatase to activate Lck 
in T cells, we were interested to see how changes in CD45 splicing affect Lck 
activation in T cells. To confirm the specificity of the two antibodies it would be 
predicted that the staining intensity (i.e. geomean) of Lck pY505 and Lck pY394 
antibodies should be higher in loc/loc T cells since they would have reduced levels of 
active CD45 protein compared to wild type T cells (discussed in chapter 1.3).  This 
was indeed the observed result as loc/loc and loc/loc:thu/thu T cells (thymocytes or 
lymph node cells) showed higher levels of both Lck pY505 and Lck pY394 compared 
to  wild type or thu/thu T cells (Figure 5.3.4).  
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Figure 5.3.4 Higher phosphatase activity of CD45RABC in T cells
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Figure 5.3.4 Intracellular staining of Lck pY505 (left) and pY394 (right) in the CD4SP 
thymocytes (a), LN naïve CD4 cells (b), and LN memory CD4 cells (c) in the Hnrpll+/+ 
(red) and Hnrpllthu/thu (green) mice. Column 1 and 3 shows Lck pY505 and pY394 
staining respectively in the Ptprc+/+ background. Column 2 and 4 compare 
phosphorylation of Lck Y505 and Y394 by the thunder mutation in the Ptprcloc/loc
background. Isotype control=blue.
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When we compared thymocytes from loc/loc and loc/loc:thu/thu mice we 
observed no difference in the levels of Lck pY505 or Lck pY394 levels (Figure 
5.3.4a). We could find no significant difference in the levels of pY505 and pY394 
between wild-type and Hnrpllthu/thu peripheral T cells irrespective of whether they 
were naïve or memory phenotype cells in the peripheral lymph nodes (Fig. 5.3.4a). 
 
In contrast there was a dramatic shift to low Lck pY505 and Lck pY394 levels in 
the CD4+ CD44lo (naïve) T cells in the lymph node of loc/loc:thu/thu double mutant 
mice (Figure 5.3.4 b), whereas there was no difference in the levels of Lck pY505 or 
Lck pY394 in CD4+ CD44hi (memory) cells from the same mice (Figure 5.3.4 c). 
Similar changes were observed with the staining of pTyr394 in the double mutant 
naïve CD4+ cells.  The same pattern of changes were also observed for CD8+ naïve T 
cells in the loc/loc:thu/thu mice compared to loc/loc mice (Figure 5.3.4 d and e). 
Importantly staining the same cells with a pan Lck antibody revealed no difference in 
abundance of the Lck protein which suggests the changes in Lck pY505 and Lck 
pY394 are real and reflect changes in CD45 activity (Figure 5.3.4 f).  
 
Thus reducing the amount of total CD45 protein in thu/thu T cells it is possible to 
detect differences in the proximal TCR signaling events in CD4+ and CD8+ T cells. 
These changes with Lck activity correlate with the constitutive expression of the 
CD45 high MW isoforms in thunder T cells.   
 
Consistent with the findings of lymph node T cells there was no difference in the 
levels of Lck pY505 in wild-type and thu/thu peripheral blood CD4+ and CD8+ T 
cells (Fig. 5.3.4 g and h). However, analysis of naïve T cells in loc/loc:thu/thu double 
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Figure 5.3.4 Intracellular staining of Lck pY505 (left) and pY394 (right) in the LN naïve 
CD8 cells (d) and LN memory CD8 cells (e) in the Hnrpll+/+ (red) and Hnrpllthu/thu
(green) mice. Column 1 and 3 shows Lck pY505 and pY394 staining respectively in 
the Ptprc+/+ background. Column 2 and 4 compare phosphorylation of Lck Y505 and 
Y394 by the thunder mutation in the Ptprcloc/loc background.
f. Total Lck staining in LN CD4 and CD8 T cells. Isotype control=blue.
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Figure 5.3.4 Intracellular staining of Lck pY505 in the blood naïve CD4 
cells (g), memory CD4 cells (h), and B cells (i) in the Hnrpll+/+ (blue dots), 
Hnrpllthu/thu (pink dots), Ptprcloc/loc (yellow dots) and Ptprcloc/loc Hnrpllthu/thu
(green dots) mice. Each dot represents an individual mouse.
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mutant mice revealed a significant decrease in Lck pY505 geomean levels compared 
to naïve loc/loc T cells (Fig. 5.3.4 g).  There was no difference in Lck pY505 levels in 
memory T cells in loc/loc and loc/loc:thu/thu mice (Fig 5.3.4 h). Lck pY505 staining 
in B cells was unaffected by thunder and lochy mutations, since all mutant B cells 
showed equivalent low level of Lck pY505 to the wild-types (Fig 5.3.4 i). 
 
5.3.5  Effects of thunder mutation on TCR coreceptor and IL-7 
receptors in Ptprcloc/loc mice 
 
Similar to the changes observed in T cells from thu/thu mice the loc/loc:thu/thu T 
cells also displayed lower levels of CD4 and CD8 co-receptor expression at the cell 
surface compared to T cells from the loc/loc mice (Fig. 5.3.5.a). 
 
Furthermore the naïve CD4+ T cells in the loc/loc:thu/thu mice showed a 
decreased expression of CD127 on the cell surface compared to naïve T cells from 
loc/loc mice (Figure 5.3.5 b).  The change is similar to the observations in naïve T 
cells of wild-type and thu/thu mice with normal amount CD45 expression (compare 
Fig. 5.2.1 c vs Fig. 5.3.5 b). There was no difference in the expression of CD127 on 
memory CD4 cells between loc/loc and loc/loc:thu/thu mice (data not shown). 
 
The fact that these effects of thu/thu mutation on the coreceptors and IL-7R still 
occur in Ptprcloc/loc T cells argues against a role for CD45 in bringing them about. 
However, this will only be firmly excluded in crossing with Ptprc null animals. 
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Figure 5.3.5 Changed CD4/CD8 coreceptor and IL-7R expression
Figure 5.3.5 a. CD4 and CD8 GeoMean in the blood T cells in the Hnrpll+/+ 
(blue dots), Hnrpllthu/thu (pink dots), Ptprcloc/loc (yellow dots) and Ptprcloc/loc
Hnrpllthu/thu (green dots) mice. Each dot represents an individual mouse.
b. IL-7Ra (CD127) expression in the blood naïve CD4 cells in the Hnrpll+/+ 
(blue dots), Hnrpllthu/thu (pink dots), Ptprcloc/loc (yellow dots) and Ptprcloc/loc
Hnrpllthu/thu (green dots) mice. Each dot represents an individual mouse.
Bottom left: histograph overlays comparing IL-7Ra expression in the wild-type 
(red) and Hnrpllthu/thu (green) naïve CD4 cells. Right: IL-7Ra expression in 
loc/loc (red) and loc/loc thu/thu naïve CD4 cells.
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5.4  Discussion 
 
5.4.1   Hnrpllthu/thu T cells homeostasis: proliferation vs persistence  
 
T cell homeostasis represents a dynamic balance between cellular proliferation 
and cell death. Heritable mutations that disable either of these key cellular 
checkpoints can have devastating outcomes on the long term health of an individual.  
A failure to control the basal proliferation of T cells could lead to T cell hyperplasia 
and predispose to malignancy, while unbridled expansion of self-reactive T cells due 
to lack of activation induced cell death could predispose to autoimmunity.  During the 
first few weeks of postnatal life there is a controlled expansion of T and B cells to fill 
the lymphocyte compartments, but once these have reached their limits the cells are 
maintained at fixed numbers (Wilson, C.B. et al. 1992; Cahill, R.N. et al. 1997, 1999; 
Petrie, H.T. 2003).  
 
Many studies on T cell homeostasis have focused on the homeostatic proliferation 
of naïve T cells after transfer to lymphopaenic hosts and established a clear role for 
both IL-7/IL-7R signaling and peptide/MHC –TCR signals (Surh, C.D. & Sprent, J. 
2005). As discussed in the previous chapters the thunder strain was identified because 
of a loss of peripheral CD4+ and CD8+  T cells and we have identified the ENU-
induced mutation in a previously uncharacterized member of the hnRNP protein 
family and showed it controls alternative splicing of CD45/Ptprc in T cells.  In this 
chapter we have tried to analyse in more detail the mechanisms responsible for the 
loss of T cells in these mice. 
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Using an adoptive transfer assays we found that thunder T cells can proliferate 
normally when transferred together with wild type T cells into a lymphopaenic host 
(e.g. Rag-/- or irradiated C57BL/6 mouse). The Hnrpllthu/thu T cells could divide at the 
same rate as wild-type cells over the first week but they were unable to persist for 
long periods in vivo.  In addition Hnrpllthu/thu T cells were unable to persist in the 
circulation when transferred to a lymphoreplete recipient.  
 
It is generally accepted that naive T cells require continuous contact with self-
peptide/MHC complexes for long term survival in vivo enabling them to persist in the 
periphery (Surh, C.D. and Sprent, J. 2005; Dorfman, J.R. and Germain, R.N. 2002). 
Both wild-type and Hnrpllthu/thu CD8+ T cells displayed lower proliferation rates in 
Tap2 mutant mice compared to wild-type C57BL/6 recipients supporting the view 
that CD8+ T cells rely on peptide/MHCI-TCR signals to promote their expansion. But 
the data in figure 5.1.2d showed there is a subset of CD8+ T cells that can expand 
rapidly during the first week. Studies by Sprent and colleagues have established that 
this subset of CD8+ T cells are rapidly proliferating and rely on cytokine signaling 
rather than TCR signals in vivo (Judge, A.D. et al. 2002).  So both the TCR dependent 
and cytokine dependent populations appear intact in the transferred Hnrpllthu/thu CD8+ 
T cells, but once the homeostatic expansion phase is completed the CD8+ T cells are 
unable to persist.  
 
Collectively, the results from these transfer assays identified that the thunder 
mutation acts in a cell autonomous manner to regulate the long term persistence of T 
cells in vivo.  These data also provide an explanation for why thunder mice lose 
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peripheral T cells with age.  In Chapter 3 we showed that there is no difference in T 
cell numbers in the periphery between wild type and thunder mice at 2-3 weeks of age, 
but by 4 weeks there is a significant decrease in CD4+ and CD8+ T cells in thunder 
mice (Figure 3.1.2). During the first 3 weeks of life there is a rapid filling of the 
peripheral pool with recent thymic emigrants until the T cell compartment is filled. By 
6 weeks of age thymic production decreases and naïve T cell numbers in the periphery 
rely on IL-7 and peptide/MHC signals for maintenance. This coincides with the age 
that thunder T cell numbers fall below than wild-type counterparts.   
 
5.4.2   Hnrpllthu/thu naive T cells display multiple cellular phenotypic 
changes  
 
IL-7 signal is a key regulator for naïve T cell maintenance mediated through the 
IL-7R. Withdrawal of IL-7 signal leads to rapid cell death (Khaled, A.R. and Durum, 
S.K. 2002). IL-7 is produced by stromal cells at a constant rate whereas the 
consumption of IL-7 by T cells is mainly dependent on the number of T cells and the 
expression of IL-7R on the cell surface. We observed lower expression of IL-7Rα 
chain on naïve Hnrpllthu/thu T cells, and most importantly, down-regulation of IL-7Rα 
expression in naïve T cells occurs in a cell autonomous manner as determined by 
mixed bone marrow chimeras and adoptive cell transfer assays. Decreased IL-7Rα 
expression was detected at both the mRNA and protein levels but there is no evidence 
that the decrease in IL-7Rα in Hnrpllthu/thu T cells is caused by a change in alternative 
splicing.  
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Limiting the availability of trophic factors like IL-7 leads to a loss of expression 
of anti-apoptotic molecules such as Bcl-2 and arming of pro-apoptotic factors such as 
Bax and Bad. Consistent with the lower IL-7Rα expression on naïve Hnrpllthu/thu T 
cells, there was also lower expression of Bcl-2 in Hnrpllthu/thu naïve T cells compared 
to memory T cells.  
 
Activation induced cell death (AICD) through death receptors like Fas (CD95) is 
another pathway to eliminate activated T cells (Krammer, P.H. Arnold, R. and Lavrik, 
I.N. 2007). We observed that naïve Hnrpllthu/thu T cells display slightly enhanced Fas 
expression, suggesting that Fas may also play some roles in limiting the survival of 
Hnrpllthu/thu T cells in the periphery. However there is no increase in FasL expression 
by thunder T cells and so the change in Fas expression may be secondary to other 
changes that occur as a result of the mutation in the Hnrpll gene. Moreover, the 
magnitude of the change is less than two-fold and there is no evidence that such small 
changes in Fas level are functional on their own. 
 
Other characteristic changes that occur in thunder T cells include decreased 
expression of TCR & CD3 levels and an increase in CD5 expression.  The level of 
CD5 expression at the cell surface mirrors the strength of TCR signalling and is 
dependent upon the activity of the Src-like kinases p56Lck and p59Fyn. Chronic TCR 
signaling in T cells can modulate TCR/CD3 levels at the cell surface. This is a natural 
physiological response by T cells that is thought to help decrease the strength of TCR 
signals in vivo in response to self-antigen-MHC complexes. The changes in 
TCR/CD3 were most significant in peripheral blood T cells, whereas T cells in lymph 
node or spleen had equivalent levels of TCR/CD3 compared to wild-type T cells.  At 
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present we do not have a suitable explanation to explain the difference between 
TCR/CD3 expression on T cells in the blood and secondary lymphoid tissues but it 
will be interesting to pursue in the future. 
 
5.4.3   CD45 alternative splicing and overall CD45 expression jointly 
modify its phosphatase activity 
 
CD45 is the most abundant membrane tyrosine protein phosphatase in T cells and 
it is still not clear why there is so much CD45 on T cells considering a recent study 
suggests that a T cells only needs as much as 3% of the total CD45 to allow normal T 
cell development and function (McNeill, L. et al. 2007).  The relevance of the 
different functional isoforms of CD45 and how this effects T cell differentiation in the 
peripheral circulation still remains a mystery.  
 
TCR signalling is dependent upon the activation of Src like kinases in particular 
Lck. Several studies have highlighted the critical role for CD45 in this process 
(Ostergaard, H.L. et al. 1989; Koretzky, G.A. et al. 1990).  There are two key tyrosine 
residues (Y505, Y394) located on the cytoplasmic tail of the p56Lck protein that need 
to be de-phosphorylated in order for Lck to become functional to interact with CD3-
zeta chains (Ashwell and D’Oro, 1999; Palacios and Weiss, 2004).  
 
We have used a unique ENU variant mouse strain (lochy) with a mutation in 
CD45 to investigate the link between CD45, TCR signalling and the T cell phonotype 
observed in thunder mice.  The lochy mice have a mutation in a splice donor site in 
exon 17 of CD45 that results in a 20 fold reduction in CD45 protein at the surface of 
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lymphocytes because of non-sense mediated decay. This leads to an increase in 
pY505 and pY394 on the Lck protein in lochy T cells. We could find no significant 
difference in the levels of Lck pY505 when we compared wild-type or Hnrpllthu/thu 
naïve CD4+ T cells. When we bred the Hnrpllthu/thu mutation onto the lochy 
background to generate Ptprcloc/loc Hnrpllthu/thu double mutant mice we could detect 
significantly lower levels of  pLckY505 in naïve CD4 T cells from the double mutant 
mice in comparison with T cells from the Ptprcloc/loc mice.  
 
The lower levels of Lck pY505 in double mutant T cells may be due to the 
alternative splicing of the small amount of CD45 on their surface. This correlates with 
previous data that enzymatic activity of the CD45 protein is enhanced by the RA, B, 
and C segments (Xu, Z. & Weiss, A. 2002; Dornan, S. et al. 2002).  It is not clear at 
this stage why we cannot detect the intracellular differences in the level of Lck pY505 
in thunder T cells until the level of CD45 is titrated below a critical threshold. It is 
also intriguing that no differences are observed in thymocytes or memory T cells, 
implying that the effect of CD45 isoforms is developmentally restricted. 
 
Consistent with a reduced function of CD45 in lochy mice there is a significant 
reduction in the numbers of thymocytes and peripheral T cells. Combining the lochy 
mutation with the thunder mutation on the same background still leads to a further 
reduction in peripheral CD4+ T cells, especially naïve CD4+ T cells. The lochy 
mutant mice have a significant increase in the numbers of peripheral CD8+ T cells 
and it is not understood why this occurs.  However, Ptprcloc/loc, Hnrpllthu/thu double 
mutant mice have a decreased number of peripheral CD8+ compared to the Ptprcloc/loc 
mice.  Taken together these results suggest that the loss of peripheral naïve T cells 
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caused by the thunder mutation is not simply caused by the increase in CD45 activity.  
The loss of peripheral T cells in thunder mice is likely to be more complex and may 
involve the effects on multiple genes. 
 
5.4.4  Interaction of TCR signalling and IL-7 signalling? 
 
The survival of naïve T cells is dependent upon IL-7 and peptide/MHC-TCR 
signals (Boyman, O. et al. 2007).  Circulating T cells are likely to have low affinity 
for self antigens since they were developmentally selected to be tolerant of self 
antigens, The intensity of TCR signals stimulated by self antigens affects the ability of 
naïve T cells to survive in the periphery that is determined by both TCR affinity and 
co-receptor expression (Marrack, P. & Kappler, J. 2004). As the level of co-receptor 
expression helps to set the level of the TCR signalling threshold, high co-receptor 
expression increases signalling by low affinity TCRs, whereas low coreceptor 
expression limits signalling by high avidity TCRs (Viola, A. et al. 1996; 1997).  
 
During T cell homeostasis the level of IL-7R is modulated to allow limiting 
amounts of IL-7 to be shared amongst the maximal possible number of T cells 
(Mazzucchelli, R. & Durum, S.K. 2007). Signalling through IL-7R can decrease IL-
7Rα transcription, while T cells that do not signal through IL-7 display increased 
levels of IL-7Rα. Thus the numbers of T cells that survive in the periphery reflect the 
amount of available IL-7.  A recent study by Singer and colleagues identified that the 
level of CD8 co-receptor expression is not set developmentally during T cell 
development in the thymus but is determined by the level of IL-7 and other common γ 
chain cytokines in the periphery. The capacity of CD8 + T cells to transduce common 
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γ chain cytokines is impaired by TCR signals induced by self antigens. These authors 
observed an inverse relationship between CD8 co-receptor expression and IL-7R 
signalling (Park, J.H. et al. 2007). 
 
 The modulation of CD8 co-receptor expression is termed co-receptor tuning and 
is thought to promote CD8+ T cell survival but only within the limits which are 
permitted by self tolerance. (Park, J.H. et al. 2007).  Coreceptor tuning is proposed to 
work in CD4+ cells but perhaps via a different mechanism. In CD4+ cells, coreceptor 
modulation is mediated by ligand induced TCR signals via activation of Lck that does 
not affect CD8 expression levels. 
 
It was showed that TCR and IL-7 signals can act independently or synergize to 
promote naïve T cell proliferation (Seddon, B. and Zamoyska, R. 2002). It was also 
well demonstrated in mouse and human that TCR stimulation cause down-regulation 
of IL-7R expression in T cell surface (Kaech, S.M. et al. 2003; van Leeuwen, E.M. et 
al. 2005). As shown here in this chapter we have observed down-regulated IL-7R 
expression in thunder naive T cells, as well as lower TCR:CD3 complex, higher CD5, 
higher Lck activity (on the Lochy background) and lower coreceptor expression on 
both CD4+ and CD8+ T cells. Collectively these phenotypic changes may reflect 
stronger TCR signalling in thunder mice under resting conditions.  
 
As shown here in this chapter we have observed down-regulated IL-7R expression 
in thunder naive T cells, as well as lower TCR:CD3 complex, higher CD5, higher Lck 
activity (on the Lochy background) and lower coreceptor expression on both CD4+ 
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and CD8+ T cells.  Collectively these phenotypic changes may reflect stronger TCR 
signalling in thunder mice under resting conditions.  
 
Although the dysregulated CD45 signalling may not on its own account for the 
loss of peripheral T cells in thunder mice, it nevertheless may contribute in a 
significant way to altering the strength of TCR signalling and thus the long term 
survival of T cell in the periphery.   
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 Introduction 
 
   TCR signal strength is critical for both T cell development in the thymus and 
activation in the periphery. Pre-TCR plays important roles during early thymocyte 
development whereas the mature αβTCR is the primary trigger for signal transduction 
through contact with peptide/MHC and is critical for both clonal selection in the 
thymus and clonal expansion in the periphery (Moisge, L. and Zamoyska, R. 2007; 
Davis, et al. 1998). If the antigen receptor on double positive (CD4+ CD8+) and early 
single positive (CD4+CD8lo or CD4loCD8+) thymocytes recognizing self-
peptide/MHC strongly are induced into cell apoptosis, whereas those do not recognize 
self-peptide/MHC generate no or weak TCR signals die by neglect. Only weak 
peptide-MHC recognizing and intermediating TCR signals lead to positive selection 
and survival (Love, P.E. and Chan, A.C. 2003).  
 
In this chapter, we wanted to examine the effect of the thunder mutation on 
positive and negative selection using a TCR-transgenic model so that we can track the 
fate of antigen-specific T cells throughout their development in the thymus and during 
the circulation in the peripheral immune system.  
. 
6.1   Normal positive and negative selection in the thymus 
 
To examine if Hnrpllthu/thu mutation affects either positive or negative selection of 
antigen-specific CD4+ T cells in the thymus, we bred Hnrpllthu/thu mice to a well 
characterised 3A9 TCR transgenic mouse strain expressing a rearranged TCRαβ 
receptor specific for the immunodominant epitope of Hen Egg Lysozyme (HEL 
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Fig. 6.1 Representative FACS profiles showing T cell development and clonotype 
positive CD4+ T cell thymic selection in TCR Tg (a) and TCR:insHEL Tg (b) mice.
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peptide 46-63) in association with I-Ak. An advantage of this model is that the HEL-
specific CD4+ T cells can be detected by a clonotype monoclonal antibody (1G12) 
which can be used to track the developmental fate in the thymus (Liston, A. et al. 
2003). Normally these T cells are positively selected into CD4 fate. A second 
transgene was added to evaluate negative selection. In TCR:insHEL double transgenic 
mice HEL protein is expressed under the control of the Rat Insulin Promoter in 
pancreatic beta cells and thymic medullary epithelial cells. Under these conditions the 
HEL protein is regarded as a neoself antigen. 3A9 HEL-specific T cells are mostly 
deleted in the thymus during negative selection (Liston, A. et al. 2003; Akkaraju, S. et 
al. 1997).   
 
In wild-type 3A9 TCR transgenic mice there is strong positive selection of CD4+ 
T cells that express the clonotype TCR. More than 90% CD4 late single positive (LSP) 
thymocytes expressing the transgenic TCR. When the Hnrpllthu/thu mutation was bred 
onto the 3A9 TCR transgenic background, positive selection of the 3A9 TCR 
transgenic T cells was normal and there was no difference in the percentage of DP or 
CD4SP cells between wild-type and Hnrpllthu/thu mice (Figure 6.1 a). The majority of 
CD4 single positive cells (about 90-95% ESP and LSP) expressed the transgenic 
αβTCR (Figure 6.1 a). The numbers of thymocytes showed no change in Hnrpllthu/thu 
3A9 transgenic mice from DN stage to SP stage (Figure 6.1 c and d). This contrasts 
with subtle mutations in Zap70 which severely cripple positive selection in this 3A9 
TCR strain (Siggs, O. et al. 2007). 
 
In TCR:insHEL double transgenic mice the expression of neoself antigen HEL 
which is under the control of the rat insulin promoter directing the majority of the 
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Fig. 6.1 c. Thymocyte numbers from DP to SP stage in wild-type (blue bar), thu/+ 
(red bar), and  thu/thu (yellow bar) TCR and TCR:insHEL transgenic mice. 3 mice 
in each group. Student’s t-Tests show no significant difference.
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TCR:insHEL mice. 3 mice in each group. No significant difference between wildtyp
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protein expressed in the pancreatic beta cells. HEL antigen is also ectopically 
expressed in medullary thymic epithelium cells (mTECs) under the control of the 
autoimmune regulatory gene AIRE that allows deletion of the organ-specific colonies 
in the thymus and the development of immune tolerance. In both wild-type and 
Hnrpllthu/thu TCR:InsHEL mice the vast majority of CD4+ T cells are deleted  
(compare Fig 6.1 a vs 6.1 b), leading to a decrease in the frequency and absolute 
numbers of CD4+ SP T cells in the thymus (Fig. 6.1 a, b, c, and d).  During the early 
stage of CD4 single positive cell differentiation approximately 60-70% of CD4+ cells 
express the HEL-specific receptor in TCR:insHEL double transgenic mice. However, 
the vast majority of these cells are eliminated during maturation in the late single 
positive stage. There was no difference in the frequency or absolute cell number of 
HEL reactive CD4+ cells in the thymus of wild-type and Hnrpllthu/thu TCR:InsHEL 
mice (Figure 6.1 b and d). These results suggest thunder mutation does not affect the 
process of negative selection of autoreactive T cells in the thymus, and contrasts with 
the lesions in negative selection when AIRE or NOD mutations are introduced (Liston, 
A. et al. 2003) (Liston, A. et al. 2004). 
 
CD69 is a membrane receptor transiently expressed on lymphocytes during 
activation (Testi, R. et al. 1994; Sancho, D. et al. 2005). It is also induced in 
thymocytes by TCR engagement to self-peptide/MHC complex during positive and 
negative selection and declines as the cells complete their maturation and exported 
from the thymus into the periphery.  The only significant phenotypic change that we 
have been able to reliably detect in the thymus of Hnrpllthu/thu TCR transgenic mice is 
the low expression of CD69 on the CD4+ 1G12+ cells at the late single positive stage 
of CD4+ T cell development (i.e. CD69-) where there is a significant expansion in the 
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percentage of CD4+ 1G12+ CD69- thymocytes which represent the most mature CD4 
cells that are ready for export to the periphery (Fig. 6.1 e and f). However there is no 
difference in the absolute number of mature CD4+ 1G12+ CD69- T cells in the 
thymus compared to wild-type 3A9 TCR tg mice (Fig.6.1 f). No difference of this 
subset of mature CD4+ T cells was observed in the TCR:insHEL double transgenic 
mice either, in both of percentages and absolute cell numbers (Fig. 6.1 e and f). 
Collectively, these results indicate that Hnrpllthu/thu mutation does not affect positive 
and negative selection of antigen specific T cells during thymic development. The 
subtle shift between CD69hi and CD69- in CD4 LSP cells may indicate enhanced 
maturation after positive selection which may be caused by increased strength of TCR 
signalling due to the constitutive expression of high molecular weight CD45 isoforms 
by the thunder cells but this requires further analysis.  This could be investigated by 
breeding the 3A9 TCR tg model onto the CD45-/- background. 
 
6.2   Different fate of thu/thu clonotype positive and clonotype negative T 
cells in the periphery 
 
6.2.1 Hnrpllthu/thu transgenic T cells are maintained normal in the 
peripheral lymphoid tissues 
 
As discussed in the previous chapters, the Hnrpllthu/thu mutation leads to a loss of 
peripheral T cells.  The loss of T cell numbers is not due to their ability to undergo 
homeostatic proliferation, but instead is caused by a intrinsic failure of Hnrpllthu/thu T 
cells to persist in vivo, particularly the naïve compartment.  The data presented above 
show that Hnrpllthu/thu mutation does not interfere with either positive or negative 
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thymic selection of antigen-specific CD4+ T cells. Therefore we were interested in 
determining if Hnrpllthu/thu mutation would interfere with the persistence of TCR 
transgenic cells in the peripheral circulation. Because the TCR and TCR:InsHEL 
strains are on a Rag1 sufficient background, peripheral T cells will express either the 
clonotype-specific TCR or the TCRVβ transgene in association with an endogenous 
TCRVα gene. Both 1G12+ and 1G12- cells coexist in  each mouse so we can study 
the homeostasis of both the clonotype HEL-specific CD4+ cells and the non 
clonotype CD4+ T cells in the same animals. The latter cell population in the thu/thu 
TCR or TCR:InsHEL mice are expected to behave like polyclonal T cells in a 
C57BL6 thu/thu mouse where naive T cells are unable to survive in the periphery and 
shift to the CD44hi phenotype. 
 
We examined the number of CD4+ 1G12+ T cells in the spleen of TCR and 
TCR:InsHEL transgenic mice on  a wild-type and Hnrpllthu/thu mutant background. 
When compared to the CD4SP population in the thymus where more than 90% of 
mature CD4+ T cells express the 1G12 TCR, the percentage of cells bearing this 
receptor drops to approximately 70% in peripheral CD4 cells in the TCR transgenic 
mice; whereas in the TCR:insHEL double transgenic mice 1G12+ cells are effectively 
eliminated from 50% of CD4LSP thymocytes to only 5% of CD4+ T cells in the 
spleen expressing transgenic TCR (Fig. 6.2.1 e and f).  
 
The peripheral CD4+ T cells pool in the TCR and TCR:InsHEL strains are 
composed of both CD4+ 1G12+ cells and CD4+ 1G12- cells. These two cell 
populations showed different fates in the peripheral lymphoid tissues in the transgenic 
mice. In Hnrpllthu/thu TCR transgenic mice, clonotype positive CD4+ cells have 
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normal percentages and absolute numbers in the spleen (Fig. 6.2.1 a and c), in contrast,  
the number of 1G12- mutant CD4+ cells decrease (Fig. 3.2.1 a and d), similar to that 
observed in the thunder strain on a non-transgenic background. In the TCR:insHEL 
double transgenic mice, Hnrpllthu/thu CD4+ 1G12+ cells are equally eliminated to 
remain in a very low level in the periphery. In the wild-type  TCR:InsHEL mice 
(Figure. 3.2.1 b and c), the number of CD4+ 1G12- cells are also very low but there 
appears no further reduction of this population in the mutant mice (Figure 6.2.1 b and 
d). 
 
Similar phenotypes were observed in the peripheral blood. Hnrpllthu/thu mutant 
mice have relative larger proportion of CD4+ 1G12+ cells and fewer CD4+ 1G12- 
cells compared to their wild-type counterparts in the TCR transgenic mice (Figure 
6.2.1 g and i). In the TCR:insHEL double transgenic mice there was an increase in the 
percentage of thu/thu CD4+ 1G12+ cells in the blood while no difference was 
observed in the frequency of CD4+ 1G12- cells between wild type and Hnrpllthu/thu 
mutant mice (Figure 6.2.1 h and j). 
 
6.2.2  Transgenic TCR restores Hnrpllthu/thu naïve T cells in the periphery 
 
Next we wanted to know if the HEL-specific T cells in the periphery of the TCR 
and TCR:InsHEL mice remain in a naïve state (i.e CD44lo)..In the TCR and 
TCR:insHEL transgenic mice, CD4+ T cells bearing the clonotype TCR are 
maintained in a naive status as the majority of cells were CD44lo. We presume this 
happens because the transgenic TCR has low avidity to the endogenous peptide/MHC 
complex. In both TCR (Figure 6.2.2 a, b) and TCR:insHEL (Figure 6.2.2 c, d) 
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Figure 6.2.1. Transgenic Hnrpllthu/thu CD4+ T cells are maintained
in the periphery
Fig. 6.2.1 g. Representative FACS profile of CD4 vs 1G12 staining of blood 
lymphocytes in wild-type and thu/thu TCR transgenic mice.
h. Representative FACS profile of CD4 vs 1G12 staining of blood lymphocytes of +/+ 
and thu/thu TCR:insHEL transgenic mice.
i. Percentages of CD4+ 1G12+ and CD4+ 1G12- cells in the blood of TCR transgenic 
mice. Each symbol represents an individual mouse. Student’s t-Tests were used for 
statistic analysis.
j. Percentages of CD4+ 1G12+ and CD4+ 1G12- cells in the blood of TCR:insHEL
double transgenic mice. Each symbol represents an individual mouse. P values were 
calculated from Student’s t-Tests.
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transgenic mice, Hnrpllthu/thu 1G12+ CD4 T cells display a CD44lo naïve phenotype 
like the wild-type CD4+ 1G12+ cells. The CD44lo status of CD4+ 1G12+ cells in the 
TCR:InsHEL background would indicate that the HEL-specific T cells are tolerant to 
HEL antigen in the periphery. In both transgenic strains the thu/thu CD4+ 1G12- cells 
showed a higher proportions of CD44hi cells that was statistically significant (Fig. 
6.2.2 b,d). It is notable that there is a strong shift to a CD44hi phenotype in the CD4+ 
1G12- cell populations of both wild-type and thu/thu TCR:InsHEL mice but the 
thu/thu CD4+ 1G12- cells have an even larger proportion of CD44hi than the wild-
type.   
 
We have shown in chapter 5 that thunder naïve T cells express lower levels of IL-
7Rα in a cell autonomous manner potentially affecting T cell longevity. So we 
examined the expression of IL-7R on CD4+ 1G12+ and CD4+ 1G12- T cells in the 
spleen and blood of TCR and TCR:InsHEL mice on a wild-type and thunder 
background. Figure 6.2.2 e shows that 1G12+ and 1G12- Hnrpllthu/thu CD4+ T cells 
expressed lower IL-7Rα compared to the wild-type CD4+ 1G12+ and 1G12- cells in 
the TCR transgenic mice. In the double transgenic mice, IL-7Rα expression was only 
significantly lower on the thu/thu clonotype negative CD4 cells (Figure 6.2.2 f) there 
was no difference in the levels of IL-7Ra on CD4+ 1G12+ cells. 
 
 
 
 
 
 
 170
a.
thu/thu
+/+
CD4+ 1G12+ CD4+ 1G12-
CD44
c.
thu/thu+/+
CD4+ 1G12+ CD4+ 1G12-
CD44
% CD44lo & CD44hi of 1G12+ 
CD4+ cells in TCR:insHEL mice
0%
20%
40%
60%
80%
100% wt  CD44lo
t hu/ t hu CD44lo
wt  CD44hi
t hu/ t hu CD44hi
% CD44lo & CD44hi of 1G12- 
CD4+ cells in TCR:insHEL mice
0%
20%
40%
60%
80%
100% wt  CD44lo
t hu/ t hu CD44lo
wt  CD44hi
t hu/ t hu CD44hi
% CD44lo & CD44hi of 1G12+ CD4+ 
cells in TCR Tg mice
0%
20%
40%
60%
80%
100%
w t CD44lo
thu/thu CD44lo
w t CD44hi
thu/thu CD44hi
% CD44lo & CD44hi of 1G12- CD4+ 
cells in TCR Tg mice
0%
20%
40%
60%
80%
100%
w t CD44lo
thu/thu CD44lo
w t CD44hi
thu/thu CD44hi
P<0.01
P<0.05
P<0.05
P<0.01
3A9 TCR Tg
TCR:insHEL Tg
Figure 6.2.2. Transgenic TCR restores Hnrpllthu/thu CD4+ naive T cells
b.
d.
Fig. 6.2.2 a. Histograph overlay of 1G12+ (left) and 1G12- (right) CD4+ splenocytes 
showing CD44 staining in +/+ (red) and thu/thu (green) TCR transgenic mice.
b. Dot plots showing CD44lo (filled) and CD44hi (open) percentages of 1G12+ CD4+ 
(left) and 1G12- CD4+ (right) splenocytes in +/+ (blue) and thu/thu (red) TCR 
transgenic mice.
c. Histograph overlay of 1G12+ and 1G12- CD4+ T cells showing CD44 expression. 
Wildtype (red), thu/thu (green).
d. Percentages of CD44lo (filled) and CD44hi (open) subsets in 1G12+ (left) and 1G12-
(right) CD4+ T cells in TCR:insHEL transgenic mice (right). +/+ (blue), thu/thu(red). 
Each symbol represents an individual mouse. P values from Student’s t-Tests.
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6.3   Discussion 
 
Transgenic TCR, T cell selection and T cell persistence in the periphery 
 
The results from the analysis of the TCR and TCR:insHEL transgenic mice 
confirmed that Hnrpllthu/thu mutation does not affect positive and negative selection in 
the thymus. This is in accordance with the phenotypic analysis performed on the non-
transgenic thu/thu mice we described in chapter 3 and is consistent with the 
observation that Hnrpllthu/thu mice remain healthy throughout life despite the T cell 
lymphopaenia. 
 
As discussed in the previous chapter, Hnrpllthu/thu naïve T cells fail to persist in 
the peripheral lymphoid tissues after leaving thymus. What makes the findings in this 
section interesting is that Hnrpllthu/thu mice have equal numbers of CD4+ 1G12+ T 
cells in the spleen and even higher percentages of these cells in the blood of TCR 
transgenic mice while those mutant CD4+ T cells not bearing clonotypic TCR 
decrease in both the spleen and blood.  
 
It is thought that the peptide required to signal naïve CD4+ 1G12+ cells is limiting 
in the periphery, therefore the CD4+ 1G12+ cells do not homeostatically expand very 
efficiently in the periphery, compared to TCR tg cells of other specificities (e.g. OT-1 
or DO-10-11). The ability of CD4+ 1G12+ cells to persist in the periphery of TCR or 
TCR:InsHel mice is somewhat of a paradox since in all other studies (e.g. analysis of  
thunder B6 mice or adoptive cell transfer studies or mixed bone marrow chimeras) 
thunder T cells consistently show an inability to persist in the circulation. One 
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possibility is that the thunder TCR Tg cells still undergo attrition in the periphery but 
this is masked by the high thymic output of TCR tg cells from the thymus. In both 
TCR and TCR:InsHEL mice the major CD4+ cell that leaves the thymus is the CD4+ 
1G12+ cell.     
 
Since commencing the write up of this thesis further studies in the laboratory have 
gone onto show that indeed the thunder 3A9 CD4+ TCR Tg cells,  as well as thunder 
OT-I CD8+ TCR Tg cells,  fail to persist in the periphery when adoptively transferred 
to either a RAG1-/- host or even a lymphoreplete C57BL/6 host (Chan, Yabas and 
Hoyne unpublished). Similar to the studies presented in Chapter 5 the thunder CD4+ 
3A9 TCR Tg cells and CD8+ OT-1 T cells can compete effectively with wild-type 
3A9 TCR Tg or OT-I TCR Tg cells during the homeostatic proliferation phase in 
RAG1-/- recipients, but once the T cell compartment is filled the thunder TCR tg cells 
are rapidly lost from the peripheral circulation. 
 
Therefore the attrition of the 3A9 TCR tg cells in the peripheral circulation of the 
thunder TCR and TCR:InsHEL mice could be masked by the constant export of 
mature CD4+ 1G12+ cells into the peripheral circulation. An alternative possibility 
that is not mutually exclusive is that the thunder TCR Tg cells may homeostatically 
expand in the periphery due to the loss of the clonotype negative T cell population and 
this helps to fill the peripheral T cell compartment.   
 
Hnrpllthu/thu TCR transgenic CD4+ T cells maintain a naïve phenotype of CD44lo 
as the wild-type cells do. Lack of specific peptide helps to keep the cells in a naïve 
state. We could show that in the same animal the Hnrpllthu/thu TCR transgenic T cells 
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remained in a naïve state whereas the mutant non-transgenic (i.e. CD4+ 1G12-)  T 
cells showed a tendency to transit to the memory phenotype. The only difference 
between these two populations in the mice is the expression of the transgenic TCR 
which have different avidity to environmental peptides. This implies that some 
changes in TCR signalling may contribute to the loss of naïve T cells in the intact 
mouse. 
 
IL-7R expression on T cells is regulated by the binding of IL-7 to its receptor 
and TCR signalling where both types of signals lead to a decrease in IL-7R expression 
at both the mRNA and protein level (Mazzucchelli, R. & Durum, S.K. 2007). 
Lymphocyte survival and death is controlled by multiple factors and through different 
pathways (Khaled, A.R. & Durum, S.K. 2002; Marrack, P. & Kappler, J. 2004). The 
expression of IL-7Rα is decrease on both CD4+ 1G12+ and CD4+ 1G12- cells in 
thunder TCR tg mice.  In the thunder TCR:InsHEL mice only the CD4+ 1G12- cells 
showed lower IL-7Rα expression. The lower IL-7Rα expression on thunder T cells 
observed on a non transgenic and TCR Tg mice background is intriguing. One 
possibility for this is that thunder T cells are more actively engaged in consuming IL-
7 to help them to survive in the periphery. Alternatively stronger TCR signalling 
caused by the change in CD45 isoform expression may drive down IL-7R expression.   
Further work is required to understand why thunder T cells have the lower IL-7R 
expression.  The phenotypic changes that occur in the thunder strain could be caused 
by the change in function of a number of Hrnpll target genes and it is through the 
combined action of these genes that will affect the survival of thunder T cells in the 
periphery. 
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 6.4   Chapter summary 
 
In this chapter, I have confirmed that the mutation in the Hnrpll gene does not 
affect positive or negative selection of thunder thymocytes in the 3A9 TCR and 
TCR:insHEL transgenic mouse. The TCR tg cells display lower levels of IL-7R 
expression but the CD4+ 1G12+ T cells appear to persist in the periphery of both 
TCR and TCR:InsHEL mice.   
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7.1  ENU mutagenesis: a non-biased approach to identify genes important 
in immune cell development, function and homeostasis. 
 
ENU mutagenesis screens are phenotype-driven approaches designed to 
identify genes in a nonbiased manner that control key biological processes.  The 
Goodnow group has pioneered the use of ENU mutagenesis screens to identify genes 
which influence lymphocyte development and function (Jun, J.E. et al. 2003; Miosge, 
L.A. et al. 2002; Papathanasiou, P. et al. 2003; Vinuesa, C.G. et al. 2005; Siggs O.M, 
et al. 2007). My studies of the thunder mouse strain have leaded to the discovery of a 
mutation in a novel gene, Hnrpll, which is involved in nascent mRNA alternative 
splicing. The biology of the thunder mouse strain highlights the important and 
nonredundant role that the Hnrpll gene plays in regulating T cell homeostasis. It also 
provides the starting point for an unprecedented insight into the role for alternative 
splicing in controlling the differentiation of naïve and memory T cells.   
 
Since SR proteins and hnRNP proteins are ubiquitously expressed throughout 
development and in multiple tissues, this has made in vivo analysis of the roles of 
these proteins difficult to address.  Mutations in SR or hnRNP proteins normally give 
rise to embryonic lethal phenotypes (Jumaa, H. et al. 1999; Michaud, E,J. et al. 1993; 
Roshon, M.J. & Ruley, H.E. 2005), therefore scientists have had to rely on conditional 
gene targeting to study the role of these genes in vivo in a cell type or tissue specific 
manner.  However, for most SR and hnRNP proteins studies have been restricted to in 
vitro analysis on transfected cell lines expressing mutant forms of the protein of 
interest.  Fortuitously, the ENU screen gave rise to the ENU 126 pedigree carried a 
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point mutation in the Hnrpll gene. Although it disrupts the function of the hnRNP LL 
protein, mice carrying the mutation are viable and can breed to propagate the mutation. 
From the data presented in this thesis, it is not possible to determine whether the 
thunder mutation is a hypomorphic mutation that retains some essential function in 
other cells, or if it is a null allele. 
 
Structural studies on the mutant hnRNP LL protein carried out in collaboration 
with Prof Gottfried Otting and colleagues revealed that the mutated Val136 residue 
lies beneath the RNA binding domain formed by the RNP1 and RNP2 motifs.  The 
VÆD mutation in thunder mice destabilizes the L1 loop of the RRM1 domain on 
which the V136 amino acid resides and the non-conservative change makes the 
RRM1 domain highly unstable at physiological temperatures. We went onto show that 
the mutant RRM1 domain can still bind to an RNA oligonucleotide consisting of the 
ARS sequence of exon 4 of Ptprc with micromolar affinity that is not dissimilar to the 
binding affinity of the wild type RRM1 domain of hnRNP LL. Although the NMR 
structure of several hnRNP proteins has been solved the studies here provide the first 
evidence for the importance of the conserved Val136 residue in the RRM1 domain of 
hnRNP LL as the amino acid is conserved across multiple species and also in other 
hnRNP proteins such as PTB and hnRNP L. This result shows that the thunder RRM1 
domain unfolds at 37°C in vitro, and this could cause the protein to be degraded 
creating an almost null allele. To resolve the question, it will be necessary to develop 
antibodies for western blotting, and to produce a targeted null allele. 
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7.2  Thunder mutation affects naïve T cell longevity 
 
The number of T cells in the peripheral circulation of mice and humans 
remains remarkably stable throughout life and the peripheral repertoire is controlled 
through a process of T cell homeostasis that represents a dynamic balance between 
cellular proliferation and cell death (Sprent, J. & Surh, C. 2005). After birth T cell 
numbers increase through homeostatic proliferation due to the initial lymphopaenic 
environment of newborn mice.  The proliferation of the recent thymic emigrants is 
dependent upon TCR signals by recognition of a self peptide/MHC complexes on the 
surface of APCs as well as survival signals mediated through IL-7/IL-7R signalling.  
Once the compartment is filled T cells will become quiescent and they continue to 
circulate through secondary lymphoid tissues and the blood until they contact their 
specific ligand.  T cell homeostasis can be defined by two distinct stages (i) the 
homeostatic proliferation phase and (ii) the persistence phase.  There is a large body 
of evidences showing that naïve T cells require TCR/pMHC and IL-7/IL-7R signals 
for long term viability.  Studies on the thunder strain highlights an additional layer of 
regulation in T cell homeostasis involving alternative mRNA splicing that is critical to 
allow naïve T cells to persist in the peripheral circulation.   
 
Thunder mice have normal thymic development and T cell maturation but 
specifically lose naïve T cell in the periphery. Spleen T cells from Hnrpllthu/thu mice 
proliferate normally in response to anti-CD3/CD28 stimulation in vitro indicating that 
TCR signalling in mature T cells is normal. Furthermore, thunder thymocytes were 
able to compete successfully during the homeostatic proliferation phase with wild-
type T cells when mixtures of wild-type and thunder cells were transferred to 
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lymphopaenic hosts.  However it was apparent that as the T cell compartment was 
filled the thunder T cells were selectively lost from the periphery. These experiments 
imply that the Hnrpllthu/thu naive T cells have a specific survival defect and cannot 
persist for long periods in the peripheral circulation in vivo. 
 
Studies with IL-7 or IL-7R deficient mice revealed the critical role of this 
cytokine in thymic T-cell development (Peschon, J.J. et al. 1994; von-Freeden-Jeffry, 
U. et al. 1995; Maraskovsky, E. et al. 1996), and in naïve T cell proliferation and 
survival in the periphery (Schluns, K.S. et al. 2000; Tan, J.T. et al. 2001; Surh, C.D. 
& Sprent, J. 2005). In light of the importance of IL-7 signalling in naive T cell 
biology, we decided to examine if there is any changes in IL-7/IL-7R signalling in 
Hnrpllthu/thu T cells. Firstly we found that Hnrpllthu/thu naive T cells had consistently 
lower IL-7R expression both of the cell surface protein and mRNA levels. Using 
mixed irradiation bone marrow chimeras as well as T cell transfer experiments we 
were able to confirm that the lower IL-7R expression on Hnrpllthu/thu T cells is a cell 
intrinsic phenotype, rather than a secondary change to the altruistic inhibition by 
circulating IL-7. More recent studies in the laboratory have shown that that 
Hnrpllthu/thu T cells can bind and modulate the IL-7R from the cell surface as 
efficiently as wild type cells.  This indicates that the thunder mutation does not affect 
the membrane proximal events of IL-7/IL-7R interactions. However thunder T cells 
are less responsive to the pro-survival effects of IL-7, suggesting that the thunder 
mutation affects naïve T cell survival somewhere downstream of the IL-7R (Yabas 
and Hoyne Unpublished observations). 
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It is intriguing that lower expression of IL-7R in thunder naïve T cells influences 
their longevity rather than homeostatic proliferation.  One hypothesis is that TCR 
signalling is the primary driving force for T cell proliferation. This was evident from 
the observation in TAP2 mutant jasmine mice that failure in presenting MHC class I 
peptides leads to weaker CD8 proliferation. Another possibility is that thunder mature 
thymocytes have normal IL-7R expression as the fact so that the recent thymic 
emigrants have normal response to IL-7. 
 
Besides cytokine signals, naive T cells require a second signal from continuous 
contact with self-peptide/MHC complexes for the long term survival in vivo (Surh, 
C.D. and Sprent, J. 2005; Dorfman, J.R. and Germain, R.N. 2002). We confirmed the 
requirement of peptide/MHC complex for the naïve T cell homeostatic proliferation 
as we showed that disruption of class I peptide presentation by the mutation in TAP2 
lead to weaker CD8+ T cell expansion, although it was not completely abolished. This 
is probably because that the TAP2 jasmine mutation is not a null allele and there may 
be residual expression of a low amount of Class I MHC proteins in the periphery of 
the jasmine mice. In addition the CD8+ T cells could expand in the jasmine hosts in 
response to IL-7 signalling and the expansion would be independent of TCR 
signalling (Surh, C. & Sprent, J. 2005).  
 
IL-7 signalling leads to activation of the serine/threonine kinase AKT and this in 
turn phosphorylates the Foxo3a transcription factor targeting it for degradation.  
Withdrawal of IL-7 in wild-type cells leads to decreased activity of AKT and the 
failure to phosphorylate foxo3a which translocates to the nucleus where it promotes 
expression of a range of target genes including Bim, Fasl, Trail and Bcl-6 (Bosque, A. 
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et al. 2005; Sabbagh, L. et al. 2006; Wojciechowski, S. et al. 2007; Riou, C. et al. 
2007; Weant, A.E. et al. 2008; Williams, M.A. et al. 2008; Ichii, H. et al. 2007). 
Down regulated Bcl-2 expression in IL-7 deprived thunder naïve T cells would from 
one arm lead to a shift in the balance of anti-apoptotic Bcl-2 vs pro-apoptotic Bim to a 
situation that would favour apoptosis.  
 
From another aspect we have preliminary results from all exon arrays showing 
that the Hnrpllthu/thu mutation leads to a change in the alternative splicing of Bim 
favouring expression of the pro-apoptotic BimS isoform. BimS is the smallest isoform 
generated by alternative splicing and, skipping of exons 3 and 4 which encode the 
Dynein-binding domain. Absence of the Dynein-binding domain results in failure to 
bind Dynein-light-chain (DLC) proteins and stronger apoptotic activity of BimS 
(O’Connor, L. et al. 1998; Bouillet, P. et al. 2002). Taken together, the reduced Bcl-2 
expression and constitutive expression of the alternatively spliced pro-apoptotic BimS 
isoform may be important factors that contribute to decreased survival of Hnrpllthu/thu 
naive T cells.  
 
However, Bcl-2 and Bim are not the only genes that modulate apoptosis in 
Hnrpllthu/thu T cells. Preliminary data from exon arrays showed that the alternative 
splicing of a number of genes involved in regulation of apoptosis are affected in 
Hnrpllthu/thu naive T cells including, Itsn1, Lrdd, Apaf1, Nalp1 and Madd. The 
expression of the Fas receptor is increased on the surface of Hnrpllthu/thu naive T cells 
too. Therefore the loss of naïve T cells in the Hnrpllthu/thu mice may not be the result 
of a single gene defect. Instead the loss of naïve T cells could be due to the combined 
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effects of multiple genes and it will take a lot more time to decipher the exact 
mechanism(s) responsible for the loss of naïve T cells in thunder mice. 
 
7.3  CD45 expression, alternative splicing, and TCR signalling 
 
CD45 is the prototypic membrane bound protein tyrosine phosphatase (PTP). 
It is the most abundant PTP in T cells covering 10% of total cell surface area 
(Hermiston, M.L. Xu, Z. Weiss, A. 2003). A recent study suggests that as little as 3% 
of the total CD45 is required for T cell development and function in vivo (McNeill, L. 
et al. 2007). CD45 undergoes alternative splicing to silence the expression of three 
variable exons in T cells upon activation (Lynch, K.W. 2004). It has not been fully 
appreciated why there is so much CD45 on T cells, and what roles the various CD45 
spliced isoforms have on T cell function.  
 
Activation of Src family kinases in particular p56Lck is the primary event initiated 
by CD45 during TCR signal transduction. CD45 can dephosphorylate two key 
tyrosine residues pY394 and pY505 of p56Lck tyrosine kinase, suggesting a dual role 
of CD45 and complex regulation of Lck activity (Ostergaard, H.L. et al. 1989; 
Koretzky, G.A. et al. 1990; Ashwell and D’Oro, 1999; Palacios and Weiss, 2004). In 
CD45 deficient animals, the Y505 and Y394 residues of Lck remains highly 
phosphorylated and Lck is functionally inactive, resulting in a severe defective T cell 
development in the thymus (Kishihara, K. et al. 1993; Wallace, V.A. et al. 1997; Mee, 
P.J. et al. 1999; Baker, M. et al. 2000).  
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We have used a unique mouse strain that was identified from an ENU 
mutagenesis screen called lochy characterized by markedly reduced expression of 
CD45 on lymphocytes. The lochy strain was used to investigate the link between 
CD45 splicing isoforms and TCR signalling with different amounts of CD45 being 
expressed on the T cell surface.  We found no difference in the phosphorylation of 
pY505 and pY394 of Lck in the C57BL/6 wild-type and Hnrpllthu/thu T cells when the 
normal level of CD45 is expressed. However, it was markedly increased when total 
CD45 levels are reduced to just 5% in the lochy mice. Homozygosity for the thunder 
mutation on this background of limiting CD45 in Ptprcloc/loc, Hnrpllthu/thu mice 
decreased the phosphorylation of Y505 and Y394 residues. This result is considered 
with published data (Chui, D. et al. 1994; Dornan, S. et al. 2002; Xu, Z. & Weiss, A. 
2002) that the CD45RABC isoforms are more catalytically active in T cells than the 
lower molecular weight CD45 forms. It was recently reported that expression of 
CD45RO, RB, and RABC at intermediate levels (10-40% of wild-type) had no 
measurable differences as assessed by T cell development or TCR signalling 
(Salmond, RJ. et al. 2008). This is an agreement with our own observations that no 
functional difference between CD45RO and CD45RABC when total CD45 levels are 
normal. Since there does appear to be different in CD45 isoform activity under 
limiting conditions,  perhaps these differences only become relevant in parts of the 
TCR synapse when CD45 is mostly excluded. 
  
Despite the difference in Lck phosphorylation between loc/loc and loc/loc thu/thu 
T cells, the number of mature single positive thymocytes was not detectably altered 
between lochy and lochy thunder mice. The fact that positive selection continues, 
although inefficiently, despite the drastically reduced level of CD45 expression is 
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consistent with the previous studies by McNiel et al who showed that as little as 3% 
of the normal CD45 levels on T cells is sufficient for some positive selection to occur 
(McNiel et al 2007). In the context of TCR synapse that may form during positive 
selection, changing the CD45 isoforms does not appear to have functional 
consequences.  
 
Ptprcloc/loc mice had normal numbers of memory CD4+ T cells and even slightly 
more CD8+ memory T cell in the spleen compared with Ptprc+/+ mice, but the naïve 
CD4+ and CD8+ T cells are reduced. The numbers of naïve CD4+ T cells in 
Ptprcloc/loc Hnrpllthu/thu mice are further decreased, suggesting that factors other than 
CD45 alternative splicing must account for the loss of naïve T cells in Hnrpllthu/thu and 
Ptprcloc/loc Hnrpllthu/thu mice. However, since some CD45 remains on the double 
mutant T cells, and is altered in isoforms and Lck phosphorylation, it remains possible 
that the thunder mutation acts on T cell survival through CD45. Future experiments in 
thu/thu CD45null mice will be needed to resolve this issue. 
 
Trans-acting factors involved in CD45 alternative splicing 
 
Although it has been known for more than 30 years that Ptprc undergoes 
alternative splicing, knowledge of the trans-acting regulatory factors that control the 
regulated splicing of the 3 variable exons of Ptprc remains obscure. I have shown that 
loss of hnRNP LL function in T cells results in failure to silence CD45 exons 4, 5, and 
6, which can be detected at the exon level on microarrays, amplified transcripts (RT-
PCR), and protein level (monoclonal antibody staining). The closely related hnRNP L 
protein was recently identified as one of three hnRNP proteins that bound to the ESS1 
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sequence within the variable exons of the human PTPRC gene (Rothrock, C. et al. 
2003; Rothrock, C. et al. 2005; Tong, A. et al. 2005; House, A.E. & Lynch, K.W. 
2006; Melton, A.A. et al. 2007). Due to the high degree of conservation between the 
Hnrpl and Hnrpll proteins, especially within the RRM1 domain, it is conceivable in 
the previous studies that implicated roles of hnRNP L in CD45 alternative splicing are 
actually performed by hnRNP LL rather than hnRNP L binding to the ESS to induce 
exon skipping of CD45. In Hnrpllthu/thu mice, hnRNP L exhibits normal mRNA 
expression yet it does not compensate the effects of Hnrpllthu/thu mutation in CD45 
splicing in T cells. This suggests hnRNP LL has an essential and nonredundant role in 
regulation of CD45 alternative splicing in T cells in mice. It is equally plausible that 
hnRNP L and hnRNP LL act in concert to regulate Ptprc splicing. However, hnRNP 
LL undergoes developmental- and activation-induced changes in mRNA expression 
that parallel changes in Ptprc splicing. Thus it is certain that hnRNP LL is the 
regulated component of the process. Future work will need to examine mice or cells 
where hnRNP L has been mutated or knock out. 
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7.4 Interplay of TCR signal and IL-7 signal pathways? 
 
TCR signals and IL-7 signals are essential for normal T cell development and 
differentiation. Different strengths and duration of these signals direct T cells to 
different fates. This is exemplified in thymocytes high avidly binding to self-
peptide/MHC causing strong TCR signals and apoptosis; no binding to self-
peptide/MHC causes death by neglect; while intermediate binding and meek TCR 
signals leads to positive selection down the appropriate CD4/CD8 lineage, survival 
and differentiation of mature T cells (Love, P.E. & Chan, A.C. 2003).  
 
Circulating naive T cells emerging from thymic positive and negative selection 
have low affinity for self-peptides. The potency of TCR signal transduction plays a 
role in the naive T cell differentiation in the periphery with a resting threshold 
determined for activation. The intensity of TCR signals is determined by both TCR 
affinity and co-receptor expression. As the level of co-receptor expression helps to set 
the level of the TCR signalling threshold, high co-receptor expression increases 
signalling by low affinity TCRs, whereas low co-receptor expression limits signalling 
by high avidity TCRs.  
 
IL-7 is a limiting factor for T cell development and persistence secreted by 
stromal cells in a constant rate. Serum IL-7 concentration is determined by the rate of 
its consumption from T cells. IL-7R expressed on T cells not only determines the 
efficiency of IL-7 consumption but also the strength of the responses of T cells to IL-
7 signal. IL-7R expression is correlated to the development of T cells. It is also 
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regulated on mature T cells by extrinsic stimuli such as antigens and common γ chain 
cytokines including IL-7. IL-7 down-regulates its receptor expression on exposed T 
cells enabling other T cells to acquire IL-7 (Mazzucchelli, R. & Durum, S.K. 2007).  
 
It is interesting TCR stimulation in peripheral T cells down-regulates IL-7Rα 
expression. Lefrancois and colleagues found down-regulated IL-7R expression in OT-
1 transgenic CD8+ T cells after activation when investigaitng roles of IL-7 in T cell 
homeostatic proliferation and survival (Shluns, K.S. et al. 2000). O’Shea’s group also 
reported that TCR-mediated activation up-regulates IL-2R expression whereas down-
regulates IL-7R expression (Franchimont, D. et al. 2002). These results indicated that 
there is potentially interplay between TCR signalling and IL-7 signalling pathways. A 
recent study from Singer and colleagues identified that the level of CD8 co-receptor 
expression reflecting TCR signalling was determined by the level of IL-7 and other 
common γ chain cytokines in the periphery (Park, J.H. et al. 2007). They showed that 
the capacity of CD8 + T cells to transduce common γ chain cytokine signals is 
impaired by TCR signals induced by self antigens. They also observed an inverse 
relationship between CD8 co-receptor expression and IL-7R signalling.  
 
 We observed down-regulated IL-7R expression in Hnrpllthu/thu naive T cells, as 
well as lower TCR:CD3 complex, lower co-receptor expression, and higher CD5 
expression on both CD4+ and CD8+ T cells.  Collectively these phenotypic changes 
may reflect increased TCR signalling and cause decreased IL-7 signalling in 
Hnrpllthu/thu naive T cells under resting conditions. Although there is no obvious 
difference in Lck phosphorylation in normal CD45 background, it is mostly possible 
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that Hnrpllthu/thu mutation may affects some other molecules in TCR signal pathway 
that strengthen TCR signalling and lead to hyper-activation status of resting T cells. 
 
This hypothesis also applies to the 3A9 TCR transgenic mice. The transgenic TCR 
has strong affinity to HEL-46-61 peptide. However it has apparently very weak 
avidity to endogenous peptide/MHC present in the peripheral lymph nodes and spleen, 
because the 3A9 cell die about 10 days after thymic emigration and do not undergo 
homeostatic proliferation in lymphopaenic hosts despite the presence of positive 
selecting I-Ak. Hnrpllthu/thu T cells bearing the same TCR still showed lower IL-7R 
expression. This result suggests that stronger signalling by the TCR does not account 
for decreased IL-7R on thunder T cells. 
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7.5  Preliminary evidence that Hnrpll is a global regulator of pre-mRNA 
alternative splicing in T cells 
 
I have shown that Ptprc exon silencing is disrupted by the thunder mutation, 
but a key question that follows is that whether or not this is the only target of hnRNP 
LL. Recently, a new generation of Affymetrix Arrays have been developed with sets 
of probes for each annotated exon in the mouse genome. Hybridizing labelled cRNA 
from thunder vs wild-type T cells to these arrays would provide a powerful way to 
address this question. While writing up this thesis, I have initiated the all exon array 
experiment in collaboration with Professor Alan Aderem’s group in the Institute for 
System Biology in Seattle of the United States. 
 
From our preliminary analysis of this exon array data, generated from naïve 
and memory T cells and CD4SP and CD8SP thymocytes isolated from thu/thu vs +/+ 
mice, hnRNP LL regulates splicing of many T cell mRNAs (Fig. 7.1a and b). While 
this work is organising, some of the preliminary results are mentioned here.   
 
In addition to Ptprc/CD45 (Figure 7.2.1a, b, and c), other important molecules 
of the TCR signalling pathway also appear to be alternatively spliced by hnRNP LL 
and are differentially spliced in memory T cells, hence are likely to modulate their 
responsiveness to antigen.  These include other transmembrane protein tyrosine 
phosphatases, Ptprt, and Ptprk, the CD3-zeta subunit (Cd247) (Tsuzaka, K. et al. 
2006), phospholipase c gamma 1 (Plcg1) (Patterson, R.L. et al. 2005), downstream of 
kinase-2 (Dok2) (Dong, S. et al. 2006), and Abelson tyrosine kinase (Abl1) (Wong, W. 
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& Witte, O.N. 2004), and the transcription factor Nfatc1 (Figure 7.2.3a and b). Hnrpll 
promotes differential promoter usage in the Nfatc1 gene. This could have important 
functional consequences in T cells because there is evidence that the long isoforms of 
NFATc1/βB or βC can promote apoptosis whereas the shorter isoform NFATc1/αA 
produced from the inducible P1 promoter plays an important role in gene transcription 
and T cell differentiation (Serfling, E. et al. 2007).  
 
With respect to T cell responsiveness upon re-infection, one of the top scoring 
Hnrpll-regulated genes in the array analysis is Nalp1 (Figure 7.2.1d, e, and f).  This 
encodes a cytoplasmic receptor for bacterial cell wall products that signals 
interleukin-1 production, inflammation, and apoptosis in innate immune cells (Church, 
L.D. et al. 2008; Tschopp, J. et al. 2003), but has not previously been linked to T cell 
function or adaptive immunological memory. 
 
Many essential genes controlling T cell responsiveness and longevity are 
among the hnRNP LL regulated gene set.  These include some core regulators of 
apoptosis, Apoptotic Protease Activating Factor-1 (Apaf1) (Fig. 7.2.2f) (Cain, K. 
Bratton, S.B. & Cohen, G.M. 2002), Cytochrome-c (Cyc1) (Orrenius, S. Gogvadze, V. 
& Zhivotovsky, B. 2007), survival motor neuron (Smn1) (Sumner, C.J. 2007), and 
Bim (Bcl2l11) (Figure 7.2.2a, b, and c) (Youle, R.J. & Strasser, A. 2007).  The pro-
apoptotic function of Bim is known to be modulated by altered splicing (O’Conner, L. 
et al. 1998). Splicing of these apoptotic molecules may potentially enhance cell 
apoptosis and contribute to the loss of naive T cells in thunder mice. 
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The change in hnRNP LL function caused by the thunder mutation is likely to 
have additional downstream effects on the program of alternative splicing since the 
thunder mutation caused alteration in splicing of a number of splicing regulators 
including Smn1, Sfrs11, Cpsf4, Prpf4b, Ccnl2 and Thrap3,   
 
Differential expression of adhesion molecules is one of the cell surface 
features of memory T cells representing homing capabilities. Several cell adhesion 
molecules were alternatively spliced in memory T cells as well as in Hnrpllthu/thu naive 
T cells. Itga9 (Integrin alpha 9) was recently reported to enhance granulocyte colony-
stimulate factor receptor (CSF-R) signalling (Chen, C. et al. 2006), surprisingly both 
Itga9 and Csf1r (Colony stimulating factor 1 receptor) are alternatively spliced by 
hnRNP LL. This spliced Integrin-CSF signalling pathway may play some roles in 
memory T cell formation. Stab2 (Stabilin-2) has been shown involving in lymphocyte 
adhesion to hepatic sinusoidal endothelium (Jung, M.Y. et al. 2007). Stab2 has a 
striking spliced isoform expression in memory T cells comparing to their naïve 
counterparts (Fig. 7.2.5). The roles of Stab2 splicing in memory T cells remain to be 
elucidated. 
 
CD46 was initially characterised as a complement regulatory molecule on all 
nucleated haematopoietic cells. Recent data suggested that CD46 is also involved in T 
cell proliferation and differentiation (Marie, J.C. et al. 2002; Kemper, C. et al. 2003). 
CD46 expression of alternative spliced isoforms is in tissue-specific manner (Russell, 
S.M. et al. 1992). So, differential spliced CD46 in memory T cells and Hnrpllthu/thu 
naive T cells may contribute to the autonomous transition from the mutant naïve T 
cell to memory phenotype. 
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Another interesting target is Itsn1 (Intersectin 1, SH3 domain protein 1A) (Fig. 
7.2.5). Intersectin 1 (Itsn1) is a multidomain adaptor protein involved in endocytosis, 
regulation of actin polymerization, and Ras/MAPK signaling. It was recently reported 
that ITSN-1 in human cells function as a negative regulator of the mitochondrial 
pathway-dependent apoptosis secondary to activation of the Erk1/2 survival signaling 
pathway. (Predescu, S.A. et al. 2007). Itsn1 ubiquitously expresses a short transcript 
Itsn1-s in mammals comprising two Esp15 homology (EH) domains and five Src-
homology 3 (SH3) domains, whereas the long form Itsn1-l has neuron-specific 
expression with a Dbl-homology (DH) or RhoGEF, pleckstrin homology (PH), and 
putative calcium-interaction domains in the C terminus (Tsyba, L. et al. 2004, 2008). 
There is currently nothing known about the role of Itsn1 in T cells and it remains 
unclear how changes in Itsn1 alternative splicing affects naive and memory T cells. 
 
 
 
 
 
 
 
 
 
 
 
 
192 
CD8
CD4
Adam33 exons and transcripts
CD8
CD4
Kif23 exons and transcripts
Figure 7.2.4  Hnrpll causes some complex splice patterns
CD8
CD4
Tgn exons and transcripts
a.
b.
c.
a. b. and c. Complex patterns of alternative splicing in Adam33, Tgn, 
and Kif23 transcripts.
Smn exons and transcripts
Itsn1 exons and transcripts
CD247 exons and transcripts
Figure 7.2.5  Some other Hnrpll spliced genes of interest
Stab2 exons and transcripts
Itga9 exons and transcripts
Chapter 7.                                                                             General discussion 
 
Concluding Remarks 
 
Transcriptional regulation of gene expression during the course of immune 
reaction and T cell transition from naïve to effector/memory subsets has been well 
studied, but post-transcriptional modifications like alternative splicing have not been 
examined except for a few genes like CD45, CD44, and IL-7Rα in man. 
 
I found that there is higher expression of hnRNP LL in T cells than in B cells, and 
higher expression of Hnrpll in memory T cells compared to naïve T cells. Since the 
heterozygous Hnrpll mutant had a striking effect on CD45 isoforms, this implies that 
induction of Hnrpll coordinates a program of alternative splicing as naïve T cells 
differentiate to the memory cell fate. The use of the Affymtrix exon array technology 
has begun to reveal an unexpected diversity of alternative splicing that occurs 
between naïve and memory T cells. These data revealed that the change in widely 
used CD45 splicing represents just the tip of an iceberg and that hundreds of other 
genes undergo alternative splicing between the naïve and memory T cells and many 
are controlled by hnRNP LL. The exploration for how this mRNA diversity 
contributes to adaptive immunity and T cell memory will be a challenging but 
fascinating problem for future research. Although many differentially spliced genes in 
Hnrpllthu/thu naive / memory T cells were detected by exon arrays I have yet to confirm 
them by other methods such as RT-PCR or quantitative real time PCR. 
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